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4Introduction
By Governor Lowell Weicker, Jr., former three-term U.S. Senator and Governor of Connecticut and
President of the Board of Directors of TFAH
Ten years ago, the September 11th and anthrax tragedies shook the country toour core.
All of us at the Trust for America’s Health (TFAH) wanted to take the anniversary
to remember those we lost and their loved ones — and to commemorate those who
worked tirelessly and heroically to respond and protect us.
This project features first hand accounts from
public health professionals who were pivotal in
the response efforts — and these stories reveal the
selflessness and bravery of these individuals, as
well as illustrating the vital role that public health
plays in protecting the health and safety of Amer-
icans.  We know these memories are tough ones.
The stories range from the steps health officials
took on September 11th in the face of uncer-
tainty to practitioners who diagnosed and
treated anthrax victims to lab directors who
tested thousands of potential anthrax samples
in rapid response time.  
The contribution that public health makes in
preventing, detecting and containing threats is
often overlooked and underappreciated.  
At TFAH, we believe every community in the
United States should be prepared to meet the
threats of bioterrorism, infectious disease out-
breaks and natural disasters.  
In 2001, we experienced the unimaginable.  In
2011, we know we need to expect the unex-
pected.  Over the past decade, we learned a lot of
hard lessons about what it means to be ade-
quately prepared for diseases, disasters and
bioterrorism.  We’ve made smart, strategic in-
vestments, and there’s been a lot of progress to
show for it.  We can be proud of the improve-
ments that have been made.  Of course, there is
a lot left to be done, which will require further ef-
fort and investment.  But, regardless, the field of
public health preparedness was forever changed
10 years ago, and we should never forget why.
The top lesson we learn and relearn in each
tragedy and emergency is that being prepared
means we must sustain enough resources and
vigilance so we can prevent what we can and re-
spond when we have to. 
TFAH would like to extend our thanks to all of the
public health professionals who work unwaver-
ingly to help keep us healthy and safe – and our
thanks to all of the individuals and organizations
who participated in this project, including the
Robert Wood Johnson Foundation, the Associa-
tion of State and Territorial Health Officials, the
National Association of County and City Health
Officials, the Association of Public Health Labo-
ratories, the American Public Health Association,
the U.S. Centers for Disease Control and Preven-
tion (CDC), the Center for Biosecurity of UPMC,
and numerous state and local health officials.  
Photo courtesy of CDC
5n September 11, 2001 — Terrorists crashed planes in New
York City, outside Washington, D.C. and in Pennsylvania. 
n October 2, 2001 — An infectious disease physician recog-
nized a possible case of inhalational anthrax in a man hospital-
ized in Palm Beach County, Florida. This physician contacted
the local health officer in Palm Beach County, who immedi-
ately began a public health investigation. By October 2, there
were already seven persons with cutaneous anthrax in the
northeastern U.S., but none had yet been diagnosed.
n October 4 — The microbiologic diagnosis of B.
anthracis was confirmed by the Florida Department of
Health (FDH) and CDC, and the diagnosis was made pub-
lic. Epidemiologic and environmental investigations were
launched to determine the source of the patient’s anthrax
exposure. Evidence of contamination with B. anthracis was
found at American Media Inc. (AMI) in Boca Raton, Florida,
where this first victim worked as a photo editor.
n October 5 — The first victim of the anthrax attacks died.
A second AMI employee, who had been hospitalized for
pneumonia on September 30, was diagnosed with inhala-
tional anthrax. He was an employee in the AMI mailroom.
nOctober 6 — The Palm Beach County Health Department
began to obtain nasal swabs from those who had been in the
AMI building in an attempt to define exposure groups. Because
nasal swab testing was known to be an insensitive diagnostic
test, the health department also recommended prophylactic
antibiotics for all those people who had been in the AMI build-
ing for at least one hour since August 1 regardless of the results
of their nasal swab tests. Environmental samples taken from
the mailroom showed evidence of B. anthracis.
n October 7 — A nasal swab was positive on another em-
ployee. A swab from the first victim’s computer screen was
positive. The AMI building was closed.
n October 9 — The New York City Department of Health
notified CDC of a woman with a skin lesion consistent with
cutaneous anthrax. The woman, an assistant to NBC an-
chor Tom Brokaw, had handled a powder-containing letter
postmarked September 18 at her workplace.
n October 13 — Another cutaneous case of anthrax was
recognized in a 7-month-old infant who had visited his
mother’s workplace, the ABC office building on West 66th
Street in Manhattan, on September 28.
n October 13 — Symptoms of cutaneous and inhalational
anthrax in New Jersey postal workers began to be ob-
served and reported by physicians to the New York City
Health Department. Diagnoses of anthrax were confirmed
by CDC on October 18 and 19.
n October 15 — A staff member in the office of Senator
Daschle in the Hart Senate Office Building opened a letter
(postmarked October 9) which contained a powder and a
note identifying the powder as anthrax. The powder tested
positive for B. anthracis on October 16. Nasal swab testing
of anthrax spores was performed on 340 Senate staff mem-
bers and visitors to the building who potentially were ex-
posed and to approximately 5,000 other people who
self-referred for testing. This testing indicated exposure in
28 persons. Antimicrobial prophylaxis was administered on
a broader scale and environmental testing was initiated.
n October 19 — CDC linked the four confirmed cases of
anthrax to “intentional delivery of B. anthracis spores
through mailed letters or packages.”
n October 19–22 — Four postal workers at the Brentwood
Mail Processing and Distribution Center in the District of
Columbia were hospitalized with inhalational anthrax. The
Brentwood facility was closed on October 21. On October
22 two of these four postal workers died.
n October 24 — CDC sent an advisory to state health offi-
cials via the Health Alert Network recommending antibiotic
prophylaxis to prevent anthrax for all people who had been
in the non-public mail operations area at the U.S. Postal
Service’s Brentwood Road Postal Distribution Center or
who had worked in the non-public mail operations areas at
postal facilities that had received mail directly from the
Brentwood facility since October 11.
nOctober 27 — A CDC alert recommended antibiotic pro-
phylaxis for workers in the mail facilities that supplied the CIA,
the House office buildings, the Supreme Court, Walter Reed
Army Institute of Research, the White House, and the South-
west Postal Station after preliminary environmental sampling
revealed B. anthracis contamination in these mailrooms.
n October 31 — A 61-year-old female hospital stockroom
worker in New York City died from inhalational anthrax
after she had become ill with malaise and myalgias on Octo-
ber 25. The source of her exposure remains unknown de-
spite extensive epidemiologic investigation.
n November 16 — A 94-year-old woman residing in Ox-
ford, Connecticut, was hospitalized with fever, cough, and
weakness. She died on November 19. Her diagnosis was
confirmed as B. anthracis on November 20 by the Con-
necticut Department of Public Health Laboratory. Subse-
quent environmental and epidemiological testing indicated
exposure from cross-contaminated letters. 
Sources: Centers for Disease Control and Prevention. Update: Investigation
of Bioterrorism-Related Inhalational Anthrax — Connecticut, 2001, Morbidity
and Mortality Weekly Report 11/30/01: 50(47):1049–1054.  And, “Anthrax
2001: Observations on the Medical and Public Health Response” Elin Gursky,
Thomas V. Inglesby, and Tara O’Toole
Biosecurity and Bioterrorism. Volume 1, Number 2, 2003. © Mary Ann Liebert, Inc.
Reprinted with permission. (http://www.upmc-biosecurity.org/website/resources/
publications/2003_orig-articles/2003-06-15-anthrax2001observations.html)
CHRONOLOGY OF KEY EVENTS FOLLOWING THE ATTACKS
Summary of the Investigation into the
Anthrax Attacks
In September and October 2001, at least five envelopes containing Bacillus anthracis(anthrax) were mailed to Senators Patrick Leahy and Thomas Daschle and to
members of the media in New York City and Boca Raton, Florida. The specific strain
which infected individuals was known as Ames – it was isolated in Texas in 1981 and
transferred to the United States Army Medical Research Institute of Infectious
Diseases (USAMRIID). No other natural outbreak of Ames has ever been recorded.
After the bioterrorist attacks were identified, the
Federal Bureau of Investigation (FBI) and the
United States Postal Inspection Service (USPIS)
formed a task force to investigate the crime. The
investigation lasted seven years and was under-
taken by FBI field offices in Miami, New York,
Newark, New Haven, Baltimore and Washing-
ton, D.C. At the beginning of the investigation,
the limitations on scientific analysis prevented
the task force from finding the culprit because it
was impossible to determine precisely which
spores the anthrax came from.
Early investigative efforts focused on genetically
classifying the spores and tracking the envelopes
used in the attack. However, it was slow going be-
cause the laboratory tests required to analyze
the spores had to be created and subsequently
validated. Furthermore any traditional forensic
protocol for examining evidence was difficult
since the letters were contaminated.
While the tests were being developed, validated
and implemented, the FBI created likely profiles
of the offender(s), which included scientific
ability, access to the Ames strain, proximity to
where the letters were mailed, any suspicious be-
havior, public tips and motive. 
At first, Dr. Steven J. Hatfill became a person
of interest because people came forward who
suspected that he might be involved. Dr. Hat-
fill worked for USAMRIID from 1997-1999
and had unrestricted access to the Ames
strain. In 2001, Dr. Hatfill had filled multiple
prescriptions for Cipro, the only U.S. Food
and Drug Administration (FDA) approved
drug to treat anthrax. In addition, he was well
versed in the intricacies for dispersing anthrax
via mail.  However, the Cipro was also consis-
tent with treatment of an infection Dr. Hatfill
had at the time and knowledge of anthrax dis-
semination was commonplace among those in
the bio-defense community of which Dr. Hat-
fill was a member. 
In 2007, after scientific spore analysis was devel-
oped specifically for the case, it was established
that RMR-1029 was the parent material to the
anthrax used in the attacks. This exculpated Dr.
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l 9/17-9/18/01 
Letters to New York Post
and Brokaw mailed
sometime between 5 p.m.
on 9/17 and noon the
following day.
l 9/18/01 
Letters to New York Post
and Brokaw postmarked
in Trenton, NJ.
l 10/3/01 
Robert Stevens 
(AMI employee in Boca
Raton, FL) diagnosed 
with pneumonia; rod-
shaped bacteria consistent
with anthrax noted in
medical report.
l 10/4/01 
Announcement made that
Stevens had contracted
anthrax.
l 10/5/01 
Stevens died from
inhalational anthrax in
Boca Raton, FL.
l 10/6-9/01 
Letters to Senators
Daschle and Leahy mailed
sometime between 3 p.m.
on 10/6 and noon three
days later.
l 10/9/01 
Letters to Senators
Daschle and Leahy post -
marked in Trenton, NJ.
TIMELINE OF THE ANTHRAX ATTACKS
Hatfill as he never had access to the bio-con-
tainment suites at USAMRIID that held RMR-
1029, meaning he never could have obtained
the specific spore batch used in the anthrax at-
tacks. Eventually the FBI settled with Dr. Hatfill
for $4.6 million.
This discovery helped narrow the search to
those who were at the USAMRIID lab where
RMR-1029 was stored between September 11
and 18, 2001 and October 1 and 8, 2001. Inter-
views, polygraphs, laboratory notebooks and
records analysis, home and computer searches,
and other investigative efforts established Dr.
Bruce E. Ivins, who worked at the USAMRIID, as
a person of interest.   
According to the FBI report, Dr. Ivins was alone
in the lab late at night and on the weekends im-
mediately preceding when the letters were
mailed. He had never before exhibited this work
pattern, never did so after the attacks and was
unable to give a legitimate explanation for why
he kept those hours. Also, as the investigation
continued, the investigators found that Dr. Ivins
suffered from psychological problems. 
The investigation was undertaken in a covert
manner until the fall of 2007. At that point,
agents obtained search warrants for his home,
cars and office. On November 1, 2007, the FBI
searched his property and found 20 years of let-
ters Dr. Ivins had sent to Congress and the news
media, three handguns, two stun guns, a taser
and other suspicious items. 
On July 12, 2008, Dr. Ivins’ home was again
searched because he had made threats in a
group therapy session. They found a bullet-
proof vest, a homemade reinforced body armor
plate, hundreds of rounds of ammunition and
handgun powder. In addition, the investigation
noted that Dr. Ivins had boasted about his abil-
ity to create highly pure batches of anthrax. 
The investigation concluded that Dr. Ivins had
the opportunity, motive (based on e-mails and
statements to friends), mental health problems,
proximity to where the letters were mailed, a
similarity in language to the letters, conscious-
ness of guilt (he decontaminated his office and
failed to report it), an inability to explain his be-
havior when confronted with evidence, and ob-
sessive behavior. During the investigation, it was
found that, dating back 40 years, Dr. Ivins had
been obsessed with the Kappa Kappa Gamma
(KKG) sorority. Many times, he would drive sev-
eral hours to visit various sorority chapters. The
letters were all mailed outside of an office build-
ing that housed a KKG sorority. 
In the summer of 2008, authorities began to
seek an indictment charging Dr. Ivins with the
use of a Weapon of Mass Destruction. Before he
was charged, Dr. Ivins committed suicide. The
investigation concluded by confirming that Dr.
Ivins was the guilty party. 
7
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l 10/12/01 
Letter to Brokaw
recovered by FBI.
l 10/15/01 
Letter to Senator Daschle
opened in Hart Senate
Office Building.
l 10/19/01 
Letter to New York Post
discovered and recovered.
l 10/21/01 
Thomas Morris died
(Brentwood Postal Facility
employee in Washington,
D.C.).
l 10/22/01 
Joseph Curseen, Jr. died
(Brentwood Postal Facility
employee in Washington,
D.C.).
l 10/31/01 
Kathy Nguyen died (New
York City, NY).
l 11/16/01 
Letter to Senator Leahy
discovered and recovered.
l 11/21/01 
Ottilie Lundgren died in
Connecticut (believed to
be the result of cross-
contaminated mail).
Source: DOJ Paper (http://www.justice.gov/amerithrax/docs/amx-investigative-summary.pdf): Amerithrax investigative
Summary, released pursuant to the Freedom of Information 
At least 22 victims contracted anthrax, with five
people dying from the infection. In addition, 31
people tested positive for exposure to anthrax
spores and 10,000 more people were deemed at
risk from possible exposure. 
In all, 35 post offices and mailrooms were con-
taminated along with seven buildings on Capi-
tol Hill in Washington, D.C. 
The investigation included over 600,000 investi-
gator hours, 10,000 witness interviews, 80
searches and over 6,000 pieces of evidence. In
addition, there were 5,750 federal grand jury
subpoenas issued and 5,730 environmental sam-
ples collected from over 60 sites. The investiga-
tion cost $100 million.
Nevertheless, the investigation never produced
real forensic evidence that proved how Dr. Ivins
made the spores and weaponized them.
While Dr. Ivins had access to RMR 1029, some
co-workers said that others at the facility or po-
tentially even outside visitors could have had ac-
cess to the stock.
In July, 2011, Justice Department lawyers filed
court papers that said Dr. Ivins lacked access to
the equipment required to actually produce
weaponized powder. 
Justice Department civil lawyers wrote in a July
15 filing that “the sealed area in Bruce Ivins’ lab
did not contain the equipment needed to turn
liquid anthrax into the refined powder that
floated through congressional buildings and
post offices in the fall of 2001.” 
However, just four days later, Justice Department
lawyers revised the filing to say Dr. Ivins merely
lacked access in his specific lab to the required
equipment, noting that the filing should have
said, “while the Army lab did not have a
lyophilizer, a freeze-drying machine, in the
space where Dr. Ivins usually worked, there was
a lyophilizer and other equipment in the build-
ing that he could have used to dry the anthrax
into powder,” according to the New York Times in
a July 19 story.
In its revision, the Justice Department contends
the original filing was mistaken and Dr. Ivins had
access to the equipment at the facility. 
According to Justice Department Spokesman
Dean Boyd, as noted in a ProPublica story on
July 20, the government has “never wavered
from the view that Dr. Ivins mailed the an-
thrax letters.”  
Sources: 
n DOJ Paper (http://www.justice.gov/
amerithrax/docs/amx-investigative-sum-
mary.pdf): Amerithrax investigative Sum-
mary, released pursuant to the Freedom of
Information Act, Friday February 19, 2010
n New York Times, http://www.nytimes.com/
2011/07/20/us/20anthrax.html?_r=1 July
19, 2011, Scott Shane: “U.S. Revises Its Re-
sponse to Lawsuit on Anthrax”
n ProPublica: Government Anthrax Flip-Flop
Could Boost Victims’ Lawsuit July 20, 2011
http://www.propublica.org/article/anthrax-
lawsuit-victims-lawsuit
n Justice Department Court Filing:
https://www.documentcloud.org/
documents/217092-doc-154-1.html 
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Public Health Response to Terrorism
and Bioterrorism: Inventing the Wheel
By Dan Hanfling, MD, Special Advisor on Emergency Preparedness and Disaster Response to the Inova Health
System; Board Certified Emergency Physician 
On the cloudless, blue sky morning of September 11, 2001, I was driving toChantilly, VA to the National Reconnaissance Office (NRO) to give a
presentation to their facility leadership on steps to take to protect workers in the
event of a terrorist attack. Drawing upon some of my experiences as a medical team
manager for the Fairfax County, Virginia Urban Search and Rescue team, my intent
was to focus on some of the simple steps everyone can take to better prepare
themselves to respond to a disaster.
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It was a beautiful day. Later, I was going to meet
my wife at her office at the National Academy of
Sciences (right across the street from U.S. De-
partment of State) for lunch. When I got to the
NRO at 9:30 am, less than an hour after the at-
tacks began, the gates to the facility were closed
and there was a guard standing out front with
the biggest machine gun I had ever seen. 
He lifted it towards my car. The guard was quite
adamant about me turning my vehicle around.
I kept asking him why and finally he shouted
“because the U.S. is under attack.” I thought I
was in a movie. 
I pulled my car over, turned off the Grateful Dead
and dialed in the radio to WTOP. I also picked up
my pager, which was flashing from a dozen missed
pages, and heard the first reports of an attack on
the Pentagon. Immediately, I made a beeline back
to the hospital, knowing I would have to oversee
implementation of the hospital emergency oper-
ations plan, and thinking I might be activated for
search and rescue. This was the first and only time
in the three years I had served as the operational
medical director of Fairfax County Fire and Res-
cue Department that I put the “Kojak” light on
top of my car. On the way, I spoke with hospital
officials to activate the disaster plan. 
As I continued my drive towards the Inova Fairfax
Hospital with the news on, I heard the report of
a bomb at the State Department. It was surreal, it
seemed there was chaos everywhere and every-
one was in danger. My immediate thought was —
that’s exactly where my wife parks her car, directly
across the street from the front entrance of State.
While I was scared for her safety, and I thought
about our little kids in school, I knew there was lit-
tle I could do about what I had just heard. So I
focused on the task at hand. Around noontime I
was picked up by a first responder and hurriedly
driven down to the fire station where the search
and rescue team was assembling. Soon thereafter,
we were at the Pentagon and our team members
were making entry into a building that was on fire
and had already collapsed.
Over the course of the next couple of hours, it
became clear that it was going to be a recovery
mission…that there wouldn’t be any more sur-
vivors. The hardest phone call I ever had to
make was to the hospital telling them to stand
down the emergency response. I know it was an
incredibly hard call to receive. 
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I didn’t learn until later that afternoon that
there hadn’t been a bomb at the State Depart-
ment. There had been a kitchen fire that morn-
ing which prompted a fire department response,
and the mistaken news report regarding an ex-
plosion. I was also able to make a quick call to my
wife, who told me she needed two hours to com-
plete what is normally a 20 minute commute
home. It was a great relief to know she was safe. 
Over the next few days, we stabilized the Penta-
gon and shored-up the many support columns
that had been wiped out. We worked inside an
unbelievably dangerous tangle of debris, metal,
fire, smoke and water — it was like Dante’s In-
ferno. But we made important discoveries. We
found the black box and located information on
some of the hijackers. We also recovered a num-
ber of bodies, helping to bring closure to many
families whose lives were tragically upended on
that September morning. 
I felt incredibly fortunate to have the ability to
contribute at a time of utter helplessness. It was
important for me to be there and to be able to
do something. 
n
On October 2, 2001, Robert L. Stevens was ad-
mitted to a hospital in Palm Beach County,
Florida after a camping trip to North Carolina.
Two days later, he was diagnosed with inhala-
tional anthrax. Shortly thereafter, Health and
Human Services Secretary Tommy Thompson
said it was an isolated case that he probably con-
tracted while on a camping trip.
I was seeing patients in the emergency department
at Inova Fairfax when Secretary Thompson’s news
conference was broadcast live on CNN. At the
time, I didn’t think this sounded right. When I fin-
ished my shift, I put together a one-page primer
on anthrax detailing what it is, how it presents clin-
ically, what the initial treatments would be, and
what it might look like on a chest x-ray and CT
scan. I faxed it to all of the hospitals within the
Inova Health System and also to my colleagues at
the fire department. I wasn’t taking any chances.
On October 15, a letter containing anthrax was
opened in the office of Senator Tom Daschle,
located in the Hart Senate Office Building. A
few days later, on October 19, the first of what
would become hundreds of patients with con-
cerns of anthrax exposure came to our emer-
gency department seeking care. The patient’s
chief complaint was that he thought he might
have been exposed to anthrax. 
The Emergency Department physician on duty
that evening, Dr. Cecile Murphy, did what all great
clinicians do — she listened to the patient. When
he diagnosed himself with anthrax, he did so be-
cause he knew his body and something didn’t feel
right — his chest felt strange. So Dr. Murphy
asked typical questions like “where do you work?”.
The patient said he delivered mail from the
Brentwood postal facility. At that time, Brent-
wood had no special meaning to anyone. Still,
Dr. Murphy asked where the bulk of the mail
eventually ended up. The patient answered that
most of it goes to the Senate. In hindsight it
seems pretty apparent what was going on.
However, at that point in time, the Centers for
Disease Control and Prevention (CDC) was very
clear that unless you were in the Hart Senate Of-
fice Building, SE Wing, 5th or 6th floor, between
the hours of 9:00 am and 7:00 pm on October
15, you had nothing to worry about.
The good news is that most patients don’t read
textbooks and many doctors don’t read CDC
alerts. What we knew of anthrax, we heard on
WTOP. Thankfully, our doctors also convinced
us that we couldn’t believe everything published
in the Morbidity and Mortality Weekly Report
because, based on what CDC had provided as
guidance, our patients wouldn’t have been in
the high risk group.
So Dr. Murphy pursued the case further. She did
an x-ray which just didn’t look right, and then
followed that up with a chest CT Scan that was
demonstrable for the telltale sign of inhalational
anthrax — a widened mediastinum. Sure
enough, it was clear as day that the patient was
suffering from inhalation anthrax. 
The first call Dr. Murphy made was to the D.C.
Department of Health, because she was watch-
ing the news and knew D.C. was dealing with this. 
At the time, there was limited guidance on the
management of a bioterrorist attack.  Treatment
protocols for anthrax were tucked away in jour-
nal articles sitting in the hospital library. And no
effective means for managing the multitudinous
information that was beginning to ripple across
the healthcare community was in place. 
Later that same night, another of our emer-
gency department physicians, Dr. Denis Pauze,
took care of another postal worker from Brent-
wood. He came in because he had the worst
headache of his life — which, in the ER, triggers
an automatic workup for a leaking aneurysm.
He had a normal Head CT scan and a normal
spinal tap. Still, he didn’t look right, so Dr.
Pauze did a chest X-ray which was borderline ab-
normal. He followed this up with a chest CT
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scan, given that the patient told him he was a
postal worker from Brentwood (and, by that
time, the words ‘anthrax’ and ‘Brentwood’ were
echoing throughout our large, suburban emer-
gency department like a rifle volley on a firing
range). The scan was abnormal, just like the pre-
vious case, and all of a sudden, Inova Fairfax had
two diagnosed cases of inhalation anthrax sitting
in our emergency department. In short, we were
inventing the wheel. This wasn’t reinventing the
wheel, because virtually no clinicians in the
United States had faced this before. 
We realized there was no cavalry coming to sort
things out, and that we would have to manage
most of this ourselves. Part of what contributed
to the difficulty in coordinating our efforts was
due to what we sometimes call the ‘Potomac
Ocean’ effect — even though the three surviv-
ing cases were in Northern Virginia (we helped
contribute to the diagnosis of the third case of
inhalational anthrax in a postal worker from the
Federal mail facility in Sterling, VA), all the
media attention was essentially focused on D.C.
Indeed, even the 9/11 attacks took place in
northern Virginia, not D.C.
We created our own treatment protocols and
put together an ad-hoc communication infor-
mation management system that reached all
Northern Virginia hospitals. It was very impor-
tant that we coordinate these emerging proto-
cols with our public health colleagues in the
Fairfax County Health Department. Late nights
on the phone with Dr. Carol Sharrett and Dr.
Gloria Addo-Ayensu produced templates for
screening patients, offering prophylaxis coun-
termeasures, and suggesting basic risk commu-
nication statements for our regional hospitals to
use. We did this under the joint imprimatur of
Fairfax County and Inova Health System. And
like many in the region, we participated in the
gazillion conference calls held to discuss and
share information about the emerging and rap-
idly evolving event, and passed this information
along to the rest of the hospitals in our region. 
We made clinical decisions on the management
of the anthrax cases by committee and involved
infectious disease and intensive care doctors.
While I helped to contribute to a number of
these early discussions, I turned my attention to
creating the systems needed to manage the on-
going bioresponse event — essentially to invent
the wheel. Along with colleagues in emergency
medicine from across northern Virginia, we cre-
ated the Northern Virginia Emergency Re-
sponse Coalition (NVERC), one of the first
healthcare coalitions in the country, and the
model for much of what HHS/ASPR has en-
couraged in the years since these awful attacks.
In October 2002, the NVERC was formally re-es-
tablished as the Northern Virginia Hospital Al-
liance, governed by the CEOs of the northern
Virginia hospitals who comprise its Board of Di-
rectors. In the 10 years since the attacks, this
group has never failed to have a quorum of par-
ticipants, which demonstrates the absolute com-
mitment to emergency preparedness by the
healthcare system leadership in our community.
We have evolved these efforts into a much
stronger community of emergency responders
in the decade since the attacks, coordinating
closely with, not only our public health col-
leagues, but those in public safety and emer-
gency management.
September and October 2001 was a frenzied and
chaotic time in the history of our country. These
successive attacks stretched thin all aspects of
the public health system. 
As an emergency physician who was deep in the
trenches in the fall of 2001, I can tell you that
the entire public health community was dealing
with a world that was turned upside down. It was
clear to me that emergency physicians and
nurses were now on the frontlines of the public
health response in this new age of catastrophe,
terror and fear.
In short, emergency physicians and nurses have
become the operational lynchpin of our new
focus on public health emergency preparedness.
While the emergency department has long com-
prised a significant portion of the public health
safety net, providing equal access to all who seek
care, we now find ourselves in the added role of
community protector. And it doesn’t stop at the
emergency room threshold. In fact, hospital staff
have become the ‘new first responders’ or what
has now been termed ‘first receivers.’ We are all
essential personnel in the continued struggle to
keep our communities safe and healthy.
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No News Wasn’t Good News
By Jack Herrmann, MSEd, NCC, LMHC, Senior Advisor, Public Health Preparedness, National Association of
County and City Health Officials (NACCHO)
It is hard to believe that 10 years have gone by since September 11, 2001. In mymemory, it feels like yesterday because I can recall the events vividly. That day and
the work I did in the days, weeks and months afterward shaped my life in many ways. 
When you think about public health and re-
sponses to natural or manmade tragedies, you
think about the physical destruction these events
leave on communities. However, the mental
health impact from disasters is also incredibly im-
portant to consider. I began my disaster relief re-
sponse work in 1993 with the American Red Cross
and was deployed to my first large scale disaster in
1994, the Northridge, CA earthquake. I had seven
years of disaster response under my belt before
9/11 and knew firsthand the importance of an in-
tegrated behavioral health response.
What I wasn’t ready for was how the events of
September 11th would transform my own un-
derstanding of terrorism as well as those of most
everyone in our country.
At the time of the attacks, I was the New York
State Disaster Mental Health Volunteer Lead for
the Red Cross and in that leadership role re-
sponsible for working with Red Cross chapters
across the state recruiting and training disaster
mental health responders. At the moment the
first tower was struck, I was in an aviation disas-
ter exercise planning meeting with city and air-
port emergency management officials at the
Greater Rochester International Airport in up-
state New York.  As we watched news footage of
the events, the second plane struck the World
Trade Center towers. I immediately called the
NY State Red Cross Disaster Lead and received
instructions to deploy to New York City. I rented
a van, went to the local Red Cross chapter to
gather supplies, packed a few personal items
and began my drive downstate. 
Ultimately, I fell into a caravan of state officials
and other responders who were deployed to the
city as well. Normally a trip that would take five
hours was accomplished in three. Having to stop
mid-way through my drive, I was separated from
the caravan. A short time later I continued my
trip and eventually had the city in sight.  I was
struck by the absence of two of New York City’s
most well known landmarks replaced by a land-
scape of billowing gray-black smoke.  I ap-
proached the Holland tunnel on the New Jersey
side, which was secured by the National Guard.
After verifying my identification and seeing I was
with the Red Cross, they allowed my van through
— it was a surreal moment being the only per-
son in the tunnel, a transportation landmark
that typically sees thousands of cars traveling
through it each day. 
As I emerged out of the tunnel into lower Man-
hattan I made my way up the westside to the New
York City Chapter of the Red Cross.  Crawling my
way up, I was driving over fire hoses and the debris
from the fallen towers.  At one point I passed close
enough to see the rubble from the buildings and
the continuing fire and smoke. At that moment I
thought to myself: “what could I possibly do, as
one volunteer, in response to this massive event?”
The thought wasn’t with me for long as I was de-
termined to do what I was trained to do. I
needed to get to the Red Cross chapter and
begin to coordinate our disaster mental health
response.  I arrived at the Chapter and was
struck by the thousands of people standing in
line.  Many of them were waiting to donate
blood, make a monetary donation, or lend their
hand to the response.  I entered the Chapter,
found the Emergency Services leader, and was
briefed on what had transpired and their initial
response plan.  Throughout the rest of that day
and into the first night I provided psychological
support to Red Cross personnel that responded
immediately to the scene after the first plane
struck the tower, many of whom found them-
selves running for their lives when the buildings
began to collapse.  I also worked with the staff
to coordinate the recruitment and selection of
volunteers that would ultimately provide psy-
chological support to victims and their families
in the days and weeks to come.
At 4:00 a.m. on September 12, I and my Red
Cross colleagues were called to a meeting with
representatives from the New York City Mayor’s
office to review the plan for opening a Family
Assistance Center later that morning.  This Cen-
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ter would be the first stop for many that were in
search of the whereabouts of their family and
friends who had still not returned home after
the buildings collapsed.
Initially the plan was to stand up the Assistance
Center at New York University Medical Center,
but the proposed auditorium could realistically
only accommodate 350 people. We knew this
would be grossly insufficient — as we were ex-
pecting thousands of people in a matter of hours.
It was announced that the center would open at
8:00 a.m., and by 6:00 a.m. there were thousands
of people in line. We filled the first few hundred
seats and began our work. Families were led to
rooms to meet with representatives of the New
York City Police Department and Medical Ex-
aminer’s Office.  Many were unprepared for the
extensive and at times traumatic questions that
would be asked of them. For this reason we also
made sure we had mental health and spiritual
care volunteers available to support these fami-
lies through this process. We also posted these
professionals outside to walk up and down the
line of those waiting to enter the Center.
Because of the volume of people arriving to the
center, we quickly ran out of space and later that
day needed to relocate to another site. By the
second day, those who had loved ones in the
World Trade Center Towers likely already had
their loved ones safely at home with them or
knew of their whereabouts. Those that contin-
ued to show up at the center were not so fortu-
nate and as the days progressed the pervading
sentiment was “no news wasn’t good news.” 
Over the ensuing five days, we moved the Fam-
ily Assistance Center three times before settling
into its permanent location at Pier 94 located on
Manhattan’s westside and the Hudson River. 
The two weeks of my deployment and the sub-
sequent year that I spent traveling back and
forth from my home in Rochester to New York
City, left an indelible mark on me.  While my ini-
tial role was to coordinate the mental health re-
sponse to this tragic event and provide
emotional support to Red Cross volunteers and
the families of those who died in the towers, my
subsequent role was to work with City and Red
Cross officials to plan for how to address the
short and long-term psychological aftermath of
this catastrophic incident.
The psychological impact I knew was big not
only for those directly involved, but for people
like myself that were called to respond. I had
been involved with disaster work before, but I
never fully appreciated the emotional impact
that disasters, such as acts of terrorism can have,
even on the most experienced disaster response
professionals. This was a real awakening of my
own vulnerabilities.
Professionally, it became clear how important it
is to prepare and train individuals to work in a
disaster environment. Frankly, one of the most
challenging situations of managing the response
to 9/11 was managing the staff, their frustra-
tions and grief, and their expectations for what
role they would play in this response. In addi-
tion, there were thousands of mental health pro-
fessionals that wanted to help. While many were
well- intentioned, few were truly prepared for
the roles they would take on as a volunteer.
These were unprecedented times that, in many
ways, many of us still find ourselves recovering
from.  On this, the 10 year anniversary, it has left
us reflecting on where we were at the time, what
contribution we made to helping those directly
impacted by this tragic event, and wondering
what would happen if something similar hap-
pened again. For those of us who are disaster re-
sponse leaders, it reinforces the importance of
building a robust and prepared nation — re-
cruiting, training and sustaining a workforce,
both volunteer and paid, that has the capability
to be at the right place, doing the right things,
at the right time.
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Questions/Answers: 
2001 Anthrax Attacks
Anthony S. Fauci, M.D., Director, NIAID/NIH
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Looking back after ten years, what stands out
to you most about the 2001 anthrax attacks? 
What stands out most to me about the 2001 an-
thrax attacks is the notion that from that point
on, bioterror was a reality and no longer an ab-
stract concept.  Although discussions had been
under way among public health officials in
preparation for such an event, and our National
Institute of Allergy and Infectious Diseases
(NIAID) had a limited research portfolio in the
area, the attacks really were a wake-up call.  
Looking back, I am also struck by the uncer-
tainty we all felt at the time.  
Today, we know and can dispassionately de-
scribe exactly what happened.  We know that
of the people potentially exposed to anthrax
in 2001, 22 people were infected, five of whom
died.  We know now that the attacks were un-
likely a concerted effort by a group or organ-
ization intended to broadly affect our society
and large numbers of people.  We know that
the attacks likely stemmed from the actions of
a single individual who was probably mentally
unstable.  Today we know the anthrax attacks
had a relatively limited and short-lived impact
in terms of morbidity and mortality.  
However, at the time the entire event was sur-
rounded by uncertainty.  No one had any idea
who perpetrated the anthrax attacks or what the
extent of their impact would be.  With the tim-
ing of the anthrax attacks coming only weeks
after 9/11, the uncertainty was accompanied by
a gripping fear of what might happen next.
People worried as they rode the Metro or
shopped for their groceries that something un-
known and unexpected would happen again,
and that they and their families were at risk.  
How would you characterize the overall re-
sponse to the attacks?  What were the biggest
challenges you faced?  
I had a dual perspective as a scientist and sci-
ence administrator and as a government
spokesperson.  As a scientist and science ad-
ministrator, I headed the effort at NIH to fund
and conduct biomedical research to develop
countermeasures to protect people against a
range of potential agents of bioterrorism. In ad-
dition, I served as one of the primary spokesper-
sons for the Federal government, which in-
volved providing the public with information
about what we knew and did not know as the sit-
uation unfolded day by day.  As a spokesperson,
it was important for me to provide information
in a way that would help calm public fears.
The overall response from a biomedical coun-
termeasures standpoint was good, though not
perfect, especially given the fact that this was new
ground for us.  The situation had been discussed
and planned to an extent, but never tested.  
I would describe the overall response as a
“leaping into action” on the part of scientists
and public health officials.  We quickly
brought together leading scientific experts
and developed two important paths forward:
the NIAID Strategic Plan for Biodefense Re-
search and the NIAID Biodefense Research
Agenda for CDC Category A Agents, a docu-
ment that describes the Institute’s accelerated
research plan for the most threatening bioter-
rorism agents.  These were developed within
five months after the anthrax attacks — and
have since been used as a starting point for up-
dates and progress reports for the future.
We asked the important questions in ways that
I think were calm, measured, and scientific:
Are there enough antibiotics? If not, why not,
and how do we procure more?  Where do we
stand with regard to vaccines?  Should we
scale-up existing countermeasures? Do we
need new countermeasures?  Are there coun-
termeasures on the horizon that will help us
Photo courtesy of CDC
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achieve our goals or not?  How do we develop
new countermeasures?  What are the readily
available options, and what is missing?
Without a doubt, the biggest challenge we
faced was to separate the science from the hys-
teria. We had to ensure that our focus re-
mained on rational planning and on
determining the most appropriate, scientifi-
cally based actions at the time.  
What are you most proud of about the anthrax
response? 
One of the things I am most proud of is the fact
that we were able to put the situation into per-
spective and maintain our focus on the scientific
and public health issues that we were con-
fronting.  We understood at the time that anthrax
would not be the end of the story — that pre-
paredness and development of biomedical coun-
termeasures should not stop with anthrax.  The
response to the anthrax attacks morphed into a
much broader effort that encompassed not only
preparedness for anthrax and other potential de-
liberate biothreats, but also for naturally emerg-
ing and re-emerging infectious diseases that
threaten both public health and national security.  
In this regard, we decided to build basic and
translational science capacity, and the intellec-
tual and physical infrastructures to develop bio-
medical countermeasures in response to a
broad range of deliberate and naturally occur-
ring emerging and re-emerging infectious dis-
eases.  We were able to convince government
officials that even though we need to address
individual agents, nature is the worst bioter-
rorist.  Through the anthrax response, we built
both a physical and an intellectual infrastruc-
ture that can be used to respond to a broad
range of emerging health threats. 
The result is that today we are in a much better
position — from the perspective of both the re-
search pipeline and public health prepared-
ness — than we would have been had we
addressed anthrax alone.  Our improved ability
to respond to emerging health threats was re-
flected in subsequent years as we addressed
SARS, the threat of H5N1 influenza, and the
2009 H1N1 influenza pandemic.
What would you like to have been in place at the
time that would have improved the response?  
At the time, I would have liked to have had
biotechnology and pharmaceutical companies
experienced in infectious disease countermea-
sures research, development, and production
already invested in responding to unexpected
public health threats — rather than having to
build that investment from scratch.  Before the
anthrax attacks, industry was reluctant to de-
velop biomedical countermeasures for an un-
predictable market.
What were the biggest challenges or gaps at the
time?  How have those changed or been ad-
dressed during the past decade?
Major gaps existed in at least two areas.
First, there were major gaps in the science.
There were fundamental gaps in basic research
as well as in applied science with regard to vac-
cines, diagnostics, and therapeutics to respond
to unexpected infectious disease emergencies.  
Second, we did not have a clear public health
response system in place for handling unex-
pected public health emergencies.  Before, we
were completely dependent upon pharmaceu-
tical companies, which based their strategies on
products for which there were predictable mar-
kets.  The challenge was getting industry to in-
vest in biomedical countermeasures for public
health threats with unpredictable timelines.
Since the anthrax attacks, we have made sub-
stantial and wise investments to address these
gaps.  Selected examples include:
n The NIAID National Biocontainment Labo-
ratories (NBLs) and Regional Biocontain-
ment Laboratories (RBLs) provide high-level
biocontainment facilities for research on
biodefense and emerging infectious diseases.
The biosafety labs also are available in the
event of a bioterrorism or infectious disease
emergency to assist national, state, and local
public health efforts.
n The NIAID Regional Centers of Excellence
(RCE) for Biodefense and Emerging Infec-
tious Diseases supports research focused on
countering threats from bioterror agents
and naturally emerging infectious diseases.
Each Center is comprised of a consortium of
universities and research institutions serving
a specific geographical region.
n The Biomedical Advanced Research and
Development Authority (BARDA), within the
HHS Office of the Assistant Secretary for
Preparedness and Response, helps address
the need for chemical, biological, radiological
17
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and nuclear (CBRN) countermeasures by
assisting the development and purchase of
vaccines, therapeutics, and diagnostics for
public health emergencies.
n Project BioShield, managed by BARDA,
helps enable procurement and advanced de-
velopment of medical countermeasures for
CBRN agents, as well as for pandemic in-
fluenza and other emerging infectious dis-
eases. BARDA also manages the Public
Health Emergency Medical Countermea-
sures Enterprise (PHEMCE).
n The NIAID Concept Acceleration Program
(CAP) enables coordination of teams of sci-
entific, medical and product development
experts to guide investigators working on
multi-use medical products for biodefense,
drug resistance and emerging diseases with
the goal of nurturing promising concepts
that might otherwise not be pursued. 
If there were another anthrax attack today, how
would the response be different from 2001?
Things are very different today.  Without ques-
tion, if there were another anthrax attack today,
our response would be significantly more coor-
dinated.  Today we have the Office of the Assis-
tant Secretary for Preparedness and Response
(ASPR), a major component of HHS.  The title
of this office reflects something we did not have
before, a “preparedness and response” focus.
Now we have a coordinated multi-agency effort
that is plugged into the intelligence community,
the Department of Homeland Security and, im-
portantly, the scientific community.  To under-
score this point, the 2009 influenza pandemic
demonstrated a substantially more coordinated
public health response than we experienced
after the anthrax attacks.  
What are the biggest threats and challenges to
bioterrorism preparedness today?
The biggest threat to bioterrorism prepared-
ness today is complacency.  If a health threat
does not happen, be it naturally occurring or
deliberate, we tend to make it a lower priority.
The worst thing we can do is to make some-
thing a priority after it happens.  After it hap-
pens is too late; you are playing catch-up.
Preparedness for a threat must be a priority be-
fore it happens.
Photo courtesy of CDC
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Questions/Answers: 
2001 Anthrax Attacks
Senator Tom Daschle, Former U.S. Senator from South Dakota and Former U.S. Senate Majority Leader
What do you remember most about the initial
response to the anthrax attacks, both nationally
and from your office?
I vividly remember the first report provided to
me by my Chief of Staff, Pete Rouse, and my
grave concern for each of the affected staff.
I remember the agony of calling parents, spouses
and families of the exposed staff to inform them
of what had happened and to share what little I
knew about how we would address the situation.
I also recall the somewhat chaotic environ-
ment involving the Centers for Disease Con-
trol and Prevention (CDC) and other agencies
of government who had limited capacity to re-
spond to the attack and little information
about next steps.
Finally, I remember the media frenzy when
President Bush made reference to the inci-
dent shortly after I informed him of the cir-
cumstances.
Fully detailing this experience is hard. I did
write a book, Like No Other Time, that includes
more information.
You and your staff were among those most
affected by the attacks.  Talk about your own
experience.  As it unfolded, what do you
remember thinking, and feeling?
As noted in my book, my greatest concern was
the health and safety of my staff and the oth-
ers who were exposed.
We knew so little about treatment for exposure
to anthrax and there were differing points of
view on the appropriate antidote.
As the Democratic Leader in the Senate, I was
also concerned that a plan of action be devel-
oped quickly that would include an investigation
to find those responsible, a plan for evacuation
of the Senate office building, cleanup and an on-
going means to share information and progress
with all interested parties.
What do you think of the investigation into the
attacks?  In your mind, what questions remain
unanswered?
Unfortunately, the investigation has been a
very arduous, frustrating and controversial ex-
perience. With both early and ongoing fits and
starts, it is accurate to acknowledge that the
confidence level relating to assertions by the
Federal Bureau of Investigation (FBI) that the
case has now been successfully closed is much
lower than it should be.
I am reasonably satisfied that the FBI’s conclu-
sion is the correct one, but I must also recog-
nize the legitimate concerns and questions
posed by many skeptics since the case was offi-
cially closed.  Was this attack the work of a lone
scientist? If so, what was his motivation?  Have
we done everything within our means to pre-
vent another attack in the future?
What role should Congress play in preparing
for bioterrorist attacks?  What role should it
play in investigating such attacks?
Congress must be a full partner with the Exec-
utive branch in every aspect of preparing for
bioterrorist attacks including policy, funding,
information and coordination.  Its primary
role in the investigations of such attacks should
be aggressive oversight.
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What are the most crucial factors to ensure that
our country is prepared for a biological emer-
gency?
It is imperative that Congress do four things in
the aftermath of this experience.  First, it must
ensure that the policies of the United States
reflect a high priority in both the prevention of
and defense from bioterrorism threats.  Second,
it is essential that the Congress provide all of the
necessary funding for research and development
of appropriate counter-bioterrorism measures.
Third, Congress should readily acknowledge that
cooperation in developing appropriate strategies
with other governments both within the United
States and internationally is critically important.
Finally, far more work on public information and
education is critically important.
In the 10 years since the attacks, how has Amer-
ica’s ability to respond changed?  Are we more
prepared to face a similar attack?  How do we
remain vulnerable?
America deserves mixed reviews in the after-
math of the attacks.  We have spent trillions of
dollars in two wars and the creation of new in-
frastructures in national intelligence, defense
and the Department of Homeland Security. We
have alienated a large percentage of the Mus-
lim population and we have committed inex-
cusable acts in violation of even the most basic
respect for human rights.
That said, over the past decade, we have im-
proved our safety and security because of the
new infrastructure and certain, established poli-
cies. We have successfully prevented a number
of potential attacks and saved thousands of lives.
What bioterrorism threats are you most
concerned about today?  Is this threat being
properly addressed on a national and state level?
While I don’t have one particular threat that
concerns me more than others, I am con-
cerned about the ubiquity of the threat and our
lack of ability to anticipate where and when an
attack may occur.
Water and transportation systems are particularly
vulnerable to catastrophic levels of harm.  Our ca-
pacity to anticipate, prevent and respond to these
potential threats is still not adequate.
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Anthrax, Risk Communication and 
Crisis Leadership
By Howard K. Koh, M.D., M.P.H., U.S. Assistant Secretary for Health, U.S. Department of Health and Human
Services, Massachusetts Commissioner of Public Health, Commonwealth of Massachusetts (1997-2003)
Until the fall of 2001, I had devoted four years immersed in the demands of a statehealth commissioner: heading the Massachusetts Department of Public Health
(M.D.PH) and overseeing a wide range of health services, four hospitals, and a staff of
3,000 professionals. The work was intense, broad and traditional. Then came 9/11. 
As a member of the National Cancer Institute
(NCI) Advisory Board, I was in the greater Wash-
ington, D.C. area that morning listening to NCI
Director Richard Klausner deliver his resignation
speech. Halfway through his remarks, an aide in-
terrupted him and whispered some information
— after which, he abruptly announced that two
planes had just hit the World Trade Center and
that the meeting was adjourned. In fact, a third
plane had also just struck the Pentagon, only sev-
eral miles away. And unbeknownst to me, of the
total of four planes involved in the attacks, two
had departed Boston’s Logan Airport that morn-
ing, as I had.  
Immediately, the entire country was dazed and
reeling. Then, to our utter disbelief, October 5
began the next chapter of national suffering
marked by the first death from inhalational an-
thrax. The cases started in Florida but over a
matter of weeks snaked up the East Coast to
northern Connecticut, just a few miles from our
state borders. It seemed unthinkable and in-
conceivable that bioterrorism could completely
engulf our public health agenda.  But this un-
welcome intruder disrupted the nation for the
rest of the Fall, leaving our daily lives in tumult.   
The following weeks were a kaleidoscopic blur of
briefings, conference calls, meetings, and press
conferences. Our Massachusetts Governor im-
mediately convened daily meetings with our state
leaders, many of whom I had never previously
met.  In particular, I found myself connecting
feverishly with officials from public safety, fire,
police and even the postal service, many of
whom became instant, if not unconventional,
partners. As reliable information on both the na-
tional and state scenes was always elusive, we
scrambled to gather accurate data through any
conceivable source. For example, once, while
driving to speak at a news conference, I heard
New York Mayor Rudy Giuliani on the radio an-
nouncing yet another anthrax case in New York
City. When I arrived, the first press question
posed to me was about the specifics of that new
case. There were many moments like that.
Our state laboratory officials, traditionally rele-
gated to obscure work in underfunded and ar-
chaic facilities, were suddenly thrust into the
media limelight. The laboratory was deluged with
samples of white powder sent for anthrax testing.
Here was a typical scenario: a jittery and unnerved
town resident would discover “suspicious” white
powder in his community. Immediate notification
of the local police or fire department would trig-
ger both the closing of the local post office and
the sudden arrival of HAZMAT teams, bedecked
in imposing space- suit paraphernalia. The teams
would delicately handle the samples under the
watchful eye of local media and news cameras.
Then, those samples would be delivered to the
M.D.PH state laboratory for analysis. A hastily-
arranged press conference would feature harried
state and local officials trying to explain the un-
folding developments to an increasingly anxious
public. And when testing in the laboratory subse-
quently yielded negative results for anthrax, that
finding would prompt yet another round of news
announcements as well. Multiply this situation by
several thousand  — and that was the Fall of 2001
in our state, and indeed, around the country. 
As Commissioner, I was charged with leading
M.D.PH through this time, interacting with
other state officials, the press, health profes-
sionals, community groups, hospital leaders, ad-
vocates, among others. It soon became clear that
my primary role was risk communicator- in-
chief. The deluge of questions from the press
and public alike seemed endless: What is an-
thrax? Why have we never heard of this before?
How many people were infected? How many
samples of white powder had been tested?  How
do I safely open my mail? Should I take antibi-
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otics to protect myself?  Is it fair that some peo-
ple have access to medications while others do
not? Would this situation get worse? What if ter-
rorists use smallpox to kill people?  Am I safe?   
In the midst of this chaos, I understood that each
interview had to focus on facts, not speculation.
With each press interaction, I shared the informa-
tion known and promised to share more as soon as
it came available.  It was important to acknowledge
the anxiety without succumbing to it. It was also
critical to project some sense of calm, setting an
empathetic and compassionate tone. It was diffi-
cult to lack ready answers in this constant swirl of
uncertainty. But I was honored to emphasize to
any audience that thousands of public health pro-
fessionals had stepped forward in this unprece-
dented time, working 24/7 on their behalf.  In
fact, the crisis represented a tremendous oppor-
tunity to underscore and reaffirm publicly the fun-
damental mission of public health: to protect
people against threats  — known and unknown —
in a time of crisis.   As a physician who has cared for
patients for decades, I had had much experience
delivering difficult news to anxious patients. But
this situation stretched me beyond anything I had
ever previously experienced.  I had to leverage
every possible skill as a physician, scientist and pub-
lic official to uphold public trust.  And across the
country, I saw my other public health colleagues
also giving it their all, trying to transform a mo-
ment of “no hope” to “new hope”.  I was proud of
them —  we all will forever share a bond.  
When it was all over, the nation witnessed 22 an-
thrax cases and five deaths, none in Massachusetts;
but the trauma left millions in its wake. For the re-
mainder of my tenure as Commissioner, we dealt
with the aftermath, dramatically realigning budgets
to balance fragile public health programs with new
preparedness demands. And when I assumed my
new positions as Professor and Associate Dean at the
Harvard School of Public Health, I also headed
their Center for Public Health Preparedness. We fo-
cused on preparedness education and training, risk
communication, integration of preparedness and
prevention, building better information networks,
and using drills and exercises to build a more pre-
pared professional workforce. I brought many of
those lessons with me in 2009 to the U.S. Depart-
ment of Health and Human Services where I now
serve as Assistant Secretary for Health.  
Looking back at the first decade of the 21st cen-
tury, our public health history now covers many
crises previously viewed as unthinkable. In addi-
tion to 9/11 and anthrax, this remarkable litany
of “low probability, high consequence” events
now includes SARS (2003), Hurricane Katrina
(2005), the H1N1 pandemic (2009) and the Gulf
Coast oil spill (2010), among others. Through
each of these episodes, as noted by Mitroff1, we
have been subjected to the predictable elements
of crisis: invalidation of previous fundamental as-
sumptions, the irrelevance of conventional
thinking and conventional responses, rapid es-
calation of events, moral trial by compelling im-
ages in the media and tremendous technical and
even ethical uncertainty. Since 9/11, our na-
tion’s ability to coordinate response has certainly
grown dramatically. But the next challenge al-
ways seems to be just around the corner. 
Each new crisis demands renewed leadership. As
we seek to train the next generation, we must at-
tract those who are willing and able to step for-
ward and serve at all times and under any
circumstance. They must be committed to trying
to unify in times of need while acknowledging the
unfamiliar and the ambiguous. They must create
uncommon bonds among untraditional partners,
and mobilize people to want to reach for higher
aspirations. This requires not just intelligence and
knowledge but also a sense of strategy, personal
will and tremendous interpersonal skill. They
must be willing to embrace the “public” part of
public health, since we practice our craft on an
open stage. In the final analysis, each crisis can
represent an opportunity to create a renewed
sense of community, reminding us yet again that
we are all interconnected, all interdependent and
we all have promises to keep. 
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Public Health Preparedness since 9/11
By, Nicole Lurie M.D., M.S.P.H., Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of
Health and Human Services
The tragic event of 9/11 and the subsequent anthrax attacks horrified thenation and the world and awakened us to the importance of health security as
a shared public health homeland security priority.  In the decade since these tragic
events, public health preparedness has emerged not as a standalone discipline but
rather as critical component of public health. 
Almost immediately after these events there was
an influx of funding to support preparedness
for public health and medical infrastructure.
Those funds have enhanced the preparedness
of our nation to respond to public health and
medical emergencies.  Now, a decade later, it’s
useful to think about how far we have come.
In 2001, we weren’t even sure what a prepared
public health system looked like.  But we knew
there were big gaps.  Many health departments
did not even have the basics, like computers or
access to the internet, and blast fax was consid-
ered a new technology.  Similarly, numerous
health departments lacked the ability to receive
and respond to urgent case reports 24/7 or to
use principles of risk communication to rapidly
communicate with the public.  The use of the
Incident Command System was by and large a
foreign, uncomfortable concept.
Looking back on the last decade, we have come
a long way.  Recent reports from both the Pub-
lic Health Emergency Preparedness and the
Hospital Preparedness programs document sub-
stantial progress, including enhanced surveil-
lance and laboratory capacity, improved
surveillance capability, and better hospital surge
capacity.  In fact, over 75% of hospitals partici-
pating in the Hospital Preparedness Program
met 90% of pre-specified goals.  
Moreover, the investments in preparedness have
strengthened day-to-day public health systems.
Numerous health departments now use the in-
cident command system structure to investigate
outbreaks, for example, and report that the in-
vestigations are faster and more complete.  In
recent tornados and floods, states have been
able to handle medical needs, including hospi-
tal and nursing home evacuation, on their own,
without federal assistance.  Many state and local
health departments report that planning and
practicing for mass distribution of countermea-
sures made a major contribution to their ability
to respond to the H1N1 pandemic, including
through mass vaccination efforts.
Moreover, events since September 11 and the
anthrax attacks have moved us from a focus on
threat-specific preparedness efforts to the con-
cept of all-hazards preparedness, and to the
identification of, and focus on, a core set of ca-
pabilities needed for public health and health
care system preparedness. The response and re-
silience at the community level demonstrated
during recent natural disasters including the
Mississippi floods in the Midwest and tornados
in Alabama and Joplin, MO are testament to
work that has been done at the federal, state,
local and hospital level over the past decade.
Yet, we still have a ways to go, including in the
development of medical countermeasures for
chemical, biological, radiological, and nuclear
threats.  The Secretary’s Public Health Emergency
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Medical Countermeasures Enterprise Review, pub-
lished last year, made a number of recommen-
dations for strengthening the medical
countermeasure enterprise, and these are now
being implemented, with a long term goal of de-
veloping rapid, flexible, nimble countermeasure
manufacturing capacity to respond to a novel
threat, whether natural or man-made.
With tightening federal, state and local budgets,
it’s tempting to ask, ‘are we there yet?’ and to
drastically cut or eliminate investments in pre-
paredness.  Maintaining and sustaining the capa-
bilities of the people and systems involved in
day-to-day public health and preparedness is a
critical, continuing requirement for our nation’s
health security.  While public health departments
and hospitals have ‘bought stuff’ that lasts for a
long time, some of it will need replacement.
Staffs need continued training and practice, and
there are ongoing needs to train new people as
the normal turnover of personnel occurs.  For me
as a primary care doctor, I liken our investments
in preparedness to caring for a patient with
chronic diseases.  There is an initial, substantial
investment that has been made in the initial as-
sessment and testing, but my patient’s diabetes or
hypertension is not cured after they take medi-
cine for a month.  It’s usually medicine they need
to take forever, and it is for them a ‘new normal.’
The same is true for preparedness; the threats will
always be with us, and our need to become and
stay prepared is our ‘new normal.’
At the end of the day, preparedness will be built
and maintained through strong, day-to-day sys-
tems in health care and public health.  Con-
versely, the preparedness imperative has, and
will continue to strengthen those systems.  
My office, the Assistant Secretary for Prepared-
ness and Response (ASPR) for the U.S. Depart-
ment of Health and Human Services, is
responsible for ensuring that the nation is pre-
pared for, and can respond to and recover from
public health emergencies.  The National Health
Security Strategy charts a course for doing just
that.  None of us wants to see another public
health emergency happen.  And while each
event—a terrorist attack, a novel infectious dis-
ease outbreak, or a massive tornado—is thank-
fully rare, taken together, it’s extremely likely that
another emergency will happen.  And we as a
country need to be ready for whatever it is.   
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A Decade After Anthrax — 
A National Commitment to Leveraging
Lessons Learned 
By Luciana Borio, M.D.,Acting Director, Office of Counterterrorism and Emerging Threats and Assistant Com-
missioner for Counterterrorism Policy, Food and Drug Administration 
When the anthrax attack happened in the fall of 2001, I was working at theCenter for Civilian Biodefense Studies at the Johns Hopkins Bloomberg
School of Public Health.  It is fair to say that most public health professionals as well
as governmental and other health-related organizations were taken completely by
surprise.  It was a time marked by considerable uncertainty with respect to the extent
of the attack; the number of people who had been exposed; how best to prevent
illness in those potentially exposed; how best to treat those who had become ill; and
how to prevent additional exposures and illnesses.  
My role in the response was primarily one of fa-
cilitating information sharing to foster more ef-
fective response activities. I, along with my
colleagues, organized working groups and built
informal networks to identify and share critical
clinical information and, later, to disseminate
lessons learned. We worked closely with U.S.
government officials at the federal, state and
local levels and with first responders in the med-
ical and public health communities.  
At the time it was very clear that we faced numer-
ous challenges. There was no rapid test to help de-
termine who needed prophylactic antibiotic
treatment to prevent potential illness, there were
limited supplies of antibiotics, and there was con-
siderable uncertainty regarding how long prophy-
lactic treatment was necessary to prevent illness.
There also was a limited supply of anthrax vaccine
and a lack of clarity on how best to use it in re-
sponse to the attack. In addition, there was fear
that subsequent attacks would ensue in rapid se-
quence, and we all knew that capacity at the state
and local level to deliver medical countermeasures
to large numbers of people was sorely inadequate. 
Since the 2001 anthrax attack, preparedness has
improved considerably. However much work re-
mains to be done, and if an anthrax attack oc-
curred today, the nation would still face many of
the same challenges as in 2001. Although our
nation’s armamentarium of medical counter-
measures to respond to an anthrax attack has
been bolstered, there is still uncertainty regard-
ing how clinicians would manage patients and
how public health practitioners would manage
the public health emergency. In the event of a
large-scale attack, difficult decisions would have
to be made on how best to use life-saving re-
sources in a resource-constrained environment.
In addition, the capacity to deliver medical
countermeasures to large numbers of people
and to surge medical care in a mass casualty
event is still lacking in many areas.
Recognizing that our nation needs to continue
to improve its capability to respond to bioterror-
ism and emerging infectious disease threats, this
past year the President announced a new initia-
tive to increase our capacity to respond faster and
more effectively to these threats.  As part of this
initiative (outlined in the 2010 Public Health
Emergency Medical Countermeasures Enterprise
Review), the U.S. Food and Drug Administration
(FDA) launched its Medical Countermeasures
Initiative (MCMi) in August 2010. 
I have the privilege to help lead this effort along
with the dedicated professionals that I work with
at FDA. The mission of the MCMi is to build on
the substantive work under way at FDA to pro-
mote development of medical countermeasures
by enhancing FDA’s regulatory processes, fos-
tering the establishment of clear regulatory
pathways for medical countermeasures and fa-
cilitating the efficient use of available medical
countermeasures by establishing effective regu-
latory policies and mechanisms.
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The new initiatives launched as part of the En-
terprise Review have put the United States in a
position to begin fully leveraging advances in sci-
ence and technology to develop innovative, safe
and effective medical countermeasures and the
systems to deliver them. These initiatives —
along with the significant U.S. government in-
vestments in bioterrorism preparedness to date
— have put the United States on a trajectory to
achieve substantial gains in preparedness and
significantly reduce the risks posed by bioter-
rorism and emerging infectious diseases.
The biggest challenge to preparedness efforts
today is complacency. The United States will
continue to face a substantial threat from bioter-
rorism (and emerging infectious diseases) for
the foreseeable future. Indeed, bioterrorism is
seen as a growing threat as advances in technol-
ogy will continue to make biological weapons in-
creasingly accessible to state and non-state actors
as well as increasing their potential lethality. As
such, we must continue and increase our pre-
paredness efforts, which will require an appre-
ciation of the long timelines, risks and high costs
associated with developing medical counter-
measures and the systems to deliver them; a sig-
nificant and ongoing investment of resources; a
broad-based effort, involving governmental en-
tities at all levels, academia, industry and health
professionals; and the continued commitment
of our leadership. 
This writing reflects the views of the author and should
not be construed to represent FDA’s views or policies.
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Before that September attack, CDC was busy with a multi-
tude of concerns that embody the work of public health.
The headlines before Sept. 11, 2001, tracked CDC’s work on
potential health concerns from mosquitoes that stowed away
on imported lucky bamboo to a Norwalk-like virus outbreak
at two summer camps.  The Task Force on Community Pre-
vention Services had just issued a report on increasing phys-
ical activity. Internationally, CDC was answering immediate
health questions during a refugee crisis in Guinea.  It was
doing what CDC does:  work with state and local public
health departments and partners across borders to find and
tackle the problems that can plague individuals, communi-
ties and the world.  And then disaster struck.
The following reflects portions of interviews with and reports by
past and present CDC leaders and subject matter experts. 
What was CDC’s immediate role in responding to the Sept.
11, 2001, attacks in the United States? 
Our first thoughts were, “how can we help?” 
Within hours of the morning attack, CDC sent a small cadre
of its public health experts from different disciplines to New
York City by private jet.  
CDC had previously established a unique FAA-issued pri-
ority flight designation that allowed people and materiel to
be flown to New York City despite the closure of airspace
over the United States. 
There were many unknowns that first day, but the team’s
primary mission was to support the city health department.
CDC expected to help in organizing for mass casualties and
conducting immediate biological surveillance for infectious
disease illnesses from the possible release of biologic agents. 
The team arrived before nightfall and integrated with the
New York City Health Department.  Concerned about the
possibility that hospitals could be overwhelmed with the in-
jured, the NYC health director and CDC’s team-lead agreed
that CDC should send up more than a dozen Epidemic In-
telligence Service (EIS) officers.  In addition, the first emer-
gency mobilization of the National Pharmaceutical
Stockpile, arrived that night in New York City.  
At the request of the New York City Department of Health,
CDC’s Strategic National Stockpile delivered a 50-ton push-
package of pharmaceuticals and medical supplies to
Ground Zero in New York City within seven hours of the
federal decision to deploy. In addition, ventilators and their
ancillary supplies and other critical medical supplies nec-
essary for the treatment of burn and blast injuries were
sent.  Along with that, thousands of respirators and other
personal protective equipment for response personnel
were delivered to New York in the 24 hours after the attack.  
EIS deployed to emergency departments
The additional EIS officers boarded a plane bound for New
York.  CDC sent epidemiologists, occupational health spe-
cialists, industrial hygienists and other professionals to sup-
port the city’s response. The EIS officers deployed to
emergency departments in sentinel hospitals to identify un-
usual disease symptoms or outbreak clusters. Their job
would be disease and injury surveillance to help identify the
types and amount of medical resources needed. 
September 11th Attack and the Intentional
Release of Anthrax
Q&A: CDC AND PUBLIC HEALTH RESPONDS — 10-YEAR ANNIVERSARY 
Atragedy is often marked in the lives of those who have experienced it as “life before,” or “life after.”  The Centers for Disease Control and Prevention does the same as it reflects on the
decade after the terrorist attack of September 11 and the intentional release of anthrax that followed.
Photo courtesy of CDC
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The expectation was that large numbers of people had been in-
jured by the crash and collapse of the buildings. When the sad
realization was that hospitals would not be receiving injured
survivors because most victims had perished, the CDC team’s
attention was also directed to occupational health.  Eye injuries
and respiratory distress ranked high.  Soon attention turned to
environmental health concerns such as air quality, food and
water safety, and rodent control. Days later, more EIS investi-
gators were deployed both to New York City and to Washing-
ton, D.C. to help establish a disease surveillance system.
What was CDC’s role in responding to the anthrax attacks?
The nation as a whole was still reeling from the terrorist at-
tack of September 11th when public health officials identi-
fied a case of inhalation anthrax in a Florida resident, the
first such case since 1976 in the United States.  As the De-
partment of Health and Human Services’ lead agency for
bioterrorism response, CDC had a much more central role
for the federal government in the anthrax attack response
compared to the terrorist attack on September 11th.  
In 1998, CDC had begun to earnestly develop a strategic plan
for addressing bioterrorism.  Public health was the lead for
increased vigilance and preparedness for unexplained ill-
nesses and injuries. There were five components to the plan:
preparedness and prevention, surveillance and early detec-
tion, diagnosis, response, and communication.  These re-
quired integrated training and research. 
CDC was making incremental progress to define, develop
and implement a set of public health capacities at the local,
state and federal level to respond to deliberate biologic or
chemical attacks on the health of U.S. citizens.  In 1999,
the CDC had begun providing selected state and local pub-
lic health jurisdictions with federal funds to develop their
public health infrastructure and response capacity. The
New York City Department of Health was one of the first
city departments funded under this program. In addition,
CDC began participating in terrorism response exercises
with local, state and federal agencies. Internally, CDC had
created the Bioterrorism Preparedness and Response Pro-
gram. Importantly, CDC established a national repository
of emergency drugs and medical equipment, which later
became the Strategic National Stockpile. 
Public health leads
Ready or not, the Florida anthrax event thrust public
health and bioterrorism to the front of the line.  A CDC-
trained laboratorian in the Florida Health Department iso-
lated Bacillus anthracis from a patient and alerted his health
director and CDC according to protocol.  The national Lab-
oratory Response Network was created specifically to en-
sure the nation had sentinel experts who could correctly
identify unusual bacteria from patient specimens and
sound the alarm. It worked.  
CDC and public health as a whole had limited science or
past bioterrorism experience to draw upon beyond basic
laboratory and epidemiologic understanding. There was
great uncertainty about what the nation was dealing with
and the magnitude of the event.  The days and weeks that
followed saw a quick escalation along the East Coast. 
On October 4, anthrax was confirmed in the first patient
and a second patient from the same media company re-
ported being ill. Three days later, a Sunday, CDC confirmed
B. anthracis from the office keyboard of the first patient —
there was no doubt it was intentional because the organism
would not naturally be found in an office setting.  
In the weeks that followed, cases accumulated in New York,
New Jersey, Washington, D.C. and Connecticut. CDC de-
ployed teams of epidemiologists, occupational health ex-
perts, industrial hygienists and environmental health
professionals in response.  In addition, it gathered nearly a
third of its workforce at the headquarters to aid in the re-
sponse.  The response was staged in an old auditorium at
the Atlanta headquarters set up on metal tables marked by
paper signs, according to their mission.
Epidemiology and Surveillance Response
Suspicious envelopes sent on September 18 were meant to
reach media company AMI and NBC, ABC, CBS and the
New York Post. Envelopes mailed on Oct. 9 were sent to
Senator Daschle’s and Senator Leahy’s offices.  Four days
after the September 18 envelopes were mailed, the first
cluster of nine cases began. The second cluster began five
days after the October 9 envelopes were mailed.
Officers from CDC’s EIS were deployed to establish sur-
veillance, track exposed individuals and collect epidemio-
logical data to identify risk factors for exposure. 
Public health uses specific tools to define the extent of an
outbreak. The team at CDC headquarters responsible for
characterizing the event created a line list of patients with
case descriptions, a database of clinical and environmental
specimens from field teams and multiple reports.  
Photo courtesy of CDC
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The team created an epidemic curve that showed the date
of onset of illness for 22 cases of bioterrorism-related an-
thrax.  Two distinct case clusters were noted, with a 13-day
period between the clusters in which no cases were re-
ported.  A single case of inhalational anthrax was noted in
Connecticut 20 days after the second cluster of cases. The
epidemiology team mapped out the flow of mail in these
areas and identified the positive environmental samples,
confirmed anthrax cases, and suspected cases.  
Soon, CDC epidemiologists created a field tool kit to guide
investigations.  The learning curve was steep and the ur-
gent requests for support unrelenting.  To capture what was
being learned in real time about how public health should
respond to an anthrax event, the team created a “tool kit.” 
The tool kit included 250 items meant to reduce the learn-
ing curve for investigations that followed by health depart-
ments and CDC. This practical tool kit included patient
handouts, diagnostic and treatment algorithms, prophylaxis
clinical materials and guidance, consent forms, training ma-
terials, templates for logs, shipping and lab protocols, and
helpful hints learned along the way. 
Environmental Response
CDC collected nearly 10,000 environmental samples to test
for the organism’s presence which aided in determining agent
sources and exposure pathways. Environmental sampling
helped determine the extent and degree of contamination
necessary to create risk assessments and support medical treat-
ment and clean-up decisions.  Environmental sampling also
helped to guide decisions about reoccupying locations. 
Laboratory Response
In 1996, CDC had only basic microbiology expertise with
anthrax.  By 2000, CDC had a highly trained but small cadre
of laboratorians who could isolate B. anthracis and do the
molecular subtyping, which became critical in the criminal
investigation.  Fortunately, CDC had also developed and
trained the Laboratory Response Network so others across
the country could isolate and identify anthrax bacterium. 
They could identify anthrax bacteria by simple tests such
as susceptibility of the anthrax bacteria to lysys by the
gamma phage, or by using a more sophisticated approach
such as direct fluorescent-antibody staining. Their labora-
tory capacity also included finding evidence of the organ-
ism’s DNA by polymerase chain reaction (PCR) from
specimens from a patient’s affected tissue or site.  
The first night after samples arrived at CDC, its anthrax lab-
oratory processed 300 clinical and environmental speci-
mens.  Molecular subtyping confirmed that this strain was
identical to the Ames strain.
Thousands of clinical and environmental specimens were
processed by the CDC anthrax lab without a single miss in
diagnosis. Isolating the anthrax bacterium from clinical or
environmental specimen is not simple.  The culture plate
used was non-selective and could grow thousands of other
bacteria present in these samples, making finding the spe-
cific organism a challenging hunt. At CDC, B. anthracis iso-
lates were found on the four suspect envelopes, in 17
clinical specimens and in 106 environmental samples.
Across the nation, the laboratory response network tested
an estimated 350,000 environmental samples and clinical
specimens over an extended period.  The results were used
in site characterization assessments, post decontamination
clearance and forensic investigations.
Interventions 
Through a combination of environmental sampling and
case-cluster investigation, CDC recommended 10,300 peo-
Figure 1. Epidemic Curve for 22 Cases of Bioterrorism-related Anthrax, United States, 2001
Symptom Onset Dates, September – November, 2002
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ple receive antimicrobial prophylaxis for 60 days.  An esti-
mated 32,000 began antimicrobial prophylaxis.  A small
number of persons requested vaccination also.  CDC’s Strate-
gic National Stockpile supported hundreds of rapid ship-
ments of antibiotics around the country.
As the investigation progressed, EIS officers helped ad-
minister antibiotics, performed logistics management, and
helped with risk communication. More than 100 EIS offi-
cers were in the field during the anthrax investigations.
Educational materials and counseling was initiated in small
groups and health fairs were held to encourage people to
continue the full course of antibiotics. CDC monitored for
adherence and found that those who perceived the risk to
be higher were more likely to finish the course of antibi-
otics. Importantly, no case of anthrax developed among the
more than 10,000 people who received a course of antibi-
otics as a precaution based on their exposure risk. 
Information Response and Partnership
Information sharing in the response became as essential as
oxygen is to life. The demand for news and guidance at all lev-
els of government, media, and a concerned public was crush-
ing. Between September 11 and the end of November 2001,
CDC issued more than 175 updates on the response reaching
an estimated 7 million health professionals and the public. 
HHS and CDC worked extensively to reach out to various
groups within the health delivery system to inform them of
what they knew. In addition to updates in the CDC MMWR,
CDC sent notifications through its Health Alert Network and
Lab Alert Network to state and local health departments. 
How did CDC work with state and local health departments
during the anthrax response?
In 2001, CDC had more than half a century of experience
collaborating with state and local health departments and
it knew their value during any outbreak response. CDC is
not a regulatory agency and is invited by states and local
health departments to work with them. During an event of
national importance CDC’s footprint may be larger, but the
need to collaborate remains.
No one knows a community or population better that the
public health officials who serve them.  However, a strong, in-
tegrated national public health infrastructure is critical to
protecting the public’s health during large events.  In 2001,
CDC was not yet there, although it had been working to in-
crease local capacity in critical response areas.  The work
state and local health departments did with the limited re-
sources they had was immense.   Naturally, the chaos of an
event of this magnitude strained capacities and relationships.
Overall, CDC tried to share what it knew as quickly as it knew
it with all of those involved. In reverse, CDC saw its local and
state partners strive to do the same. 
The anthrax cases in Florida provided a good example of how
CDC worked with state and local officials. After the first case
resulted in death, CDC moved quickly to confirm the case of
the second victim early on the evening of October 7. The
CDC, HHS, FBI, DOJ, Florida Governor’s Office, Florida Pub-
lic Health Department, and a local public health department
quickly formulated a plan that got the word out overnight to
the affected employees that they needed to come to the clinic
for medicine and testing that very next morning. CDC
shipped medicine to Florida overnight so it was there when
the people arrived in the morning. And CDC and Florida of-
ficials issued a joint release at 11 p.m. on October 7 notifying
the media and public of the second case. It was a good exam-
ple of local, state, and federal officials working together to get
out a message, send medicine and mobilize people to come
get treatment — literally overnight on a Sunday evening.
How would CDC characterize the response efforts?  What
were the most difficult aspects to respond to?
The response efforts were unprecedented.  CDC, public
health, and the nation faced a silent enemy with unknown ca-
pacity. Uncertainty permeated the environment in which
local, state, and federal governments along with private med-
ical-care systems and organizations bravely and incessantly
went to work.  Collectively, public health and medicine had
very little science or past bioterrorism experience to draw on
as well as an out-dated, weakened public health infrastructure
just beginning to get its footing in bioterrorism preparedness. 
We took every available public health tool and adapted it to
this new situation. Public health was innovative, dedicated,
and relentless in working to stop the threat from this inten-
tional release. We did it alongside new federal partners and
under intense scrutiny.  We disseminated public health in-
formation promptly and delivered medicine to people who
needed it.  As a result, five people too many lost their lives
and countless others were saved.  Deaths in this outbreak
were far below expectations in that the fatality rate for in-
halation anthrax was thought to be around 80 percent.  The
fatality rate in these attacks was about 40 percent. 
Nonetheless, the desire is always to do more, better. 
Cutaneous Anthrax Inhalational Anthrax
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What were the biggest challenges or gaps?  How have these
changed or been addressed during the past decade.
CDC was challenged by the magnitude of the event and the
weight of demand for information and recommendations.  Sit-
uational awareness became more and more difficult and peo-
ple did resort to informal ways to find out what they needed. 
Our local and state partners were frustrated by “watching
the sausage get made” at CDC as information changed and
guidance changed with it. Information never flowed fast
enough and completely enough for all of the stakeholders
involved, including the public. 
CDC had not yet adopted the incident command system
and had challenges in forming systems to move vital infor-
mation in multiple directions. 
There were gaps in knowledge or gaps in the number of
people with needed knowledge. For example, the fact that
the first cutaneous cases were unrecognized in clinical set-
tings demonstrated the challenge when preparing to re-
spond to unusual diseases. 
There were gaps in laboratory protocols, regulatory re-
quirements and procedures to alert local and state health
departments. 
CDC has had a decade of events on which to hone its pre-
paredness skills.  From anthrax it moved on to  respond to SARS,
monkeypox, Hurricane Katrina, H1N1, Haiti earthquake and
cholera outbreak, the oil spill and recently the Japan disasters. 
CDC has come a long way from attempting to respond to
9/11 at a few tables in a conference room. Today CDC ap-
plies the incident command system with modifications to
allow us to collaborate and communicate more efficiently.
CDC has created the Office of Public Health Preparedness
and Response that includes a Division of Emergency Op-
erations which stands ready to assemble the teams neces-
sary and scale up as required for any public health
emergency.  These functions now operate in a state-of-the-
art facility that serves as a 24/7 command center for mon-
itoring and coordinating CDC’s emergency response to
public threats across the nation and abroad. 
CDC laboratories and the National Laboratory Response Net-
work are more proficient in detecting a range of biological
agents that could be used as a weapon.  CDC also has greatly
increased its oversight of the safety and security of dangerous
biological agents (such as the agent that causes anthrax) and
toxins.  In addition, CDC experts have worked with states to
develop their plans for receiving and distributing antibiotics
and other medical assets from CDC’s Strategic National
Stockpile during a public health emergency including a
bioterrorist attack.  All 50 states now have these plans in place.
During the anthrax response, CDC learned that the linkages
forged between clinical and public health communities are
strong and these linkages saved lives by detecting illness early.
We learned how to shorten the time lag between acquiring new
knowledge, communication and action. We confirmed that
close collaboration of local, state, and federal public health per-
sonnel builds confidence in local response.  We have modified
recommendations, refocused investigations and are quicker to
adapt new scientific information into our response. 
If there were an anthrax attack today, do you think the re-
sponse would be different?  How? 
That’s a natural question to ask on a milestone anniversary.
The simplest answer is CDC has multi-disciplined experienced
and trained professionals now supported by a emergency op-
eration center that could provide the surge capacity and evolv-
ing support needed if another anthrax event were to occur.
CDC’s scientists and public health professionals have done ex-
haustive follow-up research and published extensively what
they learned during and after the anthrax response in 2001.
As such, CDC’s approach for communicating to the public
and partners in a crisis has changed. CDC has added labora-
tory protocols and operating procedures for sampling and
shipping specimens.  It has refined safety training and con-
ducted joint exercises for biologic agents. CDC has developed
an environmental microbiology framework to identify threat
agents, determine the risk of infection, and evaluate methods
to reduce risk.  CDC has described the reasons people may re-
ject public health recommendations and treatment and de-
veloped educational materials to address their concerns. 
CDC plays a key role in preparing the nation for all types of
public health threats, including natural, biological, chemi-
cal, radiological and nuclear incidents. When a disaster oc-
curs, CDC is prepared to respond and support national,
state and local partners to save lives and reduce suffering.
CDC also helps these partners recover and restore public
health functions after the initial response.
CDC’s Office of Public Health Preparedness and Re-
sponse (OPHPR) provides strategic direction, support,
and coordination for CDC’s preparedness and emergency
response activities. 
Protecting the public from health threats involves public
health preparedness as well as medical preparedness. Both are es-
sential for national health security and, hence, to the over-
all preparedness of the nation. 
n Public health preparedness is the ability of the public health
system, community, and individuals to prevent, protect
against, quickly respond to, and recover from health emer-
gencies, particularly those in which scale, timing, or un-
predictability threatens to overwhelm routine capabilities. 
nMedical preparedness is the ability of the health care system
to prevent, protect against, quickly respond to, and re-
cover from health emergencies, particularly those whose
31
FEDERAL RESPONSE
scale, timing, or unpredictability threatens to overwhelm
routine capabilities. Medical preparedness generally is
the responsibility of agencies other than CDC. 
Emergency preparedness requires attention not just to spe-
cific types of hazards but also to steps that increase prepared-
ness for any type of hazard, including training and exercises.
CDC developed an emergency preparedness exercise toolkit
intended to guide local public health agency staff in develop-
ing, implementing, and evaluating emergency drills and ex-
ercises, and facilitating the public health aspects of larger,
multiagency emergency exercise events. The toolkit provides
essential guidance including templates, checklists and forms
to assist with every stage of the exercise process. Emphasis is on
identification of objectives during the planning phase, a criti-
cal step for ensuring a meaningful post-exercise evaluation. 
The resources below reflect the increasingly robust resources
available from CDC to support the public health response.
n The Health Alert Network (HAN) HAN is a strong national
program that provides Health Alerts, Health Advisories, Up-
dates and Info Service Messages to state and local health of-
ficers, public information officers, epidemiologists and
HAN coordinators as well as clinician organizations. 
n SNAPS: Snap Shots of State Population Data  SNAPS provides
local-level community profile information nationwide. It can
be browsed by county and state and searched by zip code.
SNAPS serves as a valuable tool when responding to public
health emergency events at the state, tribal, and local levels.
n Surveillance  CDC has multiple resources for case definitions,
illness recognition and detection, planning and systems.
n Training & Education  CDC offers support and best prac-
tices for risk communications, public health and clinical
training, and laboratory training.
n Clinician Outreach and Communication Activity (COCA)
CDC’s COCA establishes partnerships with national cli-
nician organizations to communicate information about
disease outbreaks and terrorism events. 
nHealthcare Facilities  CDC has specific resources for in-
dividuals at healthcare facilities tasked with ensuring that
their facility is as prepared as possible for an emergency.
n Labs  CDC provides guidance on testing, agent identifi-
cation, biosafety, specimen collection and shipping.
Collectively these and thousands of other steps have made
CDC better prepared.  While outcomes can’t be promised,
CDC can promise it has learned what did and did not work
during the anthrax attack and has held itself accountable
for being as prepared as possible for future known and un-
known threats to public health. 
To learn more about CDC preparedness for anthrax and
other hazards, visit http://emergency.cdc.gov/cdc/ 
What do you think are the biggest threats or challenges to
bioterrorism preparedness today?
A potential threat may be the misguided belief that pre-
paredness is a thing, something you create once and simply
take off the shelf when you need it.  Being prepared is an on-
going process and a collective mindset among all public of-
ficials and citizenry to the degree they are willing to invest
time, resources and attention. 
Our society is interconnected and accessible from any-
where across the globe.  New technology and ill purpose
can wreak havoc without notice.  
Preparedness means good public health with an ability to deal
with day-to-day disease threats, including detecting and re-
sponding to unusual diseases, having the capacity to diagnose
rare illnesses, the laboratory acumen to know what you have,
and the insight to know what it means to our citizenry’s health.
Collectively, these things and the means to respond swiftly are
the foundation of preparedness against acts of bioterrorism.   
Because of its unique abilities to respond to infectious, oc-
cupational, or environmental outbreaks and events, CDC
plays a pivotal role in public health preparedness for cata-
strophic events. CDC focuses on strengthening response ca-
pabilities within the agency as well as externally by
providing resources to help strengthen preparedness at
state, local, tribal and territorial levels. Many preparedness
activities occur on a daily basis, such as monitoring for real
or potential public health emergency threats. These and
other types of activities can be expanded to respond to
emergency scenarios such as pandemic influenza. 
National emergency preparedness requires a coordinated
effort involving every level of government as well as the
private sector, non-govern mental organizations and indi-
vidual citizens. CDC’s work in preparedness supports the
Department of Homeland Security, which has overall au-
thority for emergency response activities as laid out in the
National Response Framework. 
CDC is committed to working with other federal agencies
and partners as well as state and local public health depart-
ments to ensure the health and medical care of our citizens.
The best public health strategy to protect the health of civil-
ians against biological terrorism is a strengthened public
health system including public health laboratory capacity, in-
creased surveillance and outbreak investigation capacity and
education and training at the local, state and federal level.  
CDC works 24/7 saving lives, protecting people from health
threats and saving money through prevention resulting in a
more secure nation.  CDC puts science and prevention into
action to make the healthy choice the easy choice.  CDC helps
people live longer and healthier to lead productive lives.
To learn more about CDC public health emergency pre-
paredness and response, visit: www.cdc.gov/phpr.  
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Questions/Answers
with James M. Hughes, M.D., President of the Infectious Diseases Society of American and Professor of
Medicine and Public Health at Emory University;  Former Director of the National Center for Infectious Dis-
eases (NCID) at CDC and Rear Admiral and Assistant Surgeon General in the U.S. Public Health Service.
What was CDC’s role in re-
sponding to the 9/11 tragedies?
Consultation and support for
NYC and D.C. health depart-
ments in numerous activities; deployment of National Phar-
maceutical Stockpile (NPS) pushpack to NYC. 
What was CDC’s role in responding to the anthrax attacks?
National surveillance; epidemiologic investigations in collabo-
ration with state and local health departments; support for state
public health labs through the Laboratory Response Network
(LRN); laboratory diagnostic support through the Rapid Re-
sponse and Advanced Technology Laboratory (RRAT Lab),
Anthrax Laboratory, and Pathology Laboratory for case con-
firmation; clinical consultation; professional and public edu-
cation; advice on postexposure prophylaxis; deployment of
antimicrobial agents and supplies through the Vendor Man-
aged Inventory of the NPS; consultation on environmental de-
contamination; development of treatment recommendations.  
How did the CDC work with state and local health departments
during the response efforts to 9/11 and the anthrax attacks?
Deployed field teams to Dade County, NYC, NJ, Washington, D.C.
and CT to assist state, local and district health departments in on-
going investigations of cases, surveillance and outbreak control.
Staff from CDC Ft Collins, CO assisted state and local authorities
in the investigation of a suspect case there.  Assisted LRN labora-
tories in the assessment of numerous powders.  Received and
processed numerous clinical and environmental specimens and
provided reference diagnostic services.  Assisted in coordination
of epidemiologic and law enforcement investigations.    
How would you characterize the response efforts?  What
were the most difficult aspects to respond to?
Response efforts were generally effective, given resources avail-
able at the time.  Major challenges related to uncertainties re-
garding who was in charge at the national and local levels,
dealing with the 24 hour news cycle, staying ahead of CNN in re-
lease of information, maintaining situational awareness (worked
best in NYC), keeping the clinical and public health communi-
ties informed, communicating clear and consistent messages,
characterizing powder preparations associated with cases (in-
cluding concerns about indicators of weaponization), sharing
information among many agencies involved in the investigation.
What were the biggest challenges or gaps?  How have those
changed or been addressed during the past decade?
Initial lack of an Emergency Operations Center and experi-
ence with incident command structure and operations.  Main-
taining situational awareness in all involved areas.  Risk
communication.  Responding to 24 hour news cycle and stay-
ing ahead of media in release of information.  Meeting the
“need to know” requirements of numerous individuals and
organizations.  Meeting need for rapid development of rec-
ommendations for post-exposure prophylaxis.  Maintaining
relationships with Department, White House, and law en-
forcement.  Expanding CDC laboratory capacity.  Coping with
fatigue and burnout.  Considerable progress has been made
in addressing each of these issues though challenges remain.
Looking back, has your perception of the attacks or the re-
sponse changed from how you saw them 10 years ago?
Anthrax attacks ushered in a new era in outbreak prepared-
ness and response at national, state, and local levels.  CDC
and the nation are much better prepared to respond today.
The attacks drove home the reality of the threat posed by
terrorism and the need to be prepared to address the unex-
pected.  Numerous challenges remain, two of which are lack
of surge capacity of the healthcare system in today’s just in
time economy and vulnerability to cyberterrorism. 
If there were another anthrax attack today, do you think the
response would be different? How?
Greater familiarity with clinical and epidemiologic features
of the disease (old dogma would be ignored).  Situational
awareness, coordination among agencies, incident com-
mand, emergency operations, risk communication capaci-
ties much improved.  Management of complexity of social
media environment and timely provision and administra-
tion of medical countermeasures would be challenging. 
What do you think are the biggest threats or challenges to
bioterrorism preparedness today?
Complacency (10 years have passed without another major
incident) leading to funding reductions which negatively
impact state and local preparedness efforts.  Lack of health-
care surge capacity and medical countermeasures includ-
ing new antimicrobial agents to address the threat posed
by genetically engineered organisms which is markedly in-
creased today compared with 10 years ago.  Just in time
economy introduces additional preparedness challenges.
What remains to be done to make sure that we can respond
effectively to bioterrorism attacks?
Maintenance of political will.  Strengthened national and
global biosurveillance capacity to ensure early detection and
situational awareness.  Continued support for medical coun-
termeasures development  Elimination of barriers to sharing
of critical information including etiologic agents during emer-
gency responses.  Strengthened biosecurity and biosafety pro-
grams internationally.  Support for effective implementation
of IHR 2005 in all countries, including the US.
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SUMMARY OF THE INVESTIGATION INTO THE ANTHRAX ATTACKS
Centers for Disease Control and Prevention, a series of articles:
The real question was, 
“Will this hurt someone?”
Not many people can bring up the risks from inhaling anthraxspores, microwave popcorn flavoring and nano particulates
in the same conversation.  CDC’s Ann Hubbs, DVM, Ph.D., is that
person.  Hubbs was selected to respond to the 2001 intentional re-
lease of anthrax, in part, because she had a unique professional back-
ground.  As a veterinary medical officer working in occupational
safety and health, she had studied anthrax in livestock as part of her
basic DVM education in Texas.  Her studies and research went on to
include respiratory disease lung pathology and then toxicology. 
People absorbing volumes
“I rotated into the anthrax response and it
changed my perspective of CDC, public
health, and my job,” she said.  “The pace was
so fast and the energy level was so high.  I saw
people absorbing volumes of data and making
decisions about risk probability in unbeliev-
ably tight timeframes.”
While information and discussions swirled
around the topic of spores released and en-
velopes at the Senate’s Hart Building, Hubbs was
working to answer questions about occupational
health.  “I saw the value in diverse people work-
ing together to make the best possible decisions
based on the information at hand,” she remem-
bers. “People cared, really cared and the burden
to get it right weighed heavily on everyone.  At
that time I had worked for CDC in Morgantown
for nine years. I was physically removed from At-
lanta.  This response let me see the big picture.
I understood public health in a new way.”
Hubbs explained that while numbers were im-
portant, when talking about inhaling anthrax
spores, the real question was, “Will this hurt
someone?”  Being part of the team trying to
answer that question left her with a different
perspective when calculating risk. 
Science can predict risks
“Science is imperfect, but it can be useful.  Sci-
ence can predict risks, some from known
sources and occasionally from new sources.
The value is in detecting the risk early and
doing something about it,” she continued.
When Hubbs discusses new sources of risk she
is referring to her research involving an emerg-
ing lung disease among food manufacturing
workers.  The illness stems from butter flavor-
ing vapors used on microwave popcorn, com-
monly known as Popcorn Worker’s Lung.  She
was part of the team that identified a compo-
nent of the vapor implicated in the respiratory
hazard. “We learned that the very thing that
gives it the buttery taste is potentially harmful
in some workplace conditions,” she explained. 
Safety of nanotechonology
Her energy is now also directed at exploring
the safety of nanotechnology.  Nanotechnol-
ogy is the means to change matter on an
atomic scale to create structures that can be
formed into new products.  This new technol-
ogy involves the tiniest known manufactured
products and is revolutionizing the science,
medicine, and cosmetic industries.  “Nan-
otechnology is an economic force and, as ex-
citing as that is, it’s important we use these
first-generation products of nanotechnology
safely.  We missed the opportunity when as-
bestos was first introduced to understand how
best to use it. As a pathologist, I want us to use
this new technology safely,” she said.
The common denominator between anthrax,
popcorn flavoring vapors and nanoparticu-
lates is lung safety.  For Hubbs, they all re-
mind her of public health’s demand to do
more and the wonderful feeling that more
can be done. 
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In 1994, as a new CDC Epidemic Intelligence Service (EIS)
Officer, he helped successfully identify the source of infec-
tion for an outbreak of pneumonia. Cases of Legionnaires’
disease had been popping up in adults along the East Coast.  
“What made this outbreak investigation unusual was that it
was a respiratory disease and, yet, we were able to trace it
back to a point source. Typically respiratory outbreaks can’t
be traced back to an original point of infection — that’s the
type of experience you get with foodborne or waterborne
investigations, not airborne,” Jernigan explained.  
Applying detection methods
Applying their epidemiologic detection methods, the pub-
lic health investigators identified legionella in whirlpool
spas on the cruise ship Horizon as the source.  It turned out
that the Legionnaires’ disease cases occurred from nine
separate week-long cruises to Bermuda.  Exposure to
whirlpool spas on the ship was the common thread among
those who became ill compared with those who did not.
On Oct. 4, 2001, the first case of inhalation anthrax in the
United States since 1976 was identified in a media company
worker in Florida. Three days later, Jernigan was asked to lead
the CDC epidemiology team based in Atlanta.  Once again, he
was in the unusual position to investigate a respiratory disease
outbreak that could ultimately be traced to a point source.
“Right away we needed to determine the source.  This was
complicated — we later found out — by the fact that two
different sets of letters were mailed.  We were using data
collected by public health investigators as we tried to an-
swer, who was affected, what were their characteristics, and
were they related to each other in some way.  These ques-
tions were meant to help us identify interventions and stop
additional disease transmission,” he said. 
Unprecedented outbreak
The investigation expanded over the weeks as more cases were
found.  “This was an unprecedented outbreak investigation. It
challenged us in the traditional sense of finding out how the
disease organism was being transmitted and the volume of
data analysis that was required, but also in shear scope. We
would ‘birth’ a new team for each new location where anthrax
cases were found. We had CDC teams working with Florida,
North Carolina, New York, New Jersey, and D.C. We also had
a postal team. They were working with public health and other
agency officials on the investigation response,” he recalled.
Through the exhaustive weeks of that response, Jernigan and
his colleagues, wittingly or not, were applying all that they knew
about investigations using an outbreak model while their ap-
proach, by necessity, began to incorporate the incident com-
mand model of response.  “We learned that the outbreak
model must persist, but in extraordinary outbreaks, the inci-
dent command model is vital too.  We needed greater situa-
tional awareness, beyond the scope of outbreak data collection.
We needed better systems to communicate and interact with
partners, elected officials, the media and public,” he said.
What he learned from a cruise ship outbreak he poured
into the anthrax response.  Next, Jernigan took everything
he learned from the anthrax attack — and subsequent re-
sponses such as West Nile, SARS and Katrina —  into his
role as the Epidemiology and Laboratory Team Lead for
the H1N1 pandemic influenza response. 
Absolutely critical to response
“What we learned from the anthrax response was absolutely
critical to our pandemic response.  Anthrax taught us the
value of having laboratory processes in place, the need for
rapid diagnostics, how to communicate uncertainty and the
importance of collaboration with others.”
Jernigan is “paying it forward” as he continues to help re-
fine public health emergency response. “It was validating to
see how extremely well the pandemic response went. We
had public health labs ready and trained.  Diagnostic tests
were created and the mechanisms and surge capacity were
in place to distribute tests and reagents to all health de-
partments and partner labs.” 
Value of consequence modeling
“We learned the value of regulatory preparedness. We must
work with USDA and FDA to identify and manage regula-
tory obstacles that can come up in a response.  We also
learned the value of consequence modeling — a capacity
we did not have during anthrax.”  
“Consequence modeling allows us to take many bits of in-
formation and analyze them to predict outcomes.  Even
with a range of expectations, we can use the information to
drive interventions and help leadership make decisions.  It
allows us a level of confidence in the way we organize and
make recommendations,” he said.
After cruise ships, anthrax letters, and pandemic viruses,
Jernigan, currently the Deputy Director of the CDC’s In-
fluenza Division, is still on the hunt.  The answers are out
there if we know how to look for them. We are determined
to intervene where we can and stop the spread of disease
— that’s public health.
The learning never ends:  
Disease detectives follow every lead
By the fall of 2001, Daniel Jernigan, M.D., M.P.H., knew his way around respiratorydisease investigations. As a seasoned epidemiologist, with CDC since 1994, Jernigan liked
the hunt — who was getting ill, was there a cluster of cases, what relationship did patients have
with each other, how long were they ill, when did symptoms begin, what was the attack rate.Ph
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Anthrax response in D.C.: Very Intense
Rima Khabbaz, M.D., led the CDC field team to the nation’scapital during the public health response to the anthrax attacks
of 2001. “I would characterize that time as very intense, we were
acutely aware that we were dealing with an intentional attack, and
focused on doing all we could to try and mitigate the consequences
and save lives,” she explained. “A few of us from CDC arrived in
D.C. just hours after anthrax was confirmed in the letter that was
opened in Senator Daschle’s office. By the end of the first week the
team grew to close to 100 staff, and more than double that at the peak of the response.”
How they did it was a feat of agility and flexibil-
ity — there was no guidebook for responding
to a bioterrorist event that affects politicians,
postal workers and media. “Public health had
identified anthrax as a potential agent so we
had some expertise, but there were gaps in our
scientific knowledge. What happens in nature
and what happened in an intentional release
can be very different,” Khabbaz noted. 
Requests seemed endless
While Khabbaz and her team tried to under-
stand the layout of the Hart Building and re-
spond to the many concerns from congressional
members and staff, the requests for briefings
seemed endless. “Recognizing that we were deal-
ing with very important people, I wanted to be
responsive to all, but at some point all I would
have been doing is talking on the phone or
going to meetings. I learned quickly to delegate
even some high-profile meetings. We had to an-
swer questions about exposures and make deci-
sions on prophylaxis.”
A confusing element of this response was the
question of who had authority where in the
District, including for example at the Capitol
and in the different Federal facilities. “We
worked very closely with the Washington,
D.C., health department but they did not have
jurisdiction at the Capitol. Straightening that
out was important,” she said.
When the outbreak investigation took them to
the Brentwood mail facility, the environmen-
tal sampling took on a whole new meaning.
“People can easily understand where to swab
in an office if a letter is opened, but under-
standing how mail moves in an oversized open
warehouse on machinery that could sort en-
velopes at incredible speed was something else.
It was difficult for people to imagine. We had
our investigators all over that facility, mapping
out the logistics,” she explained. “We needed
to be able to follow the path of the letters.” 
Investigators used swabs, HEPA vacuum filtra-
tion and air sampling. Sampling was used to
determine the presence and extent of con-
tamination. The investigators also sampled
postal facilities that received mail from the
Brentwood facility. 
Controversy and regret
A point of controversy and regret was the per-
ception that postal workers and people work-
ing at the Capitol were being responded to
differently. “We started prophylaxis with
Ciprofloxacin first because we did not know
whether the anthrax from the envelopes was
susceptible to Doxycycline. As soon as we con-
firmed that Doxycycline was effective, we
switched to using it because we had it in the
Strategic National Stockpile. The message that
they were equally effective did not get through
clearly,” Khabbaz shared.
“It is so important that people understand the
steps that are being taken and why we recom-
mend what we do. I’m glad CDC has a new ap-
proach to communicating to people in a crisis.
To this day, I feel angry and very sad that peo-
ple lost their lives from this attack, but I be-
lieve our providing timely prophylaxis to a
large number of exposed people likely pre-
vented more illnesses and deaths,” she said.
Khabbaz understatedly calls the experience she
had in the anthrax response “very intense.” That
means something coming from a professional
who has also responded to outbreaks of Nipah,
Ebola, West Nile virus, SARS and monkey pox.
Dr. Khabbaz is the Deputy Director for the
Centers for Disease Control and Prevention and
Director for Infectious Diseases. 
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In 2001, the laboratorian who detected the first case of in-
halation anthrax in the United States since 1976 was trained
by Popovic. “Phil Lee from the Florida Health Department
laboratory called to tell us he had an anthrax case. This was
incredible news. My word of confidence that Phil had it right
was an important component of CDC’s leadership to quickly
send the CDC team to Florida, even without the final labo-
ratory confirmation at CDC,” Popovic said. “I spoke with
him and was confident that he knew what he was doing.”
Five years of intense work
That confidence stemmed, in part, from nearly five years of in-
tense work and vision to get the United States laboratories pre-
pared to respond to a bioterrorism attack using anthrax. “I view
Brad Perkins [M.D.] as the key visionary who, in 1996, recog-
nized CDC did not have the laboratory expertise it needed with
anthrax.  He asked me to put a lab together that could do work
with anthrax and develop a standardized protocol that could be
used throughout the country to identify this bug,” she credits. 
However, this accomplished scientist and physician, who im-
migrated to the United States from Croatia with her hus-
band and two young children in 1989, had mixed feelings
initially about the new assignment. “Anthrax was not on the
tip of everyone’s tongue.  Some wondered what I had done
wrong to get this seemingly insignificant task. It was a dead
end they thought. But when Brad explained what was at
risk, he was so convincing. I saw his vision too,” she said.
CDC leadership asked Popovic to create a state-of-the-art lab
at CDC and then to teach what she knew to a network of lab-
oratories across the nation. “This was about preparedness.
We were building overall capacity for multiple agents, an-
thrax, brucellosis, tularemia,” she explained. Popovic
wanted to teach lab techniques that could be used for an-
thrax, but also could be used for other possible threats. “If
you learn how to do PCR [polymerase chain reaction — a
simple tool that can take a portion of DNA and copy it bil-
lions of time so it can be detected] for anthrax, you have
that knowledge and it can be modified for other diseases, in
a suspicious situation or not — that way the overall level of
public health laboratories is strengthened. That was the key.”
Just six months before 
Popovic and her small team of experts completed training a
national network of laboratorians just six months before the
anthrax letters were mailed.  The seasoned scientist brushes
off questions of “what if” and concentrates on what did hap-
pen.  “This did not come from luck. This came from the vi-
sion of some dedicated people to whom we all owe a lot.” 
“We were ready. I was confident, very confident of our mi-
crobiology. I never doubted what we did and our conclu-
sions. And we never missed. I never had to come back and
say our lab got it wrong,” she declared. 
The stress was not in questioning what they were doing — the
stress came from other places, like creating protocols “on the
fly” for environmental sampling. “In the first days of the in-
vestigation, we settled on using moist swabs to collect the en-
vironmental samples in this event.  At times we also brought
the entire sample to CDC; for example, an air vent filter,” she
said. Also stressful were the constant demands for informa-
tion and the interruptions of the lab work they caused before
the formal chain of communications was established.
We didn’t go home for weeks
“We set up cots in our conference room and our team rotated
between the lab and sleeping. For weeks, some of us went
home only for a brief shower and change of clothes,” she re-
calls.  While some might lament the upheaval in their lives
from the weeks of unrelenting demands, Popovic sees her
work as a tribute to her nation, public health and CDC. “I had
the opportunity to see what CDC does from a front row seat.
The CDC laboratory community wanted to contribute to pro-
tecting this country, and we were really damn good.” 
From the moment her lab confirmed anthrax from a swab
that was swept over the keyboard in the office where the first
anthrax patient had worked, Popovic knew it was not a natu-
rally occurring event. “This was intentional. We didn’t know
who, but we knew we needed to find the source. We needed
to determine where the exposures occurred,” she said. 
Her work on anthrax did not conclude after the last specimen
collected was tested. In the first year following the response,
Popovic co-edited a special publication with 32 scientific pa-
pers on what the public health community did and learned.
However, her lasting lesson is the importance of vision and the
willingness to invest for the future — to resist slipping into com-
placency.  Popovic wishes more than anything to clear the path
for scientists who do public health research. “We have obsta-
cles that should be removed to make it easier for our scientists
to do their work,” she challenges.  Popovic seems undaunted by
the prospect of confronting these obstacles — not surprising
from someone who took a “dead end” assignment not so long
ago that, in turn, helped protect a nation. 
Vision, duty and confidence creates a
no-miss laboratory
Few stories cast the laboratory scientist in a leading role. However, laboratorians acrossthe nation led in the response to the intentional release of anthrax through the mail in
2001. This crisscross of highly prized experts was trained to be able to detect anthrax in lab
specimens with uncompromising precision by CDC’s Tanja Popovic, M.D., Ph.D.Ph
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How do you talk to people
when the unthinkable
happens?
Atrip to Hong Kong in 1997 set CDC’s Barbara Reynolds,Ph.D., on a quest to answer the question, “How do you talk
to people when the unthinkable happens?”  The attack of September 11, 2001, and the subsequent
intentional release of anthrax made answering that question a priority for CDC and public health.
In the late 90s, CDC had declared the world
“past due” for a pandemic, just as the Avian
Influenza H5N1 outbreak in Hong Kong was
killing healthy young adults, reminiscent of
the 1918 influenza pandemic.  The severity of
the outbreak ignited the people of Hong
Kong and the world to ask tough questions of
its public health leaders.
Magnitude of loss not seen in our lifetime
“How do you prepare people to manage loss
at a magnitude we had never seen in our life-
times?  At the time, CDC was projecting that a
severe pandemic could mean one million
Americans would die from influenza. It was
truly unthinkable,” Reynolds said.
When the dual tragedies of 9/11 and anthrax
consumed the nation and public health,
Reynolds saw the challenges that can descend
when responding to the information needs of
multiple stakeholders.  “The need for infor-
mation was voracious during these events. The
public and affected population groups wanted
answers, reassurance and consistency in what
they were being told,” she recalled.
In 2002, with funding from the Department of
Health and Human Services, Reynolds devel-
oped the Crisis and Emergency Risk Communi-
cation (CERC) framework.  “What we have
learned from previous events, including the an-
thrax event, is that the public can withstand am-
biguity if they are allowed to follow the process
health officials are using to find answers. The
key is to tell the public, from the very beginning,
what we know and what we don’t know. We must
continue to explain that ‘things can and do
change.’  A big dollop of humility and openness
is crucial to effective communication,” she said.
Threats perceived on a personal level
“People perceive threats on a very personal
level. When people become aware of a new
threat, they ask themselves ‘What does this
mean to me?  What does this mean to my loved
ones?’  While we have their attention, we should
share what we recommend and where to go if
they want to know more now, or later,” she said.
Reynolds characterized the initial phase of the
crisis communication lifecycle and described
the five most common mistakes made in emer-
gency communication to the public and how
to counter them.
Expect the public to immediately judge the
content of an official emergency message in
the following way: “Was it timely? Can I trust
this source? and Are they being honest?” How-
ever, Reynolds points out that there are five
common mistakes in crisis communication:  
nMixed messages from multiple experts,
n Information released late,
n Paternalistic attitudes,
n Not countering rumors and myths in real
time, and
n Public power struggles and confusion.
“You can help to avoid these mistakes by using
the six principles of crisis and emergency risk
communication, or CERC,” she said.
Be First:  If the information is yours to provide
by organizational authority — do so as soon as
possible. If you can’t, then explain how you
are working to get it. Don’t sit on factual in-
formation. If you do it will leave a vacuum that
may be filled by people who do not have the
public’s best interest at heart.
Be Right:  There is a natural tension between
being fast in sharing information and being ac-
curate. The answer is to give facts in incre-
ments. Tell people what you know when you
know it, tell them what you don’t know, and
tell them if you will know relevant information
later. Release accurate information quickly and
be comfortable with the idea that people can
tolerate getting reliable information in pieces. 
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Be Credible: Tell the truth. Do not withhold
to avoid embarrassment or the possible
“panic” that seldom happens. Uncertainty is
worse than not knowing — rumors are more
damaging than hard truths.
Express Empathy:  Acknowledge in words
what people are feeling — it builds trust. For
example, one may say, “We understand this is
worrisome.” Expressing empathy is the ability
to “put yourself in someone else’s shoes and
then acknowledging what they are feeling in
specific words. It is not “I know how you feel,”
it is a statement that captures, in words, the
emotion they are feeling. 
Promote Action: Give people things to do. It
calms anxiety and helps restore a sense of self-
control.  Give people things to do that they
can actually carry out. 
Show Respect: That means treat people the
way you want to be treated — the way you
want your loved ones treated.  Avoid being
paternalistic in your communication to the
public. 
These best practices and more are included in
a free 250-page course book called, Crisis and
Emergency-Risk Communication (CERC).  “It was
first and foremost a practical guide meant for
communication professionals at all levels of
public health and emergency response to help
them empower the public’s decision making
in a crisis. I wanted it to be accessible, down
to earth, and still based on good science and
research,” Reynolds said.
In the decade following the back-to-back crises
of September 11 and anthrax, the CERC frame-
work has taken hold across the spectrum of
public health and emergency response. “CDC
was committed to sharing the framework as
widely as possible. Today, it is an accepted foun-
dation for risk communication during disasters
of any magnitude,” Reynolds said. 
Today, thinking the unthinkable and prepar-
ing for it is the vital work of many.  It’s help-
ful to know that there is now a shared
pathway to communicating to people if the
worst does happen.  
Photo courtesy of CDC
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“Please tell me, is it safe to
go home?” After 9/11,
science offers comfort
The listening skills honed years earlier at a kitchen table onLong Island helped Rear Admiral Sven Rodenbeck, Sc.D.,
recognize the comfort his science could offer the people of Lower
Manhattan following 9/11. 
On September 11, 2001, the collapse of the
World Trade Center’s twin towers created a
thick cloud of dust that blanketed the neigh-
borhood in gray.  “The environmental sampling
being done was outside on the streets. But, any-
one who lived there knew that a fine coat of
grime seeped into apartments of Lower Man-
hattan,” Rodenbeck explained.
“There was so much to attend to for the na-
tion — our security, getting Wall Street back
up and running —  it was understandable that
the response didn’t immediately focus on in-
door living conditions,” he explained. 
But there was a group of scientists poised to hear
the community’s plea to answer whether it was
safe to return to living in their apartments.
“ATSDR [CDC’s Agency for Toxic Substances
and Disease Registry] was experienced in hear-
ing community concerns about environmental
health and responding.  It was a natural fit for us
to look into residents’ concerns in collaboration
with the New York City Health Department.”
Having led teams for 90 public health assessments
in communities across the nation, Rodenbeck
combines the analytic mind of an engineer with
the empathetic ear of a counselor, an exceptional
bridge between the technical and the emotional.  
“Before 9/11, I remember coming to a com-
munity on Long Island where some of the citi-
zens were highly upset about a potential cancer
risk. One community leader in particular was
very vocal.  I sat down at his kitchen table and
over a cup of coffee I listened. I simply asked,
‘what questions do you want answered?’  We
discussed every question and I explained what
we could and could not answer.  Technical an-
swers mean very little if you don’t first relate on
an emotional level,” he said.
Asbestos was the question on the minds of
most residents in Lower Manhattan after
9/11. “There had been some outdoor sam-
pling that did detect asbestos in pockets. Peo-
ple wanted to know if it was widespread and if
it had seeped indoors,” he explained. “People
were reporting irritation in their throat. They
wanted answers. Asbestos was a big concern.”
When he recognized no one was systematically
addressing the concern, Rodenbeck directed
the sampling in the apartments and condo-
miniums in Lower Manhattan.  Less than two
months after the attack, the team tested 30
residential buildings in Lower Manhattan and
four others above 59th street for comparison. 
Significantly, Rodenbeck’s team pushed for the
analysis to be done by scanning and transmis-
sion electron microscope procedures instead of
the more common light microscope.  “We
pushed the science forward on how to analyze
environmental samples. At the time, the elec-
tron microscope procedures were not the stan-
dard of practice for analyzing environmental
samples,” he said.  “The analysis using the elec-
tron microscope procedures found primarily
fiberglass fibers as the irritant, not asbestos.”
The light microscope could detect the pres-
ence of fibers, but it could not answer the
question whether it was asbestos fibers or
something else. However, the electron micro-
scope procedures could detect the difference
between asbestos and fiberglass fibers.  “As-
bestos versus non-asbestos was a huge consid-
eration for residents in their clean up and
health concerns,” he recalled.
The analysis was shared with residents and
they were encouraged to continue to conduct
frequent cleaning with HEPA vacuum and wet
mop methods of their apartments and con-
dominiums.  “We knew they were concerned.
I’m grateful we had the expertise and re-
sources to address their immediate concerns.” 
The expertise for Rodenbeck included a doctor
of science degree in environmental health but it
also included the vision to listen to concerns
voiced by a community. The resources included
an electron microscope, but it also included the
wisdom found sometimes at a kitchen table. 
FEDERAL RESPONSE
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“CDC-1, cleared for approach” —
Drop-in surveillance on 9/11
What started as a clear, sunny day in Atlanta for CDC’sCaptain Tracee Treadwell, D.V.M., M.P.H., ended in
smoke, soot and tension in New York City. 
“I was at work
when the planes
struck the towers
and many of us
congregated in an
office with a TV,”
she said.  Soon
after, Treadwell and her colleagues on the
main CDC campus in Atlanta were evacuated
because of evolving threat concerns expressed
by the FBI.  
CDC leadership met in an alternate site and
began to develop the response.  Treadwell was
assigned to lead a team to respond to New
York City. 
Before that day, she had been working on bioter-
rorism preparedness projects at CDC. In 1999,
she had served as a team leader for surveillance
and response activities at the World Trade Or-
ganization Ministerial in Seattle.  In 2000, she
did the same at the Democratic and Republican
Convention cities. “We were doing ‘drop-in’ sur-
veillance in high profile events, looking for un-
usual disease clusters or symptoms being
reported within the population,” she explained.
Early warning system
The value of this “drop-in” surveillance, at the
time, was it could serve as an early warning sys-
tem and supplement what was being done by
local and state health departments. 
Despite the closure of airspace over the
United States, Treadwell and three others
raced to a local airport to board a small cor-
porate jet. CDC had previously established a
unique FAA-issued Priority Flight Designation
that allowed people and materiel to be flown
to New York City. They would be looking for
suspect pathogens in the city.
While on the flight up to New York City,
Treadwell started to organize her team’s ac-
tivities, anticipating what support the health
department might need. “There was a lot of
tension because we knew we were truly under
attack,” she said.  
They called us CDC-1
Nearing the city, the pilot invited Treadwell to
come up to the cockpit. “It was early dusk,
night was approaching.  Suddenly, in the dis-
tance was a black dot in the sky and it was mov-
ing rapidly toward us. Of course, my mind
jumped straight to someone is shooting us
down,” she admits.  In seconds, she saw a
fighter jet come up near the plane. “They
were so close I could clearly see the face of the
pilot. They did a wing wave and moved on.
We were the only civilian plane in the sky.
They called us, CDC-1.”
With that welcome to New York, the team
landed. While in the movies everything works
smoothly, this was real life. They found them-
selves hampered by spotty phone service and
difficulty determining just where they needed
to meet up with the city health director. A sher-
iff finally got them where they needed to be.  
“The city health department was fairly close to
ground zero. There was smoke and soot in the
air. A little past midnight we hammered out
what was needed for the bio-surveillance. The
concern was about what agents might be dis-
persed. We developed case definitions and cre-
ated a rudimentary system of surveillance and
assessment. We were assessing hospital capacity
and clinics. We expected to be overwhelmed
with injuries. It was clear this was going to be
labor intensive,” Treadwell remembered.
CDC should send more
They decided the first night that CDC should
send more Epidemic Intelligence Service
(EIS) officers to New York and more than a
dozen arrived within days.  Worker safety at the
site became a primary concern. Treadwell as-
signed her team across hospitals in the city to
collect information about the types of illness
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and injuries being seen in the ERs. “We wanted
to ensure medical supplies and personnel got
where they were needed and to see what sort
of public health recommendations and health
education would be needed onsite.”
The days for Treadwell may have blurred one
into another, but not the scene outside the
temporary site of operation for the health de-
partment:  it remains starkly vivid.  “We were
across the street from Bellevue Hospital.  The
refrigerated trucks for the bodies being re-
moved from the site were next to the hospital.
The constant noise from the motors, the rum-
ble of the refrigerator cars and the sirens were
reminders of the magnitude of loss. It defies
description,” she admits.
I was going to turn back around
Treadwell had little time to adjust to her in-
volvement in the 9/11 response, when she was
thrust into the response to the anthrax letters.
“I needed to return to CDC briefly for a specific
task and I traveled back to Atlanta thinking I was
going to turn back around to New York the
same night.  Again, it was late at night and I
drove up to the CDC campus — the lights were
out [CDC had experienced a temporary black-
out on the campus] and it felt so strange. The
weather was still warm and I walked up to some-
one and they welcomed me back,” she said.  
However, Treadwell did not get back on that
plane. She was again tapped, along with Jay
Butler, M.D., to co-lead the state liaison team.
This was the first team that received all of the
calls from state health departments or private
physicians concerned about a possible an-
thrax case.  The team would literally start the
investigation over the phone and, if needed,
form the team to visit the site in person.   
Treadwell has not left emergency prepared-
ness. Today she is the associate director for in-
fectious disease preparedness in the CDC
center responsible for emerging and zoonotic
diseases.  “I’m proud to have been a small part
of an agency that dealt with a crisis of this mag-
nitude with dignity and dedication,” she said.
When revisiting her early drop-in surveillance
work, she cautions, “we have created some so-
phisticated systems, but surveillance is best
done by supporting the capacity at the state
and local level. No one knows a city and
county better than the people who live there.
We need to invest in them.”  
Photo courtesy of CDC
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From forest fires to terrorism: 
A champion for structure within chaos
Rear Admiral Scott Deitchman, M.D., M.P.H., actually is able to see the forestfor the trees and has diligently championed more coordinated emergency response
at CDC since his work with forest fires in 1988. 
“I was a second year EIS [Epi-
demic Intelligence Service]
Officer working in occupa-
tional health at CDC/NIOSH.  We were investigating
smoke inhalation risks to firefighters at the Yellowstone
forest fires. To work in the fire environment, we had to at-
tend Wildland Firefighter Training and there I was in-
troduced to the incident command system. I saw the
organization it brought to the response,” he said.
Deitchman went on to investigate occupational illnesses
and deaths in diverse workplaces. On the morning of
September 11, 2001, this medical officer returned from
a morning run in Wyoming to see images of the burning
Twin Towers on televisions in the hotel lobby. 
Didn’t want to be out of touch
“I was attending a National Emergency Management As-
sociation conference. We had a number of FEMA staff
out there,” he said.  While the FEMA staff caught a mili-
tary plane back to D.C., others at the conference were
scrambling for available cars to drive back. “I was on tele-
phone and laptop with CDC and was helping from there.
I didn’t want to be out of touch for a three-day drive back
to Atlanta, so I stayed.”
The occupational health veteran helped craft recom-
mendations for workers, including the use of personal
protective equipment and respirators. “It was important
to take the worker’s perspective and understand the con-
ditions in which they were responding,” he noted. During
the anthrax response that started soon after, he led the
working group that addressed both occupational and en-
vironmental health issues including worker protection,
environmental sampling, and building clearance. 
Ultimately, Deitchman led CDC’s first program to ensure
the safety of first responders and other workers respond-
ing to acts of terrorism and other diseases. His path was
set as he went on to lead the environmental and health
work for terrorism and emergency response, preparing
for chemical and radiological disasters. He also collabo-
rated with infection control specialists at CDC to develop
worker safety measures against TB, SARS, monkeypox,
smallpox, and plague.
No formal protocols
When the anthrax response started at CDC, Deitchman
knew we had no effective emergency management system
in place.  “People did exceptionally well with what they
had, but we soon saw information overload and no for-
mal protocols for responding to the demands,” he said.
“At the time of the 9/11 attack, CDC had a small opera-
tions center at Chamblee focused primarily on environ-
mental health response. CDC had to build a makeshift
operations center in the old Building 1 in Auditorium A,
with specialty teams working at side-by-side tables in the
classrooms beneath Auditorium B. It was so noisy you had
to step out to make a cell phone call,” he recalled. An-
thrax also exposed weaknesses in CDC’s efforts to com-
municate with its public health partners and the public.
CDC was criticized for its failure to communicate vital in-
formation to health-care workers and the public. 
“We had to accept the chaotic nature of disasters and the
need to have effective protocols in place to coordinate
and communicate with others,” he explained.  “We finally
modernized and found a permanent place for an emer-
gency operations center.  Based on the incident com-
mand system, it provides an infrastructure to support
specialized teams that can disseminate timely and reliable
information.”
A penchant for calmly managing 
Deitchman discovered, as did his leadership, he had a
penchant for calmly and effectively managing large pub-
lic health responses.  He has been designated as the in-
cident manager for CDC during a number of high-profile
events, including the Asian tsunami disaster, Hurricane
Katrina and the more recent oil spill and Japan disasters. 
Since 9/11 and anthrax, much has changed at CDC in
emergency response. “Compared to 10 years ago, the way
we think is as different as night and day. I can see that
our scientists here get it. We understand the 80-percent
solution. We may not have statistical certainty when we
make a decision and, yet, we have to recommend some-
thing and be willing to modify it later if the information
warrants it. It’s better than doing nothing at all,” he said.
Deitchman perceives himself as a “generalist,” with ex-
perience that spans environmental and biological health
threats — useful for someone managing complex and
overlapping health concerns in an emergency.  What
Deitchman may actually be is a unique public health pro
who can see the forest and the trees. 
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NYC’s Response to 9/11 and Anthrax:
An excellent example of dedication,
commitment and caring.
By Sara T. Beatrice, Ph.D., Assistant Commissioner, New York City Public Health Laboratory
The New York City (NYC) Health Department’s Public Health Laboratory (PHL)first began to participate in the city’s bioterrorism response planning in the late
1990’s. This process established links between it and members of NYC’s Office of Emer-
gency Management (OEM), Fire Department (FDNY), Police Department (NYPD) and
the FBI. NYC’s Health Department was represented at citywide planning meetings, train-
ings and drills. PHL staff conducted biological trainings focused on helping the FDNY
HazMat team identify anthrax, at the time using rapid field tests, becoming key members
of their response teams which were activated whenever a suspicious package or letter was
discovered. It wasn’t unusual to receive a cell phone alert at the lab, be picked up by a first
responder within minutes, and go to the potential bio-threat site (often a women’s health
facility that received hoax letters). All of this was in place years before September 11, 2001.
The laboratory, located in midtown Manhattan,
was close enough to witness the attacks on the
World Trade Center Towers, yet far enough north
to avoid personal evacuation. The role of the lab
became one of support. The avenue in front of the
laboratory was a main route for tens of thousands
of people evacuating lower Manhattan on foot. We
set up a “decon” site on the front steps of the build-
ing to assist individuals covered in fine powdered
dust returning from Ground Zero. The laboratory
opened its doors to assist other government agen-
cies; we set up a makeshift dormitory for children
being housed by the NYC Administration for Chil-
dren’s Services, brought in computers and phone
lines and provided space for NYPD Missing Per-
sons detectives, and became the early site for peo-
ple looking for missing loved ones. The wide,
one-way avenue in front of the building became a
two-way main route for emergency vehicles trans-
porting the victims to the medical examiners of-
fices for months to come; an escort with sirens
announced the transport of each of the hundreds
of uniformed fatality that passed the building. Days
after, PHL staff assisted in collecting environmen-
tal samples at Ground Zero.
Our building also became the back-up emer-
gency operations center for the Health Depart-
ment, whose headquarters were just blocks from
ground zero and forced to shut down until
deemed safe to reoccupy. The Department’s In-
cident Command Structure was in full activation
with many of the agency’s staff involved in re-
sponse to the aftermath of the attacks.
One of the newest units at the PHL was our Bio-
Threat (BT) Response lab, which occupied spaces
shared within our molecular microbiology labora-
tory. Two technologists were funded through an
Emergency Preparedness Cooperative agreement
with the Centers for Disease Control and Preven-
tion (CDC). Some lab equipment, testing reagents
and protocols were also supplied by CDC. The
technologists and space were assigned to other
public health responsibilities when they were not
working on BT specimens. Prior to October 2001,
an Anthrax hoax letter was received every couple
of months. On October 12, 2001, we received our
first Anthrax laden letter which was mailed to the
office of NBC News here in NYC. The ensuing in-
vestigation and media coverage resulted in our
PHL receiving thousands of clinical specimens and
environmental samples for anthrax testing. 
The PHL’s anthrax response took on a life of its
own. Space needs expanded from one lab to 10
labs, including moving from BSL Level 2 into a
BSL Level 3 lab belonging to a research institute
located in our building. We established a separate
law enforcement entrance and specimen intake
area with a decontamination station, locked evi-
dence rooms and we developed an interagency
Chain of Custody protocol enforced by Health De-
partment police officers. The Department of De-
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fense (DOD) set-up three labs within our building
and sent their scientists to do on-site rapid testing.
These laboratories were fully operational in hours
of arrival. Our virology staff went home on Friday
when it was business as “usual” and came in on
Monday to massive security checks because two of
the three DOD labs were using classified assays.
CDC also sent us scientists who were trained in
Biosafety Level 3 (BSL-3) protocols and airlifted in
six tons of supplies to the PHL. We went from two
people working part time on anthrax to 75 people
working on various components of accessioning,
testing, reporting and monitoring biosafety proto-
cols. Our 7-hour/5-day work week extended to a
24/7 schedule. We worked in unison as a single
team. It was an excellent example of selfless dedi-
cation, commitment and caring.
As a group, we continued to receive many samples
— coffee tables from a department store, suitcases
from the airport, dollar bills that had been rolled
up, you name it. A sampling protocol was devel-
oped to standardize and simplify the collection
and transport process to ensure the safety of staff
at all links in this incredible chain from the field
to the laboratory.  The entire response was a les-
son on how to reshape our public health labora-
tory. Originally, our lab had subject matter experts
who were responsible for their unit, staff and spe-
cific testing mission, i.e., the tuberculosis (TB) lab
only did TB testing and the Retrovirology lab only
tested for HIV; that is until the week after the NBC
letter, then we set up a more unified response.
The PHL became one cohesive unit: the chemists
did the molecular testing; the HIV folks — who
were doing enzyme immunoassay tests and Poly-
merase Chain Reaction (PCR) tests — became BT
PCR responders; and our microbiologists, who
were classic bacteriologists, did the BT micro
work; all were now identifying a weapon of mass
destruction  —  Anthrax. 
The response certainly showed what kind of
people work in public health because everyone
willingly put in very long hours doing tasks that
had often little to do with their regular jobs. Un-
known to the public outside of the PHL, their
personal lives were put on hold for months.
In the years since 9/11 and Anthrax 2001, much
has happened to strengthen the NYC Public
Health Laboratory. We set up a more robust lab-
oratory that included a BSL-3 component for
bio-threat response, ultimately, expanding this
capability to an entire floor. We also created a
cross training program that prepared staff on
how to undertake various surge responsibilities.
Working under the unified Laboratory Re-
sponse Network (LRN) of CDC, protocols, state
of the art equipment and funding for staff be-
came available. Initially ample funding was avail-
able, which has eroded over time.
In 2006, we put all of this into action responding
to an interstate case of human anthrax. Trained
responders were deployed who could triage the
collection of potential bioagents and decide
which samples needed to come to the lab and
which did not. Sampling and testing were focused
and the PHL didn’t get overrun with submissions.  
Now, if there are outbreaks or emerging
pathogens, the network is in place to send out blast
communications to link the local medical and lab-
oratory community to the Health Department;
like we did for the 2009 Influenza pandemic which
erupted in the schools of NYC and spread through
the nation within weeks. We ramped up in a few
days to cross-train staff, validated testing systems
and successfully set up our incident command sys-
tem. It was a remarkable difference from 2001. 
I can not state enough how willing and able the
public health world is to handle potential bio-
threats. However, that doesn’t mean we aren’t
vulnerable.
The biggest threat is a sustainability of funding
— it’s just not there. So much of the response
was driven and made possible through federal
resources. Unfortunately, these federal grants
have consistently been cut so that even service
contracts for equipment purchased under the
grants can’t be maintained. 
Funding is also tied to the workforce. Federal
grant support for staffing is decreasing annually
for initiatives relating to PHL emergency pre-
paredness, as well as existing and emerging dis-
eases. In addition, challenges to hiring staff
compromise our ability to cross-train staff for
surge responses and, ultimately, our readiness.
The laboratory community is an aging population
and fewer people are going into this field. Budget
cuts and non-competitive salaries with the private
sector are some of the biggest challenges we face,
not just for emergency preparedness but for main-
taining high quality laboratory systems. Commer-
cial, university and hospital laboratories will not
“risk” their mission and operations to perform the
services of your local, state and federal public
health laboratories. With bare resources, the pub-
lic health community can respond to whatever
comes its way for a short period of time. We need
to ensure the resources and people continue to
make it into these vital jobs. As first or last re-
sponders in a health related emergency, your pub-
lic health laboratory is your only laboratory whose
mission and staff are dedicated and trained to
handle these responsibilities.  
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The Anthrax Events In Florida
By Phil Lee, MSc FIBMS, Biological Defense Coordinator, Molecular Biology, Florida Department of Health
Bureau of Laboratories 
In March 2000, I accepted the newly created position of Biological Defense Coordi-nator at the Florida Department of Health (DOH), Bureau of Laboratories (BOL)
in Jacksonville.  I had worked for the BOL for almost five years as a microbiologist in the
virology, tuberculosis and molecular biology laboratories.  In response to a growing con-
cern for bioterrorism, the Centers for Disease Control and Prevention (CDC), the Fed-
eral Bureau of Investigation (FBI) and the Association of Public Health Laboratories
established the Laboratory Response Network (LRN) in August 1999 with the mission
to provide a robust laboratory infrastructure to detect agents of bioterrorism.  In 2000,
three of the five Bureau of Laboratories’ locations (Jacksonville, Miami and Tampa) be-
came LRN reference laboratories.  Pensacola was later added in the summer of 2005.  
In October 2000, I participated in the first training
course at CDC to identify agents of bioterrorism.
The week-long course covered the organisms of
greatest concern, including Bacillus anthracis, the
causative organism of anthrax.  Almost a year to the
day we received a call late in the afternoon from a
clinical laboratory in Fort
Lauderdale, Integrated Re-
gional Laboratories (IRL),
that they were sending us a
patient’s specimen that
they could not rule out B.
athracis.  In the previous
months the BOL had
trained clinical laborato-
ries, including IRL, on the
microbiological methods
used to rule out bioterror-
ism threat agents and the
referral procedures in the event that they could not
rule out such an agent. I received that specimen
around noon on October 3, 2001.  I immediately
started the analyses that I had been taught at CDC.
At that time, LRN reference laboratories had the
capability to confirm the identification of biothreat
agents using only conventional microbiological
techniques, which involve culturing and growing
the organism.  This can take up to 24 hours for B.
athracis.  Rapid molecular methods, such as real-
time PCR, that detect DNA specific to the organ-
ism were not available to us at that time.  However,
CDC had already performed a multi-center valida-
tion study for B. athracis DNA detection and re-
leased the method to the public health LRN
laboratories mid-October 2001, only then allowing
detection of the organism in less than six hours.  
Without the benefit of the rapid molecular meth-
ods, two key conventional microbiological meth-
ods were required to identify B. athracis, one of
which required overnight growth of the organ-
ism in culture.  Throughout the afternoon and
evening of October 3, I ran the one key test and
obtained a positive result
for B. athracis a little after
10:00 p.m. that night.
During this time, CDC
arranged the transfer of
the specimen to Atlanta
for additional testing and
characterization.  I left the
laboratory at 11:30 p.m.
and returned the follow-
ing morning to read the
results of the second key
test.  At 8:30 a.m. on Oc-
tober 4, 2001, I confirmed the identification of B.
athracis in the index patient who had been ad-
mitted to JFK Medical Center in Atlantis, Florida,
and whose specimen had been submitted by IRL.
The sample was flown to CDC on October 4.
During my training as a Biological Defense Co-
ordinator, I had learned that a typical bioterror-
ism scenario could involve an intentional release
of an organism in a localized, highly populated
area, such as a football stadium.  In such an
event, numerous patients would be expected
from a small geographical area.  Since this fol-
lowed so closely the tragedy of September 11th,
the Florida Department of Health sent an alert
to all hospitals and physicians within the state re-
questing immediate notification of any patient
exhibiting symptoms of anthrax.  One additional
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patient was identified that had been hospitalized
since October 1.  Because only one additional pa-
tient matched the criteria rather than hundreds,
I was hopeful that these were naturally-acquired
infections, not an act of terrorism.  However, the
fact that anthrax is not endemic in Florida was
more than a little concerning.
In addition to surveillance for new cases of an-
thrax, the DOH Bureau of Epidemiology inves-
tigated both cases identified.  They obtained
samples from areas where the patients had been
prior to hospitalization, including their work-
place.  These samples were sent to the BOL  —
Miami.  A nasal swab of the second patient was
also tested by the BOL.  Both this nasal swab and
a sample taken from the index patient’s com-
puter workstation tested positive for B. athracis.
Since the second patient was a coworker of the
index patient at American Media Inc. (AMI)
and the index patient’s computer at AMI was
contaminated with B. athracis spores, it then ap-
peared that this was an intentional release at the
workplace.  Further laboratory testing on sam-
ples collected by the Environmental Protection
Agency (EPA) confirmed this.
Following a press release, on October 8, 1,114
people who worked in or had visited the AMI
building during the previous 60 days presented
at the Palm Beach County Health Department
(CHD) for prophylactic ciprofloxacin.  Palm
Beach CHD collected 1,076 nasal swabs and sub-
mitted them for testing at the BOL  —  Miami.
One additional AMI mail worker tested positive,
but never developed symptoms of the disease.
The additional laboratory testing determined
that the AMI mail room and company mail van
were grossly contaminated so it was assumed
that the source of the B. athracis spores was pos-
sibly via the U.S. Postal Service.  Once this was
communicated through the media to the gen-
eral public, people felt they were potential vic-
tims and started seeing mail and common
spilled household white powders (flour, corn
starch, etc.) as potentially spore-laden materials.
On October 10, 2001, we started to receive these
suspicious materials at the BOL.  The first such
sample received was delivered by our FBI Weapons
of Mass Destruction Coordinator.  It was a Federal
Express package of film slides and negatives sent to
a Jacksonville business from the AMI photographic
editing department.  Thankfully, the presence of
B. athracis was able to be ruled out, to the relief to
the business owner and the employees.  
The following day saw a steady increase in the
numbers of such samples received and it soon be-
came obvious that help was needed.  Fortunately,
the BOL — Jacksonville laboratory is one of the
largest tuberculosis testing laboratories in the
United States.  TB laboratories are high contain-
ment facilities, designated biosafety level 3 (BSL-
3), with engineering controls and special
microbiological practices, including the use of res-
pirators, designed to ensure the safety of labora-
tory personnel and prevent release of organisms
into the environment.  BSL-3 laboratories are also
required to safely handle and work with B. athracis.
With such facilities, including many biological
safety cabinets and isolation rooms, and many
staff trained to work in them we were able to man-
age the increased workload.  Employees volun-
teered and were reassigned with everyone having
a role to play.  At BOL — Jacksonville, we had 18
microbiologists from the TB and General Bacte-
riology laboratories participating in the analyses
of samples; Yvonne Salfinger, Microbiology Labo-
ratory Administrator, organized staffing; Susanne
Crowe, Virology/Serology Laboratory Adminis-
trator, managed the sample database; Dr. Dean
Willis, Chief of Infectious Diseases and Clinical
Services, facilitated laboratory operations and lo-
gistics and was media liaison; Dr. Ming Chan, Jack-
sonville Laboratory Director and Bureau Chief,
coordinated the activities of all BOL sites and
communicated essential information to the
Florida Department of Health Secretary and Gov-
ernor.  In addition, a plethora of support person-
nel were involved in sample receipt, data entry,
ordering and receiving supplies, financial man-
agement, information technology support and re-
sults reporting.  At the height of the crisis, the
laboratory operated 18 hours per day, seven days
a week, with staff work hours staggered to opti-
mize availability to manage the workload.
As the crisis escalated with additional anthrax vic-
tims identified in other states, the work volume
remained high for several months.  Between Oc-
tober 2001 and June 2002 the BOL  —  Jack-
sonville, Miami and Tampa LRN laboratories
processed 10,690 samples for B. athracis.  This in-
cluded both clinical patient specimens from our
hospital sentinel laboratory partners as well as
environmental samples, including many hoax
threats.  One of the more concerning of these
was perpetrated by Clayton Lee Waagner.  Waag-
ner, at the time one of the FBI’s 10 most wanted
fugitives, mailed letters and Federal Express
packages to more than 250 abortion clinics na-
tionwide.  The packages contained powder laced
with high concentrations of Bacillus thuringiensis
spores.  B. thuringiensis, an insect pathogen used
as a biological insecticide, is genetically closely
related to B. athracis, but is not harmful to peo-
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ple.  Between October 15 and 17, 2001, BOL  —
Jacksonville received and tested seven such let-
ters mailed to Planned Parenthood Clinics in
Florida and an additional seven Federal Express
packages received November 8 through 10,
2001.  These tested positive for B. thuringiensis
and negative for B. athracis.
The types of environmental samples received were
variable to say the least.  From the obvious bulk
mail from post offices, suspicious mail from home-
owners and powder samples (including powdered
doughnuts), to the more obscure airline seat cov-
ers, dead birds, body bags, teddy bears, disposable
underpants, a Marilyn Monroe effigy and resi-
dential mail boxes together with post and con-
crete anchor.  It seemed nothing was too bizarre,
but each presented a new challenge, not only to
those of us in the laboratory attempting to safely
handle and provide quality testing, but also to the
first responders collecting and packaging such
items for delivery to the laboratory.
The partnerships we had begun to develop with
the first responders during the previous year
were solidified.  We worked so closely with a mul-
titude of agencies, such as local, state and fed-
eral law enforcement officers, postal inspectors,
fire department hazardous materials (HazMat)
teams and police bomb squads, that we knew
each other on a first name basis.  The same can
be said of our clinical partners in the hospital
sentinel laboratories and county health depart-
ments. Over the past ten years these partner-
ships have continued to strengthen.  With the
direction of Associate Bureau Chief and BOL —
Tampa Director, Dr. Phil Amuso, and the Uni-
versity of South Florida’s Center for Biological
Defense, we provide environmental sample col-
lection training to all HazMat and first respon-
der personnel in Florida and sentinel laboratory
biological defense training to all clinical micro-
biology laboratories.
Despite the increased workload and extended
working hours, throughout the entire anthrax
event, the BOL continued to deliver all daily
public health services.  Each day thousands of
specimens were received and tested for tuber-
culosis, HIV, hepatitis viruses, sexually transmit-
ted diseases, rabies, influenza, food borne
illnesses, genetic disorders of newborns and
many others.
Throughout the anthrax events the BOL LRN
laboratories proved to be essential to both the
public health investigation as well as the FBI’s
criminal investigation.  The laboratory con-
firmed B. athracis as the cause of infection in
the index patient; identified
other exposed persons by
isolating B. athracis from the
nasal swabs of the second pa-
tient and an asymptomatic
AMI mail worker; ascer-
tained a workplace exposure
to spores; and together with
the EPA determined the
mechanism of dissemination
of the agent via the U.S.
Postal Service.
The foresight that went into
the establishment of the LRN
was phenomenal.  Before the
inception of the LRN, the ma-
jority of state public health
laboratories were not able to
quickly and definitively iden-
tify B. athracis.  Cultures would
have to have been sent to
CDC for identification.  The
decentralized LRN approach
gave state and local public
health laboratories the capa-
bility to identify many bioter-
rorism threat agents.  A key
part of the LRN is a CDC com-
prehensive training program
for biological defense person-
nel such as me, on which I
have been an instructor since
2005, as well as sentinel labo-
ratory outreach performed by
the public health LRN labora-
tories.  Without the LRN, the
2001 anthrax events could have taken a very dif-
ferent path, likely delaying initial patient diagno-
sis and almost certainly lengthening the
turnaround time for environmental sample test-
ing due to the overwhelming number of samples
to be tested at CDC.  The major consequence in
delaying diagnosis, particularly with organisms
such as B. athracis, which can be fatal if not rec-
ognized early in the course of infection, could
have been a much higher incident of clinical
cases and resulting mortality.
The lessons learned from the anthrax events of
2001 and the subsequent injection of additional
state and federal funding has greatly increased
Florida’s capability and capacity to respond to
public health emergencies, whether due to ter-
rorism, natural disasters, or outbreaks or emerg-
ing infectious diseases, such as SARS and 2009
H1N1 Influenza.  
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During 9/11 and Anthrax
While it appeared that the 9/11 and anthrax tragedies were unforeseen andcaught the country totally unprepared, public health departments and
laboratories had been planning for disaster for years. 
For public health laboratories, the coordinated na-
tional response framework began with the forma-
tion of the Laboratory Response Network (LRN)
by the Centers for Disease Control and Prevention
(CDC), the Federal Bureau of Investigation (FBI)
and the Association of Public Health Laboratories
(APHL). This national resource became opera-
tional in August 1999 and continues as a collabo-
rative effort among the founding partners. That
early framework has been strengthened by the in-
fusion of federal preparedness funding in the
decade since the events of 2001, but support is
eroding and new challenges face the network.
When the planes hit the World Trade Center tow-
ers, the LRN steering committee was meeting at
CDC. The first crisis driven action of the LRN was
the preparation and distribution of a message re-
minding member laboratories to consider the risk
of secondary attacks and to be on the alert for un-
usual packages and samples. The LRN planning
provided the contact information needed to
quickly send critical information to every state
and major city public health laboratory. 
The initial planning, development, distribution
and use of common laboratory assays, training
of personnel and consistent use of those proce-
dures prevented total chaos when anthrax
spores were dispersed through the mail in 2001.
Laboratories would have cultured those ‘white
powders’ and other environmental specimens
and used unfamiliar testing protocols to identify
the organisms that grew. Misidentification would
have happened and the credibility of the state
laboratories would have been challenged.
Hitting Home
The people in Virginia who contracted anthrax
survived. Part of the reason for the positive out-
come was the responsive infrastructure devel-
oped through the LRN. 
One patient went to an emergency room and was
discharged after having a blood sample drawn for
culture. When the blood culture developed growth,
the hospital sent the lab the positive bottle. Within
40 minutes of receiving the specimen, the LRN
polymerase chain reaction was reactive for Bacillus
anthracis. The patient returned to the hospital and
was successfully treated with the appropriate antibi-
otics. The LRN provided the assay, the equipment,
the reagents and the training. Having that labora-
tory infrastructure available prevented deaths, and
having consistent, reliable laboratory testing avail-
able in every state and major city helped calm the
hysteria after it was determined that anthrax was
being sent in letters through the postal system.  
The Division of Consolidated Laboratory Services
(DCLS) avoided inundation with low or no priority
samples because relationships had been built.  Dis-
trict Health Departments, local police departments,
fire departments and hazardous materials teams co-
ordinated sample collection and triage to assure
that only credible samples reached the laboratory.
The system didn’t always work, but the laboratory
wasn’t completely overrun with samples. Still, the
laboratory ran out of space to secure samples be-
fore and after analysis.  People worked 16-hour days
to keep up with the workload; white powders and
other samples were tested for anthrax and timely re-
ports were issued to the submitters. And the labo-
ratory system learned from the experience.
A Decade of Progress
Still the relationships weren’t perfect. When an-
thrax hit, hazmat teams and many local respon-
ders had not identified DCLS as their laboratory.
They do today and they know how to access and
use DCLS. While the early response was good, the
interactions today between the local first response
communities and the lab have improved dramat-
ically. First responders train with laboratory per-
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sonnel. Procedures now instruct first responders
to split the sample and send a portion to DCLS
before exhausting the sample with field assays. Pri-
ority and high profile samples are split and a por-
tion is sent to DCLS for a definitive analysis. 
In 2001, DCLS was in an old building that didn’t
have secure evidence storage for samples before
testing. Locks were put on the conference room
to secure the ‘evidence.’ Shelves were added.
Someone stood at the building entrance to log
samples and assure chain-of-custody and in-
tegrity of packaging was intact. Without a Labo-
ratory Information Management System (LIMS)
everything was logged, analyzed and reported
on paper. Samples were placed in red bags and
moved to the pre-analytical evidence room. The
lab did not have an evidence storage facility for
samples that had already been tested. An un-
used firing range in the basement was retrofit-
ted for post-analytical evidence storage.
Retrospectively, the attacks proved to be a great
training exercise. The ability to respond has been
improved by the Public Health and Emergency
Preparedness cooperative agreement. That surge
of funding helped restore the failing public health
infrastructure and provided staff, new equipment
and a far more robust training mechanism. 
The preparation/capability/infrastructure is
eroding — state and local salaries have not kept
up with the times; we lose good people to posi-
tions in other laboratories or to other careers.
Routine equipment maintenance agreements
are essential to assure timely service and pre-
ventive maintenance on critical equipment, yet
those agreements are expensive. A maintenance
agreement on a $150,000 piece of equipment
can cost $20,000 or more per year. 
Unfortunately, aging of the existing laboratory
infrastructure isn’t the country’s only vulnera-
bility. Currently, the country has very limited ca-
pability and capacity to test environmental
samples for chemical weapons materials, and
few laboratories have the equipment and ex-
pertise to test human samples for radiation. If
someone in the United States was exposed to
Polonium, similar to the event that occurred in
England, our total country-wide laboratory ca-
pacity would be overwhelmed in hours. Radia-
tion testing equipment is expensive and trained
personnel are in very short supply. Ramping up
laboratory capability and capacity after an attack
would be incredibly difficult if not impossible. 
My view of laboratories and their relationship to
public health might be different than others be-
cause of the way the Virginia laboratory is struc-
tured. We are not just a state public health lab
charged with providing support for the Virginia
Department of Health.  DCLS also provides lab-
oratory consultation and support for the Depart-
ment of Environmental Quality, the Department
of Agriculture and Consumer Services, the De-
partment of Labor and Industry and many other
local, state and federal Agencies.
The laboratory is a Division in the Department
of General Services, an agency that does not use
DCLS testing. Consequently, the laboratory had
to build strong relationships with various gov-
ernment agencies, law enforcement groups and
others to ensure the pipeline of samples and
other responsibilities flows efficiently. 
We moved into our new building in May of 2003.
A training lab was a priority in design. We knew
that access to laboratory training was essential
to having a robust laboratory system in Virginia.
Science changes and the laboratory must adapt.
Laboratory space was designed for maximum
flexibility to accommodate change without ren-
ovation. The events of 2001 provided many in-
sights into how that flexibility might be needed.
LIMS now support critical laboratory functions.
We are better staffed. We have much more ca-
pacity and more equipment. 
If a similar attack occurred today, the laboratory
would be far more capable of providing timely
and accurate laboratory support.
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Connecticut’s Anthrax Experience of
2001:  A Public Health Laboratorian’s
Perspective
By Diane Barden, Bioterrorism Response Laboratory Supervisor, Connecticut Department of Public Health —
Public Health Laboratory
In March of 2001, I joined the State of Connecticut Department of Public Healthas a Bioterrorism (BT) Coordinator in the Public Health Laboratory.  My pri-
mary responsibility focused on training hospital microbiology laboratory staff to
spot potential bioterrorist threats.  
My role would drastically change in a matter of
a few months, after Ottilie Lundgren, a citizen
of Oxford, Connecticut, became the last known
victim of the anthrax attacks in November of
2001.  Instead of focusing on training, I became
an integral part of the investigation and re-
sponse team.  At the time, the late Dr. Katie Kelly
was the Laboratory Director. She had previously
been the Chief of the Laboratory Practice Train-
ing Branch at the Centers for Disease Control
and Prevention (CDC) and had participated in
bioterrorism preparedness. She was instrumen-
tal in coordinating the laboratory response to
the anthrax mailings in Connecticut.
In just a short time, the training conducted in
Connecticut hospitals paid off, as we quickly
identified Bacillus anthracis from specimens of
the suspect anthrax case. CDC flew to Con-
necticut to pick up our samples for further test-
ing, which confirmed our results and worst fear
— a Connecticut resident died due to inhala-
tional anthrax.  
The Connecticut Department of Public Health
quickly became part of a multidisciplinary re-
sponse team that included representatives from
public health, CDC, law enforcement, the U.S.
Postal Service and others working together to
determine the source of the anthrax and pre-
vent further contamination and infection.  
How Ms. Lungren was exposed was a mystery
then and now. Our epidemiologists scoured Ms.
Lundgren’s home and the places she frequented
such as her church, beauty salon, a restaurant
and even the cars she had traveled in, taking
hundreds of samples.  These samples were trans-
ported to the Public Health Laboratory for test-
ing.  The death of a nearby Connecticut resident
was investigated and it was concluded that he
died of natural causes, however, the laboratory
tested mail recently received by the deceased and
it was positive for B. athracis.
This led the investigation to the local postal dis-
tribution center, where we found anthrax in the
processing machines.  Subsequently, 450 postal
employees had nasal cultures performed to en-
sure no one else was exposed to the deadly an-
thrax spores, all of which tested negative. Once
we determined which machines were involved,
decontamination was necessary.  Using valida-
tion methods available at the time to confirm
decontamination, there were no additional
traces of anthrax recovered. However, in April
of 2002, we found anthrax had remained in the
facility and a more extensive building-wide de-
contamination was done.  
After we offered testing to the public, the public
samples started flooding in to the laboratory.
We accepted new samples from 8:00 a.m. to 9:00
p.m. Samples included everything from grocery
store floors to confetti, packing peanuts and
white powder contained in malicious letters. We
also processed postal samples from New York
and New Jersey and uncovered yet more posi-
tives.  In all, we processed 50 or more samples a
day, every day for several weeks. 
My staff was great, working long hours under
great pressure. We had six staff that performed
the testing and virtually the rest of the entire lab-
oratory staff provided support services for every-
thing else.  I will always remember the
Thanksgiving dinner we shared that year in the
Public Health Laboratory.  One of our adminis-
tration staff and his wife cooked a turkey for us
with all the trimmings. It was not exactly where
I wanted to be during Thanksgiving, but it was
one that I’ll always remember.
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We learned how to manage this crisis as we went
along, and realized we needed some additional
expertise. For example, we hired an evidence
control officer to manage chain of custody con-
trol and associated law enforcement issues. He
taught us how to receive samples correctly and
preserve evidence.  He also helped develop and
deploy the emergency response kit that is in
every emergency room in acute care hospitals in
Connecticut today for the collection of biologi-
cal, chemical and radiological samples. 
Looking back over the past 10 years, we have
come a long way in regard to our ability to re-
spond to a bioterrorism event. Biosafety Level 3
laboratory space was not a standard feature in
state public health laboratories, as it is today.  We
built a modern Biosafety Level 3 laboratory, sig-
nificantly increasing our capacity to process po-
tentially weaponized samples.  We train regularly
with first responders and law enforcement, and
have systems in place to properly manage and
preserve evidence. In all hospitals in the state,
laboratory staff receive annual proficiency train-
ing to recognize select agents and emergency
rooms receive training on what to do when they
encounter a suspect bioterrorism agent.
In 2007, there was a naturally occurring case of
anthrax in Danbury, Connecticut.  This time,
our response went much smoother than in 2001.
We knew how to correctly process the samples,
had state of the art testing methods and the nec-
essary reagents and had strong relationships
with law enforcement and other partners. 
When I came to the Department of Public
Health in 2001, I didn’t think I would be on the
front lines of responding to a major bioterrorist
incident, and I hope I don’t have to go through
a similar experience in the future.  But I’m
proud of our response and the work we’ve done
since 2001 to enhance Connecticut’s capacity to
respond to future threats.
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Lab’s Lab: How Missouri’s State Public
Health Laboratory Helped the Public
Survive Anthrax
By Eric C. Blank, DrPH, Senior Director, Public Health Systems, Association of Public Health Laboratories
On September 7, 2001, I broke my leg. On September 11, 2001 a senior scientistran down to the lower floor of our lab with the most shocked look on her face
I have ever seen. Much like my leg, that was the initial feeling (or lack thereof):
numbness. We had prepared for something like 9/11 and the anthrax attacks that
followed — but we could never really imagine something like that until it happened.
In 1997, we began working with law enforce-
ment to put in place protocols should a biolog-
ical attack occur. By 2001, we had a level of
understanding with the Federal Bureau of In-
vestigation (FBI) and I, as head of the Missouri
state lab, had met with the FBI weapons of mass
destruction coordinators to create protocols for
how to process suspected biological agents. Be-
cause of these relationships, it was much easier
to coordinate with local law enforcement and
draw resources from our state health depart-
ment to ensure first responders knew how to
process potential biological agents. 
Consequently, we had the authority to exercise
more control over what was submitted to the lab-
oratory and what we had to test. This saved us
from being completely overrun with samples
like some other states. This groundwork proved
to be invaluable. 
As head of the Missouri state laboratory, I knew
my job was to keep things running as close to
normal as possible. This meant efficiently testing
all the powders and other oddball things that
came in, but also ensuring that we were meeting
our routine obligations such as the newborn
screening, since babies were still being born. In
short, we had to handle the influx of samples
while not cutting vital services to Missourians. 
Immediately after 9/11 we enacted our emer-
gency response plan which included specific
measures for microbiological attacks. We ex-
tended work hours and set up rotations to han-
dle the massive amount of samples. Instead of
working 8:00-5:00, we worked 6:00-8:00 and had
people on call 24 hours a day. But I made sure we
rotated people through so as not to burn them
out. Given the shock of the events, we had to be
careful not to over-stress people more than they
were already. In total, we ran around 500 samples
over the course of about five weeks — with most
coming during the first three weeks. We also
processed a hundred or so additional samples for
the Centers for Disease Control and Prevention
(CDC) because a pallet wound up in Kansas City
that was originally in New Jersey. 
In total, we had done a pretty good job prepar-
ing for some sort of tragedy — we knew there
would be a massive influx of work. However,
what we didn’t account for nearly enough was
the need to help the public work through these
tremendous tragedies. 
Lab’s Lab
In a sense our lab staff was lucky. With security
heightened, our building was determined to be a
possible target so we were given guards. Our secu-
rity detail was pulled from the state fire marshals
office and with him came his Labrador retriever.
Quite simply, the dog helped our workers. If the
marshal and his dog were there to greet them in
the morning, they knew all was well. The dog
would greet every person with a wag of its tail. The
dog was calming and reassuring — it was some-
thing normal during a time that was anything but.
We rechristened the dog “the Lab’s lab.” 
I knew that we had to try and provide the same
level of comfort to the public.
As the head of the lab, I took it upon myself to be
the front end of the response and shield my staff
from the media so they could perform the real
and potentially life-saving tasks. Since the media
knew where the suspect anthrax samples were
coming, I worked with the health department ad-
ministration and became the spokesman because
I knew what to say, what not to say and that I
could give the right amount of information suc-
cinctly — so I spoke with media across the state
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for about a month — almost nonstop. It was cru-
cial to place myself at the center of the informa-
tion because there were so many rumors
circulating and it was difficult to coordinate
within all levels of the health department. 
That said, I don’t know if there was much we
could do to completely ease the public’s con-
cerns. Nevertheless it’s vital to work with the
public and disseminate clear, concise and con-
sistent messages. I think this is overlooked as a
critical element in response to any tragedy.
As we tried to calm the public, samples came in
less frequently, eventually returning to the norm
of two to three environmental samples per month. 
Lessons Learned
Aside from the learning curve involved with in-
forming the public, the biggest challenge we had
was that no one was really battle-tested when it
came to operating the incident command center
concept. This concept is “a set of personnel, poli-
cies, procedures, facilities and equipment, inte-
grated into a common organizational structure
designed to improve emergency response opera-
tions of all types and complexities” according to
the United States Center for Excellence in Disas-
ter Management and Humanitarian Assistance.
Once samples stopped coming in, we immedi-
ately worked to get people trained in incident
command. With the funding from the Public
Health Emergency Preparedness (PHEP) agree-
ments, Missouri and other states were able to
stand up their emergency response operations,
specifically utilizing incident command princi-
ples. This represented a major shift in how labs
prepared for potential attacks.
By the time H1N1 rolled around, there was a dra-
matically improved ability to quickly stand up
emergency response centers — a capability we
didn’t have in 2001. This really represents the big
change in the last decade. While we incorporated
some of these response strategies in 2001, we
were slower to get there and it wasn’t under one
unifying umbrella. Now with all the training and
certifications, it can be stood up much quicker. 
Quite simply, with incident command, we can bet-
ter respond on a broader front as a health depart-
ment and lab to the public and are better equipped
to organize the response to the event itself. 
We Need to Keep Going
The current budget situation and economic cli-
mate has started to erode the response capabil-
ity and capacity in public health laboratories and
agencies. I’m not trying to overstate this but the
PHEP agreements have been diluted by funding
more activities with the same amount, or less
money.  States have laid people off, reduced
services and lost people who have the response
expertise and experience. 
We have worked hard to build incident com-
mand and expanded the number of labs with in-
formation management systems. However, my
real fear is that now that we can take lab data and
zip it from state-to-state and get it to providers
and public health agencies, there won’t be any-
one in the labs to do the tests and in the health
agencies who know how to act on the informa-
tion. I am truly concerned that what we have
built up to respond to these events (which
worked for H1N1) is eroding significantly.
If you said to me that tomorrow we’ll have an-
other event, I’d think that you’ll see states scram-
ble to be able to respond. We are probably
victims of our own success because the H1N1 re-
sponse went so well that the laboratory role is
taken for granted and undervalued by policy-
makers and our public health colleagues.
My concern is not abstract. When you think about
what is happening in Japan with their nuclear
plants, it reminds me of the situation in Chernobyl
in the late 1980s. Back then, the United States had
many sites throughout the country monitoring air.
Yet now we are looking to just state capabilities on
the west coast to monitor air quality and possibly
standing up 10 more labs to monitor air quality
across the country. If there is a release, we need to
know more than just what is dropping on the west
coast. What about the central part of the country?
The east coast?  With this recent event in Japan and
our experience 10 years ago, we know a biological
event requires a country-wide response, yet we
haven’t maintained that capability and there does-
n’t seem to be the interest or will to restore it. 
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A decade after the Anthrax Attacks we
are better prepared but can we 
maintain Laboratory Preparedness
activities at this level?
By Victor Waddell, Ph.D., Bureau Chief, Arizona Public Health Laboratory, Arizona Department of Health Services
Just before September 11, 2001, I joined the newly formed BioEmergencyResponse Section at the Arizona State Public Health Laboratory. As a public 
health scientist, I was one of only a few people in this section, but we rallied together
to tackle all the challenges — from location and space to staffing and supplies.
Prior to the first confirmed anthrax attack and
in preparation for a potential bioterrorist attack,
we had to ensure the BioEmergency Response
Lab would be fully functional to serve the needs
of Arizona. This was incredibly difficult as we
had an older facility which made bringing on
new programs a challenge. Before purchasing
new equipment and instruments, we had to
make sure the footprint of the equipment would
actually fit in the lab. We looked at every inch of
available space and used it as best we could. 
At the outset of the anthrax response, we were
basically operating out of a closet. We built a
makeshift lab in an unoccupied office — this be-
came our BioEmergency Response lab.
While our group was small, we had great support
from staff in other sections of the lab. This was
incredibly important as we watched our sample
volume increase rapidly. In fact, we received
over 1,000 samples in the six months that fol-
lowed the attacks. We worked morning, noon
and night, every day, including Thanksgiving,
Christmas Eve and Christmas with three shifts
every day. We tested everything from letters to
full suitcases that had been rubbed against dry-
wall — try getting those types of objects into a
biosafety cabinet.  
In addition, the resources we needed posed a
significant challenge, especially since the testing
demand was greater than anyone could have
imagined. Further exacerbating the issue, real-
time polymerase chain reaction and specific flu-
orometry tests were in their infancy in our
public health laboratory. We had to perform all
tests with culture or biochemical methods,
which could take up to 72 hours before you
could see growth of anthrax if it was present in
the sample. We met the testing demand, but we
would have faced difficulties if the samples kept
flooding in at such significant numbers. 
As we responded to the attacks, we began to
work closely with the Emergency Preparedness
and Response Bureau at the Arizona Depart-
ment of Health Services, the Department of
Public Safety, Federal Bureau of Investigation
(FBI), local health departments and law en-
forcement agencies to develop protocols for
bringing samples to the lab for testing, main-
taining chain of custody requirements, and pro-
tecting those individuals handling and shipping
the samples from any hazards.
In addition, we started coordinating at the na-
tional level with the Association of Public Health
Laboratories (APHL) and Centers for Disease
Control and Prevention (CDC) Laboratory Re-
sponse Network (LRN). APHL became a great
conduit for information exchange which helped
us deal with questions and calls from the news
media; something we had never had to deal with
on this scale before. Samples were flooding in
and phones were ringing off the hook.
In the decade since the anthrax attacks, things
have changed dramatically. While we still per-
form the culture testing methods, we also use
real-time polymerase chain reaction methods
which provide preliminary results in a 4-6 hour
timeframe. As a fledgling program, originally we
could only test for anthrax and a few other se-
lect agents, now we can test for many more
agents and toxins.
The anthrax attacks demonstrated a weakness
in our Public Health Laboratory infrastructure
in Arizona. We recognized the restrictions
placed on us by the existing laboratory facility,
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which then was more than 30 years old. This
laboratory severely lacked space and appropri-
ate equipment to meet the surge in anthrax
testing while maintaining other critical public
health testing such as rabies, influenza and Tu-
berculosis.  As a result of this desperate situa-
tion, the Arizona State Legislature approved
close to $25 million in 2002 to construct a new
laboratory facility. We now have a state of the
art lab with 15 biosafety cabinets and 22 chem-
ical fume hoods. Recognizing and responding
to this weakness allowed us to put in place the
necessary infrastructure with significantly more
qualified trained personnel to respond effec-
tively to the surge in sample testing volume dur-
ing the 2009 H1N1 pandemic. 
We have come a long way since the anthrax at-
tacks 10 years ago, with much improved com-
munications between the lab and all parties
involved in response to a Bioterrorism event. All
of this could not have happened without the in-
flux of funds from CDC and the state of Arizona.
Are we better prepared today? Certainly we are,
however six months from now my answer to this
question might be different as we continue to
see reductions in both federal and state fund-
ing. Still, make no mistake; it has been a dra-
matic improvement.
With federal funding for Biological Laboratories
from the Public Health Emergency Prepared-
ness grant gradually dwindling after hitting its
apex in 2002, we’ve scaled back some capabili-
ties, and given the current economic downturn,
maintaining capabilities has become an even
greater challenge.
In addition, we continue to struggle with the
challenges of finding and hiring qualified labo-
ratory staff.  One way to cope with fewer people
is to automate the testing process, and rather
than manufacture lab testing supplies in-house,
we now rely heavily on CDC and private compa-
nies to provide us with these supplies. While this
may be more cost effective, it leaves us vulnera-
ble. When you lose workforce skills for those
basic lab necessities, you end up competing for
the same source of lab testing supplies nation-
ally if not internationally.  This happened dur-
ing the 2009 H1N1 pandemic and could also
happen in the event of a large scale bioterror
event across multiple states.  To truly be pre-
pared, we need to have qualified, trained staff
and there needs to be dedicated funding for lab
testing and reagent stockpiles.
There are still some weaknesses in our nation’s
laboratory preparedness, particularly in regard
to radiological testing capabilities. I fear this
could be the case if we experience a radiologi-
cal attack or nuclear event such as what hap-
pened in Japan in March. Across the nation,
there aren’t enough radiological testing labs
with response capabilities. But we should not
build up radiological testing capacity at the ex-
pense of our current response capabilities in
both Biological and Chemical testing areas.
We’ve spent a lot of money to be prepared for
another bioterrorist attack; those skills and ca-
pabilities cannot be replaced overnight if we let
them lapse. 
I believe we’ve come a long way in our state. We
will handle any potential attack much better than
we did a decade ago. The question is whether
we’ll be able to maintain the important capabili-
ties the public deserves.  Currently it’s a legiti-
mate fear that we may not be as prepared one,
five or 10 years from now. 
“In sharp contrast at one point we had to make
sure the footprint of a new instrument would fit
in the old lab, now the new lab is incredibly flex-
ible preparing us for anything that might come
our way.” 
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Public Health Staff: Unsung 
National Heroes 
By Segaran P. Pillai, Ph.D, MSc, SM (AAM), SM (ASCP), Chief Medical and Science
Advisor, Science and Technology Directorate, U.S. Department of Homeland Security
In 2001, I was the director of the Florida State PublicHealth Laboratory in Miami which responded to the first
anthrax attack in the history of the United States. In that capacity, I was one of the lead
investigators and worked in collaboration with members of the Centers for Disease
Control and Prevention (CDC), Federal Bureau of Investigation (FBI), United States
Postal Inspection Services (USPIS) and the Palm Beach County Health Department. 
As such, I was involved in the entire response to
anthrax, from sample collection to testing and
aiding the criminal investigation. In addition, I
also helped create the process for medical coun-
termeasure dispensation to the employees and
visitors of the American Media Inc (AMI) build-
ing where anthrax exposure occurred. 
During the response, I worked 18-20 hours a day
for several weeks with my Assistant Director Dr.
Peter Shih and other members who performed
shift duties from the laboratory (notably Ms. Jody
Dielmann, Ms. Romy Erase, Ms. Rosy Cortes, Ms.
Elsa Merlo and Mr. Marc Diamante, Ms. Aurora
Garcia, Ms. Christine Pillai (volunteer) and Mr.
Dwight Frazier) as well as members from the
Miami Dade County Health Department(notably
Mr. Pablo Gonzalez, Mr. Walter Livingston, Mr.
Gabriel Garcia and Mr. Robert “Sterling” Whisen-
hunt) and the FBI WMD coordinator, John Bel-
lamy. We worked tirelessly to ensure the public
health mission was met. At times, when I headed
back home to catch a nap, I would receive a call
a couple of hours later relating to a high priority
sample that required immediate testing. After a
few instances, I and my Assistant Director Dr.
Shih decided to catch little naps when possible at
the office. We operated 24/7 because samples
were coming in at all times throughout the day
and laboratory testing was being conducted as
they arrive.  My lab processed a total of 14,244
samples (12,687 Environmental Samples and
1,557 Clinical Samples) over a period of two years
between September 2001 and August of 2003 as
a result of the 2001 Anthrax attack.
The hardest part of dealing with the anthrax at-
tack in 2001 was the lack of resources and per-
sonnel to support the excessive number of
samples that ended up in the laboratories. This
was due to the challenge for the First Respon-
ders to perform appropriate hazard assessments
in the field to determine true potential threats.
Most of these samples required immediate test-
ing because of the fear associated with a biolog-
ical threat agent that had a very high mortality
and morbidity rate. In addition, the lack of ro-
bust laboratory processes and mechanisms to
support high volume testing, the lack of appro-
priately trained laboratory scientists, the lack of
available Biosafety Level-3 (BSL-3) laboratory
space to conduct high volume select agent test-
ing, the lack of appropriate technology, assays
and reagents and the lack of appropriate sam-
ple collection and processing methods and pro-
cedures to support investigations contributed to
the complexity and difficulties to the response.
At the time, laboratory funding was inadequate
to support a response — the CDC focus C
grants, which help laboratories enhance their
preparedness capabilities, had not been created.
Under these grants and state funded efforts, we
now have fully trained laboratory scientists who
can conduct high complexity tests on select
agents. The grants also went toward creating
BSL-3 space that support the testing of biologi-
cal threat agents in a safe and secure manner. In
the 10 years since the attack, 160 public health
laboratories have become part of the CDC Lab-
oratory Response Network (LRN).
In 2011, we now have the appropriate technol-
ogy and assays to support rapid detection and
high volume testing and have developed sample
collection and processing methods that incor-
porate epidemiological investigation methods. 
We’ve also better trained those on the front
lines, including primary care and infectious dis-
ease physicians and nurses. I am confident they
can recognize a disease associated with select
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agents rapidly and effectively. In addition, they
are able to safely and quickly handle and ship
samples to LRN laboratories. 
All aspects of the response to a bioterrorism
event have been strengthened in the last 10
years. In fact, we saw incredible improvements in
just two years. In 2003, a joint investigation be-
tween FBI and CDC was initiated to understand
the level of contamination of the AMI building;
this resulted in approximated 6,500 samples.
The Florida State Public Health Laboratory in
Miami assembled sample collection kits and per-
formed all the testing. The lab operated 24/7 for
two weeks to analyze each and every sample. As
with the initial anthrax response, there was no
compensation for the incurred overtime, but
that wasn’t a problem. Those who join the pub-
lic health community realize that we don’t do
what we do in anticipation of compensation. In
other words, public health staffs are the unsung
national heroes who give time and risk their lives
to ensure the safety and security of the public. 
The anthrax attacks also brought the public
health, medical, law enforcement and first re-
sponder communities together. Quite simply, no
single agency, office or team is capable of han-
dling, responding or mitigating a biological at-
tack. As such, the success stories of the 2001
anthrax attacks are the collaboration and coor-
dination of activities among state and local pub-
lic health members with law enforcement, first
responders and the federal government. Even
though we were extremely challenged in 2001,
information was shared in a timely manner with
all the critical members. 
Today, the nation is better prepared to prevent an
adversary from acquiring a biological threat agent,
protect the critical infrastructure, rapidly detect an
attack through robust surveillance and respond
and recover from a potential biological attack. 
Biological attacks can be devastating. A biological
attack can result in high morbidities and
mortalities if we are not prepared to handle it
effectively and swiftly. The economic impact
associated with a biological attack can be
significant. We need better methods for
decontamination and clearing a facility for re-
occupancy. We need better assays and technology
to support rapid detection and surveillance. We
need better medical countermeasures and better
and faster methods for distribution and
dispensation of these medical countermeasures to
potentially exposed individuals. We need better
tools to support laboratory diagnostics to
differentiate and identify infected individuals
early to initiate rapid clinical interventions. We
need better methods to protect the biological
select agents so that our adversaries are not able to
acquire them. We need to explore innovative
approaches to conduct biosurveillance, public
health surveillance and biomonitoring to prevent
an event or to acquire advance/early warnings
about an attack. We need better methods for
assessing credible samples versus non-credible
samples prior to subjecting to laboratory analysis. 
My biggest concern is that the country is getting
complacent and we might be losing focus on the
importance of being prepared. We, as a nation,
invested in building an infrastructure to ensure
that the public health program is better pre-
pared to respond to a biological attack. As time
passes without an event and the budget contin-
ues to shrink, so does our ability to be fully pre-
pared. The failure to maintain the infrastructure
we have built can result in reverting us back to
where we started. It will cost significantly more
to get up to speed if an event were to occur, than
it would to maintain the infrastructure we have
and continue to build. Terrorists are still out
there and they have every intention to attempt
to cripple the country again. Although we have
made significant progress in comparison to
2001, we still have a lot more to do. 
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First Case 
n 63 year male photo editor employed by AMI.
n Onset 9/30/01: Symptoms included fever, fatigue, sweats, and an altered mental status.
n Early 10/2/01: Admitted to JFK Medical Center. 
n 10/3/01: State Public Health Lab — Jacksonville — received isolate from Integrated Regional Labo-
ratories and presumptively identified it as B. anthracis by DFA; isolate was also forwarded to CDC
BRRAT Laboratory.
n 10/4/01: CDC BRRAT Laboratory confirmed the isolate to be B. anthracis virulent strain by RT-PCR
and contacted the Florida State Public Health Laboratory- Miami. Dr. Segaran Pillai initiated syn-
dromic- and laboratory-based surveillance. 
n 10/5/01: Index patient expired.
n 10/5/01: Dr. Pillai and his team along with members from CDC and FBI collected environmental
samples from various sites visited by the index patient to determine if this was a bioterrorism
event.  These samples were brought to State Public Health Laboratory in Miami, Florida at
approximately 2 a.m. by Dr. Pillai.
n 10/6/01: Collected samples were subjected to testing immediately at the laboratory by Dr. Pillai
and Dr. Shih. Samples from the AMI building tested positive for B. anthracis.
n 10/7/01: Planning for intervention was initiated collaboratively with CDC, Palm Beach County
Health Department members, Florida Department of Health State Epidemiologist and Dr. Pillai.
n 10/8/01: Dr. Pillai helped set up the booth and worked with CDC and Palm Beach County Health
Department to initiate intervention at the Delray Beach County Health Department by adminis-
trating prophylaxis and performing nasal swabs to determine exposure.
n 10/9/01: Nasal swabs were subjected to testing at the Florida State Public Health Laboratory in
Miami by Dr. Pillai. 
Second Case:
n 10/5/01: 73 year old AMI worker was admitted to Cedars Medical Center due to pneumonia with
left pleural effusion. 
n 10/5/01: The attending Physician contacted Dr. Pillai on his way to the AMI building. 
• Dr. Pillai requested the attending physician collect two citrate tubes of blood, two nasopharyngeal
swabs, and bronchial washes for submission to the Florida State Public Health Laboratory in
Miami for laboratory analysis. 
• Dr. Pillai and Dr. Shih performed real-time PCR analysis and culture on blood and bronchial
washes which yielded negative results. But: Nasopharyngeal swabs were positive for B. anthracis
and so were the Bronchial washes using time resolve florescence immunoassay. 
• A Trans bronchial biopsy was conducted by CDC Chief Pathologist for Immuno Histo Chemical
Staining which confirmed that the second case was a true positive anthrax case. Further
investigation by Dr. Pillai by reviewing the hospital records revealed that the reason for negative
results associated with the PCR and culture, was due to sample collection after the patient was
placed on antibiotics. 
– Provided by Segaran Pillai
THE ANTHRAX ATTACKS IN FLORIDA 
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Questions/Answers: 2001 Anthrax Attacks
Isaac Weisfuse, M.D., MPH is Deputy Commissioner of the Division of Disease Control of the New York City Department of Health and
Mental Hygiene 
What do you remember most about the initial response to the
anthrax attacks, both nationally and from your office?  
It all happened on October 12, 2001, one of the most re-
markable days in the long history of this health department.
I remember working at NBC at Rockefeller Center that first
day.  There were many leaders of NBC, NBC news, and later
on General Electric (parent company of NBC) present.  The
first meeting was with Mayor Giuliani, and CDC (on the
phone).  This meeting focused on the anthrax biopsy result
from an NBC employee and what it meant.  After that came
a meeting with NBC nightly news staff, where Tom Brokaw
spoke eloquently to his staff, informing them of the diag-
nosis in one of their coworkers.  Thereafter there was a
meeting with staff from one of their investigative reporting
shows that was tense.  I was on the firing line for questions
on anthrax and many were difficult if not impossible to an-
swer.  It didn’t help that the HVAC system was shut off, and
it was hot in the room.  Later that day we held probably the
first point of distribution for antibiotics, and that too be-
came chaotic, with NBC staff who worked an early morning
shift still waiting to get antibiotics that night.  We didn’t fin-
ish at Rockefeller Center until the early hours of October
13, 2001.  Having done outbreak investigations in some dire
settings (such as refugee camps) I will say that the physical
space and amenities at NBC headquarters were far beyond
what I had ever experienced in any other outbreak investi-
gation!  The surroundings were luxurious with an in house
TV station and other technological capabilities.  By the next
day, I was assigned a personal ‘shadow’ by NBC who fol-
lowed me everywhere to better understand what our issues
were, and I suppose to brief higher ups about what was
going on in their building.  I had several heated arguments
with NBC usually on the turn around time for lab speci-
mens, or on the speed of our investigation but all in all they
were thankful for the health department’s contributions. 
What was your and your agency’s role in responding to the
anthrax attacks? 
We were responsible for the epidemiologic workup of cases,
oversaw environmental sampling, environmental clean up,
and provided prophylaxis to those at risk.  Once letters
were confirmed to have had anthrax in them, we had to
map out the flow of the letters starting in the mailroom and
throughout the building.  We even had to map out the flow
of garbage at Rockefeller Center.
How did you work with CDC and other state and local health
departments during the response efforts to the anthrax at-
tacks? 
CDC EIS officers were already in NYC working on World
Trade Center issues.  We had great support from CDC lab-
oratories in making diagnoses, as well as expert support in
the epidemiologic investigations.
How would you characterize the response to the attack(s)?
What were the hardest parts of the response to the attack(s)? 
First we started out exhausted by our response to the World
Trade Center disaster.  We had communication problems be-
cause of damage to NYC’s phone system downtown.  The nasal
swabs we took of potentially exposed people were particularly
troublesome.  In all the chaos the swab results were frequently
delayed, tough to track down, but yet always wanted immedi-
ately for press announcements.  Lab staff worked extraordi-
narily hard under difficult circumstances: their lab was
contaminated on October 12, and some staff were exposed to
anthrax and put on prophylaxis.  All of the initial cases were
high profile, in part because of anthrax, in part because they
occurred in staff from some of the most influential corpora-
tions in the United States.   Coming after the WTC, there was
also a sense of not knowing what was going to happen next.  
What were the biggest challenges or gaps at the time?  How
have those changed or been addressed during the past decade? 
Many issues have been addressed; lab facilities have been ex-
panded, and staff cross trained.  Surveillance for bioterrorism
is certainly more robust today than it was in 2001.  We’ve bet-
ter instituted an incident command system to streamline our
response, as well as developed communication back up plans.  
What did the country/you learn most from the successive
attacks? What was the biggest take away? 
First the obvious is that we are vulnerable to bioterrorism, which
I don’t think people took that seriously prior to 2001.  It also
pointed out that  public health is a vital part of an emergency
response.  We also need to do a better job in communicating
with the public and give them information on what individu-
als, families and communities can do to keep themselves safe. 
If there were another anthrax attack today, how do you
think the response would be different? 
Better communication: we have developed and stockpiled
information sheets and frequently asked questions on a va-
riety of types of emergencies.  
More efficient laboratory response: we built a level three
bio safety laboratory, cross trained our staff, and have bet-
ter computer systems at our public health lab.  
Better plans for providing countermeasures: we now have
a system of pre-selected sites for points of distributions
(PODs), pre-staged equipment for these PODs, and have
done extensive staff training. 
What are the most crucial factors to ensure that our country
is prepared for a biological emergency? 
Assuring an adequate workforce, support of the strategic na-
tional stockpile, development of better mechanisms for
rapid distribution and administration of antibiotics and vac-
cines, creation of environmental clean up standards.
Charlotte-Mecklenburg’s Brushes with
Anthrax, October 2001
By Stephen R. Keener, M.D. M.P.H., Medical Director, Mecklenburg County Health Department, North Carolina
In the wake of the attack of anthrax letters in October, 2001, Charlotte-MecklenburgCounty (North Carolina), like many other jurisdictions, was besieged with so-called
“white powder incidents,” in which anxious citizens reported unnecessary testing of a
variety of granular compounds such as salt, sugar, ash-tray sand and tile grout. In
addition to these incidents, however, Charlotte-Mecklenburg experienced two potential
actual brushes with anthrax. 
On Thursday, October 4, the Mecklenburg
County Health Department was notified that
Robert Stevens, a photo editor at American
Media, Incorporated in Boca Raton, FL who was
stricken with inhalation anthrax the previous
week, had died. He had spent five of his last
seven days in North Carolina; visiting his daugh-
ter in Charlotte, sightseeing in the Chimney
Rock area, and traveling to Durham, North Car-
olina. At this point, the hypothesis was that Mr.
Stevens had acquired anthrax from a naturally-
occurring source.
Staff from the Health Department visited Mr.
Stevens’ daughter’s apartment, looking for clues
that might point to such a natural source — pet
food and accessories, HVAC filter, vacuum
cleaner filter, sinks and plumbing, etc. Staff also
visited two restaurants in Charlotte where Mr.
Stevens and his family dined. Later that evening,
to the amazement of curious neighbors, military
personnel in full protective gear entered the
apartment again to obtain specimens for cul-
ture. Fortunately, none of the cultures grew.
The following week, hospitals in Mecklenburg
County and several other counties in North Car-
olina were asked by the Centers for Disease Con-
trol and Prevention (CDC) to review results of
laboratory cultures that could have been Bacil-
lus species, records of inpatients with undiag-
nosed illnesses during the prior three months
and records of patients who were directly ad-
mitted to ICUs. This process, which took ap-
proximately two weeks, revealed no evidence of
other anthrax diagnoses in North Carolina, and
when the first anthrax letters were discovered,
the focus of the investigation shifted from epi-
demiology to law enforcement.
At least two of the letters postmarked 10/09/2001,
were processed at the Brentwood mail facility in
Washington, D.C. On October 21, one of the
postal workers became ill, and that worker and an-
other died the next day from inhalation anthrax.
Two other workers became ill and survived. Postal
workers and public health officials feared for their
safety, and the Brentwood facility was closed. In ad-
dition, letters that had been processed at Brent-
wood were believed to be the source of
contamination of other government and postal
service buildings where anthrax was detected. 
Later in the week, the Mecklenburg County
Health Department received a telephone call with
concerns from the headquarters of a North Car-
olina based bank. The bank maintained a bill pro-
cessing center in Charlotte, where approximately
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300 employees processed envelopes containing
payments to the bank. This facility received a daily
shipment by courier of bag mail containing up to
100 letters directly from Brentwood. Bank execu-
tives, having heard about the Brentwood em-
ployee’s illness, were legitimately concerned
about the health and safety of their workers.
Health Department officials and Charlotte Fire
Department’s HazMat team, supported by law en-
forcement, responded to the site within an hour
and were given a tour by managers. In consulta-
tion with colleagues at the North Carolina Divi-
sion of Public Health (NC DPH) and CDC,
environmental samples were collected from some
of the letters, the letter-opening machinery, and
an air filter in the main work room. The samples
were submitted to CDC for testing.
When the deaths of the two Brentwood employ-
ees were reported the next day, CDC and NC
DPH made the recommendation to offer pro-
phylactic antibiotics to the bank facility employ-
ees. The Health Department quickly gathered
its inventory of ciprofloxacin and Doxycycline
(used in the Sexually Transmitted Disease
Clinic), and borrowed an additional supply
from a partner hospital. Important information
sheets about ciprofloxacin and Doxycycline
were developed by the Health Department’s
pharmacist. Health Department nurses were
mobilized to distribute a 10-day supply of an-
tibiotics to second and third shift workers that
evening and through the night under a pre-
scription order from the medical director. At the
same time, NC DPH requested additional an-
tibiotics from the CDC Vendor Managed Inven-
tory, which was delivered early the next
morning. By the time the first shift arrived, a suf-
ficient supply of antibiotics was available to dis-
tribute 10-day supplies to the remainder of the
workers. The duration of the response was ap-
proximately 36 hours.
Subsequently, all environmental laboratory tests
for anthrax revealed no anthrax, and it was not
necessary to distribute any more antibiotics. To
our knowledge, none of the employees of the fa-
cility became ill, nor suffered any untoward re-
actions to the antibiotics.
These two incidents were the impetus for Meck-
lenburg County Board of Commissioners to al-
locate local funding to create a county
electronic active surveillance system for com-
municable diseases which utilized a pre-existing
emergency department syndromic disease sur-
veillance system and a school absentee report-
ing database. This system was replaced by a
statewide syndromic surveillance system several
years later. The incidents also pointed out the
need for enhancements in local public health
department capability and capacity to respond
to all types of public health emergencies, and
launched the Department into the modern era
of public health preparedness. 
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In Today’s World, Biological Agents Can
Turn Up Anywhere
By Karen Spargo, M.P.H., MA, RS, Director of Health, Naugatuck Valley Health District, Connecticut
Right after September 11, 2001, we implemented our response proceduresbut no one really thought an attack would reach our part of the country.  On
November 19, 2001, the Monday before Thanksgiving, I was in an emergency man-
agement meeting and the talk centered on how our small towns would never face a
bioterrorist event. In the back of my mind, I was thinking yes we could.
That very same day, my health district, in Nau-
gatuck Valley, was asked to transfer a specimen
from a local hospital to the state lab — a some-
what simple and ordinary request. 
Going to work at 7:30 a.m. on November 21, I
heard on the radio that local postal workers and
citizens were receiving antibiotics in response to
a potential anthrax case in the area. I immedi-
ately thought of the specimen from two days ago
and wondered who was giving the antibiotics to
the workers. 
When I got to my office, I received a call asking
our health district to administer the antibiotics.
By 2:00 p.m., we had a clinic up and running
and dispensed antibiotics to approximately 80
postal workers and family and friends of Ottilie
Lundgren, who was the last person to die from
the attacks. We also took nasal swabs of everyone
who may have come into contact with Ms. Lund-
gren or letters that contained anthrax.
Right after Thanksgiving dinner, the Connecti-
cut Department of Public Health asked our dis-
trict to host a meeting for the entire community
on Friday — giving us just a few hours to prepare.
At the meeting, it was surreal to look out at the
largest community gathering I had ever been a
part of and see my family, friends, neighbors and
press from all over the world (as far as Japan). It
was just five days, one work week, yet it forever
changed our district. 
From November 24 to December 3, we per-
formed surveillance to see if additional people
contracted anthrax. Meanwhile, the Centers for
Disease Control and Prevention (CDC), the
state of Connecticut, the Federal Bureau of In-
vestigation (FBI) and the United States Postal
Inspection Service recovered a letter in another
home in our town that tested positive for an-
thrax. This became the first documented case of
cross contamination of anthrax spores. 
Now we know that the world is a much smaller
place (and growing smaller) and everywhere is
connected. If another attack occurred, we’d be
less surprised and more prepared.
The importance of communication
Looking back, one of the most taxing aspects of
the tragedies was receiving and disseminating in-
formation — what we knew, thought we knew,
and could and could not communicate. It doesn’t
seem like that long ago, but we had to rely on
faxes — e-mail wasn’t nearly as prevalent. We re-
ceived information from CDC or our state health
department at 8:30 a.m., and would send those
guidelines to physicians. Frequently, just 30 min-
utes later, we would get a “stand by” for new
guidelines and then we’d send out the new guide-
lines. We didn’t have a mechanism to send a blast
fax either, so everything was done manually. It was
the 21st century, but communication was light
years behind where we are now.
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In addition to the shear quantity and frequency of
communications, because it was a criminal issue,
the FBI was involved. This was completely new to
our world. But we learned quickly how to work
with them. A few months after the attacks, I was
doing a presentation about our response at the
University of Connecticut. One of the FBI agents
was in the audience and began waving his hand
during my presentation. I immediately stopped be-
cause I thought I passed along sensitive informa-
tion. In actuality, he was swatting a fly away from
his ear. So I think the FBI trained us well!
While intra-government communication was im-
portant, it was vital to calm the public. Looking
back, what stands out in the forefront of my mem-
ory is how calm the postal workers remained. In our
district we had a lot of respect for them and could
meet individually or in small groups to allay their
fears. They were an incredibly brave group. The
main sentiment was that they hoped people would
simply pick up their mail — a return to normalcy. 
Better Prepared in 2011
The pace of change in the world is amazing.
Since the tragedies, technology — when it
comes to communication, testing and scientific
analysis — has improved dramatically. In addi-
tion, we are much better connected to partners. 
When the attacks occurred, we unearthed mu-
nicipal response plans and found they dated
back to World War II and the Cold War. While
our current plans can’t always keep up with the
times, we have certainly made vast strides. 
That said, there are still threats in this world.
Perhaps our biggest threat is complacency. We
responded swiftly and successfully to H1N1
without the public being affected. So it’s been
10 years since we’ve had a massive public health
emergency. Unfortunately, to be truly prepared
requires continual training and staffing. With
complacency comes an erosion of the public
health infrastructure which could send us all
the way back to the Cold War. Quite simply, I
don’t have any more staff in 2011 than I did in
1972 and the pristine plans we’ve created
might start to gather dust. Without consistent
funding, we cannot continually drill, so the
next generation could be back where we were
a decade ago.  
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The 2001 Terrorist Events Radically
Transformed “Public Health” 
By Alonzo Plough, M.A., M.P.H., Ph.D., Director of Emergency Preparedness and Response, Los Angeles County
Department of Public Health Board of Director, Trust for America’s Health
In Seattle, the morning when the towers came down, there was a sense of trauma.I went to my office and walked the floors and there was this sense of shock
amongst everyone. 
As director and health officer for the Seattle and
King County Department of Public Health, I
had to spearhead the response to ensure the
public was safe. The public heath implications
of the 9/11 attacks were instantly clear. We had
to identify what might be next. At the time, any
city that had a significant landmark could be at
risk and there were all kinds of rumors that
iconic architecture symbols were on the list. 
Once it became clear the 9/11 attacks were iso-
lated to the east coast, our role shifted to focus-
ing on the mental health needs of the public. 
The events were highly transformational —
something had fundamentally changed in the
public health field after 9/11. It was, in a way, al-
most similar to AIDs and HIV in the 1980s in
that public health was being taken in a com-
pletely new direction and would have to serve
new functions.
This was nailed home when the anthrax attacks
occurred. Quite simply, never in the history of
public heath had diseases we thought were in
the past been reintroduced as a weapon. 
Even though we had been thinking about
bioterrorism in Seattle since we hosted the
World Trade Organization (WTO) conference
in 2000 and had a syndromic surveillance sys-
tem, these public health attacks were unprece-
dented. We had thought that our senses were
heightened to bioterrorism, but, in reality, our
focus wasn’t that high. September 11, 2001
pumped it up high and anthrax took it to new
heights. It was a frenetic period. 
Because of the WTO conference, we were able
to, somewhat, reassure the public that the city
was prepared. We had a syndromic system that
would give us pattern recognition if there was
anything going on in our vicinity. 
So our response to anthrax was mainly one of
surveillance and risk communication. We had to
keep public concerns at a level commensurate
to the actual level of risk. We were able to do
this, but not without a lot of effort. I mean we
were getting press calls about whether people
should steam iron their mail. 
While the public was our main concern, we
quickly discovered that we had no relationship
with the intelligence community. We were say-
ing things that the intelligence community knew
not to be the case. At one point the public
health department was on record saying anthrax
hadn’t been weaponized, when law enforcement
knew that it had been. 
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We also had to build relationships with the first
responder network. One day, I looked out the
window (we were across the street from the re-
gional Federal Bureau of Investigation (FBI)
building) and saw fire trucks and tape all
around it. I spoke with the fire chief who said
there had been a white powder scare, yet they
hadn’t thought to contact anyone in public
health. Clearly, we had a major and immediate
need to work better together, especially during
the flurry of white powder scares. 
As the crisis went on, we worked with law en-
forcement and first responders to allay public
fears and educate. As director, my main role be-
came to interface with the public and government
and take on the risk communication function. 
When I look back on that frenzied time, the
biggest gap was the lack of a relationship be-
tween public health and intelligence. Now,
through Homeland Security, we jointly perform
combined threat assessments. I have a security
clearance. If anthrax happened now, we would
be doing two-way surveillance, intelligence as-
sessments and have real-time knowledge of the
threat. This was entirely missing in 2001. In ad-
dition, we are able to pass correct information to
the public — during the initial response to an-
thrax, the information we had was wrong.
As a nation, we took a lot away from this. In the
aftermath, we were one of the first groups to
work with the Centers for Disease Control and
Prevention to form what would become the Pub-
lic Health Emergency Preparedness (PHEP) co-
operative agreements, which now support
preparedness nationwide in state, local, tribal,
and territorial public health departments.  
With the agreements and lessons learned, we’ve
come a very long way. I think about H1N1 and
how quickly and successfully we were able to re-
spond — that response was totally based on the
funding and knowledge that had been built com-
ing out of the PHEP agreements. Bioterrorism
programs had evolved to include pandemic and
all-hazards programs. I think that, appropriately,
the field has moved from just a single concern of
bioterrorism to focus on a variety of low-proba-
bility, high consequence events.
Currently, as the director of emergency pre-
paredness and response for the Los Angeles
County department of Public Health, I know my
job is a lot easier now. We have biowatch moni-
tors, which can identify the top five bio agents
that could be used in an attack. We have fusion
centers with FBI, Homeland Security and first re-
sponders. In addition, there are specific proto-
cols in place that determine when intelligence
becomes actionable during a particular scenario.
We can also do pattern recognition and early de-
tection for bioagents. In LA county, we fund hos-
pital preparedness programs — 102 hospitals are
trained to respond to terrorist events. None of
this existed during 9/11 and the anthrax attacks.
It’s clear, we’re much more prepared now than
at any time before. Yet it requires a lot of juggling
to remain this prepared. There are oscillating
funding streams that peak up when there is a
problem and are cut when things appear to be
quiet. But we need to view preparedness the way
we view the fire department. There will be some-
thing in the future — it’s true. As we get 10 years
away, there is just complacency that bioterrorism
attacks might not be probable — that’s not true.
Every major study says that this isn’t true. 
As a country, we need to think about the in-
credible times in 2001 and ensure we are better
capable to respond in 2011, 2021 and on.  
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Bioterrorism: A Public Health
Responsibility
By Diana T. Yu, M.D., M.S.P.H., Health Officer, Thurston and Mason County, Washington
On March 11, 2011, I watched, horrified, as the news of the Japan earth-quake and tsunami unfolded. Within days, the potential radiation expo-
sure escalated to the point that, in Washington State, 5,000 miles from the nuclear
reactor, we were fielding calls from citizens, health care professionals and the media. 
The events in Japan left me feeling the same as
the anthrax incidents on the east coast in 2001.
Both incidents posed a true human health
threat, not for Washington residents, but for in-
dividuals far away. In both instances, the com-
munity concern was elevated and internet
information was readily accessible and not al-
ways accurate. It was our responsibility to de-
velop and coordinate a local and statewide
response quickly — doing so before the federal
government was able to provide guidelines.
Emergency preparedness requires careful plan-
ning before an incident occurs.  Having written
plans agreed upon by partners in preparedness
helps ensure a more controlled rather than a
chaotic response.  As the public health officer
for Thurston County, Washington, which in-
cludes Olympia and the State Capitol, I worked
to build plans and protocols to respond to
bioterrorism with some of our response partners
for a number of years. However, until October
11, 2001, many of us did not believe that a
bioterrorist event would really happen.
The news about possible mail exposure to an-
thrax spurred me into developing mail handling
guidelines, which included input from the Fed-
eral Bureau of Investigation (FBI), community
physicians, citizens, and public health depart-
ment staff. After 12 years of being the health of-
ficer of this community, I was able to anticipate
some citizen concerns. My main fear was that
our staff alone would not have the resources to
handle all the “what if” situations. 
After meeting with the disaster management
group and the unified law enforcement group,
which included all city police chiefs, sheriffs and
state patrols, I refined the guidelines for han-
dling suspicious mail. This was used as a template
for a triage protocol for our local 911 center so
that the entire community would have a unified
response. The information was discussed, agreed
to, widely distributed and shared with all crisis
lines and hospital consultation lines. 
With everyone on the same page, our response
was clear and consistent. Still, we encountered
problems — some expected and some that
seemingly came out of nowhere.  For the most
part, suspicious mail was not accompanied by a
credible threat. It quickly became apparent that
potentially contaminated mail was going to be
turned in by the hundreds and we would not
have the capacity to deal with all of the samples.
On the rare occasion when we did encounter a
credible threat, there was a clear lack of person-
nel trained to handle hazardous materials.
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n September 11, 2001 – disaster rocks 
the country
n October 4, 2001 – possible bioterrorism
reported in Florida
n October 11, 2001 – alert from CDC re:
anthrax in New York
n October 12, 2001 – I developed mail
handling guidelines for health 
department staff 
n October 15, 2001 – The guidelines were
shared with county disaster response teams
during a bioterrorism emergency
management meeting
n October 16, 2001 – Thurston County law
enforcement chiefs held joint meeting to
formulate plan, procedures and guidelines
for community bioterrorism response 
n October 17, 2001 – We revised mail
handling guideline based on new information
n October 25, 2001 – CDC releases
guidelines for handling mail
In addition, some members of the public were
disappointed with our response because we used
“threat assessment” to triage which items were
tested and which were discarded. With Olympia
being the seat of state government, the guide-
lines included “persons of importance” in gov-
ernment as potential targets for threat. To some,
this implied that citizens were not as important
as government officials. The situation worsened
after deaths in New York and Connecticut were
published in the media, because their source of
exposure was never really determined. So, the
risk of casual or accidental exposure became
more of a concern. 
For some reason, calling this bioterrorism in-
stead of communicable disease control gave the
impression that this was something new and ex-
otic. The reality is that epidemiology is a cor-
nerstone of public health practice. Disease
control and surveillance are part of everyday
public health functions. Some doctors and hos-
pital practitioners responded with an “I don’t
know what to do” even when they had handled
similar situations in the past.
While our guidelines were not perfect and we
faced problems, our response was successful
because we established relationships in the
community, created mutual aid agreements
and had a history of working cooperatively
with all stakeholders. It definitely helped to
have all agencies deal with situations in similar
ways. In reviewing the guidelines we devel-
oped, and comparing those to subsequent
published guidelines, it is clear that our infor-
mation was good and our guidelines were writ-
ten in a more “prescriptive” manner to fit our
community needs.
Over the last 10 years, our public health emer-
gency preparedness response has been fine-
tuned. Public health leaders have emerged as
very credible sources of information. We have
also become excellent risk communicators, un-
derstanding the needs of our individual com-
munities, so that we can tailor messages locally.
The public health, health care, law enforcement
and emergency management systems are closely
linked and work well together.
That said, the biggest threat to bioterrorism pre-
paredness is the lack of stable funding for the
public health system.  Preparing to handle a dis-
ease outbreak is one of the fundamental day-to-
day activities of a local public health agency. As
funding has gotten tighter, the cutbacks in the
public health workforce remove a huge number
of people who have experience and expertise in
dealing with disease outbreaks. A bioterrorist
threat is one we are capable of recognizing and
responding to, but we may soon reach a point
where we will have no capacity (in terms of re-
sources and staff) to do so.
Responding to bioterrorism is a public health re-
sponsibility. We need a constant stream of re-
sources to remain vigilant in our preparation. 
68
Communicable Disease Bureau —
Anthrax 2001
By Jan Tenerowicz, Arlington County Public Health, Virginia Communicable Disease Bureau Chief (ret.)
Before 9/11 and anthrax, the Arlington County communicable disease bu-reau’s primary concerns were HIV, sexually transmitted diseases and Tuber-
culosis control. In fact, screening and other communicable diseases were much
smaller efforts and managed by part time staff. 
Then, in October 2001, the Arlington commu-
nity — still reeling from the attack on the Pen-
tagon — was in the middle of one of the biggest
public health emergencies the country had ever
faced. We wondered if this new threat was part
of a general assault on the United States and we
didn’t know what else could be coming.  
Our immediate priorities were heightened mon-
itoring and surveillance, external and internal
communications and establishing partnerships
with local emergency responders and medical
care providers. We were charged with protecting
the community and preventing the spread of
disease. The public expected us to keep them
safe and we had never before experienced this
kind of public health emergency.
Staff already had demanding workloads and
now were being asked to work extra hours and
maybe even place themselves at unknown risk.
In addition, resources were limited and we had
to find additional staff from other programs and
quickly train them.  Everyone assigned to the an-
thrax emergency worked long hours including
week-ends. Staff was “on call” 24 hours a day. 
Monitoring and surveillance for individuals who
had possible exposure was critical.  All calls, re-
ports and stories had to be evaluated and inves-
tigated. We also provided 24 hour a day disease
surveillance at local hospitals by reading se-
lected patient records to find anything related
to the signs and symptoms of anthrax exposure.
This information had to be analyzed, reported
and recorded. 
Communications both external and internal
were a top priority. We maintained direct and
frequent communications with the State
Health Department and the regional staff.
County officials, especially emergency response
departments, needed regular updates from our
health director.  Hospitals and community
physicians were important partners and all had
to receive timely CDC information which had
been sent to us through the state health de-
partment. We soon learned about “blast fax” —
as it was important to give regular briefings to
all public health department staff.   We also
had to create or find anthrax informational
materials for public distribution and then pro-
duce them on a massive scale.  
Questions and concerns came from everywhere.
Physicians, first responders, hospitals, businesses
and offices, mailrooms, schools and individuals
all needed information all at once. We received
as many as 200 calls each day at the height of the
event. One memorable phone call came from
someone who had found a powdery substance
in a napkin dispenser at a shopping mall — this
wasn’t the only “mysterious white powder” call.
Another came from a large mail sorting center
fearful that their mail sorters, who were disabled
workers, were at increased risk. Local physicians
were seeing increased patients concerned about
possible exposures and their questions had to be
resolved.  All calls required evaluation, infor-
mation, entry into a tracking system and some-
times additional follow-up. 
At the same time, we weren’t sure that appro-
priate post exposure medication would be avail-
able to medicate large numbers of people if we
needed it. Identifying resources for these med-
ications and then considering options for distri-
bution was another issue.
When the anthrax event was over, it was time to
review what we had learned and to identify more
and better ways to meet these new kinds of pub-
lic health emergencies. Our department soon
hired a public health emergency planner and
much progress has been made over the past 10
years. While strategic plans are in place and crit-
ical partnerships have been established, we must
not be complacent as new and different kinds of
public health emergencies occur. 
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September 11, 2001 was to be a signature day for
public health in Illinois as we looked to launch
our state oral health strategic planning process
with a meeting engaging experts from Illinois
and the nation at the University of Illinois School
of Public Health.  I was driving down Chicago’s
Western Ave, a straight shot from my home to
the meeting site, when I heard reports of first
one then another plane crashing into the World
Trade Center.  When I arrived at the conference,
I realized how much our world had changed
when the television in lobby showed the first
tower going down. The soon to be cancelled con-
ference would have to go on without me. 
I was trained in Emergency Medicine and began
preparedness work in 1978 while still at the Uni-
versity of Chicago.  After my appointment as Di-
rector of the Illinois Department of Public Health
(IDPH)  in 1990, I got directly involved in our dis-
aster planning work.  Springfield, Illinois, the state
capital, was over 200 miles from my home in
Chicago, but we had contingency plans if a major
event occurred.  I proceeded to the City of
Chicago Emergency Operations Center where a
desk in the control center was reserved for me.  I
was in constant contact with the State Emergency
Operations Center and IDPH staff as the day pro-
gressed. I still remember the surrealistic scene
watching the looping replays of the collapse of the
Twin Towers on the five giant screen televisions
and looking out at the Sears Tower, suddenly the
tallest building in America.  I remember the anxi-
ety wondering if that huge building would be next.  
As a nation, we got through that day and all of us
assessed what our post 9/11 would be like.  The
next day, I drove to Springfield to coordinate our
on-going response as we all wondered what would
be next.  Immediately, IDPH was placed on the
Public Safety Sub-Cabinet where I joined discus-
sions with the State Police and National Guard
about how to arm police officers protecting our
nuclear power plants.  Days passed as we reviewed
and re-reviewed our public health response plans.
Illinois is a state that has suffered a number of
natural disasters from the major Mississippi river
floods in 1993 to periodic tornados.  We had
planned for the impact of a magnitude 8 earth-
quake in the nearby New Madrid fault and for
acts of bioterrorism.  Back in the 1990s, when we
formulated our bioterrorism plan and started our
molecular biology lab, we believed that we would
activate our earthquake plan before we would see
an act of terrorism on our soil.  We also felt that
it was important to plan for all hazards regardless.   
Three weeks after the fall of the Twin Towers, our
nation was again rocked as headlines announced
that we faced another attack. This one was much
more insidious because it came to its victims via
the U.S. Mail.  Alerts were sent out to emergency
departments across the state detailing the symp-
toms and treatments for suspected anthrax cases.
While we had plans in place to handle a mass ex-
posure or a mass casualty event, we were not pre-
pared for thousands of “white powder” calls to
police and local health agencies.  Protocols were
developed on the fly with the State Police, the FBI
and the Emergency Management Agency.  Our
laboratory was put on overdrive as the two-year-
old equipment was run at full capacity.  While
some of the calls seemed frivolous, like the calls
about white powder at a changing station in a day-
care center and white powder at a counter where
powdered donuts were consumed, all of the calls
reflected the fear and uncertainty of the time.
Each day, we implemented additional systems and
procedures that are still in place today.  The im-
provements in the state laboratory prepared us for
the huge demand when West Nile hit Illinois in
2002 leaving four dead and 71 sickened.  
Some good things came out of this time of trial
including a much stronger relationship with the
Illinois Emergency Management Agency whose
director, Mike Chamness, declared that every
disaster had a public health component and
public health needed to be at the table.  Our na-
tion realized once again how important our pub-
lic health system is to our health and well being
and placed a priority on funding.  
I look back on that time with mixed emotions,
remembering the fear, uncertainty and the sat-
isfaction that the IDPH was up to the task.  I also
look back with regret as I realize that once again
our country has forgotten the lessons of the
past.  Health departments across the nation are
being ravaged by budget cuts and layoffs.  I won-
der that should we face the challenges that we
faced in September and October 2001 today, will
our battered, underfunded, public health com-
munity be able to respond? 
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When Disaster Strikes, 
Public Health Responds
By John R. Lumpkin, Senior Vice President and Director, Health Care Group, the Robert Wood Johnson Founda-
tion and former Director of the Illinois Department of Public Health
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How Public Health Preparedness Changed
in North Carolina after Anthrax
By Steve Cline, Assistant Secretary for Health Information Technology, North Carolina Department of Health and
Human Services Office of Health Information Technology, North Carolina Department of Health and Human Services 
When the first case of intentional anthrax occurred, I was the NorthCarolina State Epidemiologist. I received the phone call from the Centers
for Disease Control and Prevention (CDC) as soon as there was suspicion of terrorist
activity and the potential for further exposure/cases of inhalational anthrax.
Coincidentally, the NC Governor’s Terrorism Task Force was meeting that day.  
We, at public health, shared the development
with members of the task force including Fed-
eral Bureau of Investigation (FBI) agents before
they heard of it through their own channels.
This further established the lead role of public
health for this event in NC.
Based on what we knew about anthrax at the time
and the travel history of the index case, it was be-
lieved that the exposure occurred in North Car-
olina.  Therefore, the state was at the center of
this public health emergency. I was tasked with
leading the public health response along with the
State Health Officer, Dr. Leah Devlin.
Our history of natural disasters (floods and hur-
ricanes mostly) provided a strong base of expe-
rience for organizing the State Emergency
Response Team (SERT) and partnering with
local responders. Consequently, the framework
for organizing the response was similar to other
emergencies. 
Of course, it differed dramatically in scale with
the whole state potentially at risk and with the
fear of the unknown.  In a hurricane, we can see
it coming, track the flooding and devastation and
then organize the clean up and recovery efforts.
With anthrax, we did not know who the enemy
was, if they were going to attack again and we
couldn’t see the weapon.  This meant that FEAR
ruled the day and public communications were
critical. During the response we established a
“battle rhythm” of regular communications with
1), our local response partners; 2), our national
response partners; and 3), the media to keep the
public appropriately informed.
The attack created many challenges for the pub-
lic health and emergency response system
throughout government.  In addition to com-
munication, there was a lack of public health in-
frastructure.  One area where this was keenly
acute was in the lack of electronic systems for
public health surveillance.  Since the attacks,
North Carolina has made tremendous progress
in this regard.  Instead of having to wake hospi-
tal infection control staff in the middle of the
night to pull charts and track down lab results,
we now have a near real time electronic emer-
gency department surveillance and reporting
system in every hospital that allows us to do pub-
lic health surveillance much more efficiently.
Ultimately it became known that North Carolina
was not the site of the powder drop. However,
we made incredible public health improvements
in the decade since the attacks.
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Strengthening Local Preparedness Statewide
n Provided funding and guidance to all (85) local
health departments and the Eastern Band of
the Cherokee Indians to establish public health
preparedness and response programs,  includ-
ing a smallpox vaccination plan, a Strategic Na-
tional Stockpile (SNS) distribution plan, and
other plans.
n Established seven Public Health Regional Sur-
veillance Teams (PHRSTs) in strategically lo-
cated local health departments to provide
statewide public health preparedness and plan-
ning capacity.  PHRSTs consist of a physician, a
medical epidemiologist, an industrial hygienist,
an administrative assistant, and an affiliated
field veterinary officer.  
Providing State Level Leadership and Expertise
n Established a state level Public Health Prepared-
ness and Response (PHP&R) team to build ex-
pertise and response capacity at the state level.  
n Appointed the Public Health Preparedness and
Response Advisory Committee to guide efforts
around state and local preparedness. 
n Created the Public Health Coordinating Cen-
ter (PHCC) in accordance with the NC Emer-
gency Operations Plan to provide space and
equipment for key public health operations re-
sponse personnel to come together during a
public health event to enhance effectiveness.
The PHCC has been activated for multiple
public health events, including Hurricane Is-
abel, Charley, Frances and Ivan; SARS; the
Apex Chemical Emergency and the influenza
vaccine shortage. 
Creating Necessary Legal Authorities
n Sought passage of two new laws by the NC
legislature in the June 2004 session and one in
2008. One mandates reporting by hospitals of
Emergency Department data for NC DETECT.
The other extended isolation and quarantine
authority to better respond to practical needs.
Public health isolation or quarantine orders can
now be given for duration up to 30 days. 
n Secured new legislation to allow access to
medical records when an emergency or poten-
tial environment risk is occurring.
n Sought passage of major legislation to include
reporting of zoonotic diseases from the state
veterinarian to public health.
n Secured legislation to give embargo authority
for state environmental health specialists for
contaminated food. 
Developing And Exercising The Plans
n Developed numerous state level plans includ-
ing the Public Health All-Hazards Plan as a part
of the NC Emergency Operations Plan, devel-
oped a SARS Response Plan, Smallpox Plan, a
plan to dispense the Strategic National Stock-
pile, a Chempack Utilization Plan, and the
Avian Influenza Plan.
n Developed the first FEMA approved mitigation
plan for infectious disease and zoonotic agents
which will allow for federal reimbursement for
corrective measures to minimize damages in-
curred as a result of an outbreak.
Assuring Earliest Detection: Surveillence
n Initiated the development of the North Car-
olina Public Health Information Network (NC-
PHIN), an enterprise level information
technology infrastructure to integrate key state
and local public health data systems.  Key com-
ponents within NC-PHIN include the NC-
Health Alert Network, a statewide disease
reporting and surveillance system that is com-
pliant with the National Electronic Disease Sur-
veillance System (NEDSS), the NC Hospital
Emergency Surveillance System (NCHESS),
and a pre-hospital emergency medical services
data system called PreMIS, the Laboratory In-
formation Management System (LIMS), and the
NC Immunization Registry.
n Created the NC Hospital Emergency Surveil-
lance System (NCHESS) which receives emer-
gency department data from NC’s hospitals to
assist state, regional and local public health
professionals in disease surveillance efforts.  
MAJOR INFRASTRUCTURE DEVELOPMENTS IN NORTH CAROLINA PUBLIC
HEALTH PREPAREDNESS AND RESPONSE SINCE 9/11/2001
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n Established NC-DETECT (North Carolina Dis-
ease Event Tracking and Epidemiology Collection
Tool) which receives, compiles, and analyzes data
from a variety of sources with public health impli-
cations.  Data currently being collected includes
hospital emergency department data, reportable
diseases and conditions, poison control center,
pre-hospital management information system,
and NC Wildlife surveillance.
Improving Communications
n Established the North Carolina  —  Health
Alert Network (HAN), a highly secure and fully
redundant communication system that is de-
signed to immediately alert key state and local
health officials and care providers to acts of
bioterrorism, emerging disease threats, and
other public health emergencies.  
Identifying The Agent Early
nDeveloped the NC Laboratory Response Net-
work (LRN) in the State Laboratory of Public
Health, which is designed to respond to acts of
bioterrorism or other public health threats and
emergencies. SLPH doubled its Biosafety Level 3
(BSL-3) capacity in Raleigh and established three
new strategically located regional BSL-3 labs.  
n Created the first statewide registry of biological
agents in the nation which allows for  tracking
and improved security of agents of bioterrorism.
n Developed the white powder protocol used by
all first responders, provide laboratory testing
for white powders while maintaining the ap-
propriate chain of custody.
n Secured $101 million from state legislation to build
a new state of the art public health laboratory.
Learning from Real Life Experiences
n Established and operated shelters in Wake and
Mecklenburg counties for hundreds of Hurri-
cane Katrina and Rita evacuees in NC.  These
shelters initially focused on providing for the
basic public health needs of these evacuees.
State, regional, and local public health staff con-
ducted surveillance studies to assess pre- and
post-event health and social issues, and then as-
sisted with assimilation of these evacuees into
the communities.  Other hurricanes in North
Carolina such as Isabel in 2004 provided addi-
tional real life experiences including the use of
GIS and handheld technology to identify people
in need and target resources accordingly. 
n Investigated and contained one of the eight lab-
oratory confirmed cases of SARS in the country
in 2003.  This investigation included the use of
quarantine and isolation, public health direc-
tives to the families, health care workers and
the employer — a major university system.
nManaged the distribution of limited flu vaccine
available during the 2004 flu season.  This ef-
fort included issuing legal orders to providers
of all types limiting vaccine to high-risk groups,
communicating with the public and providers,
coordinating with long term care facilities, hos-
pitals, health departments, private distributors
to maximize the use of the vaccine and provid-
ing follow-up evaluation.
n Continue to respond to suspicious substance
(“white powder”) incidents. Local, regional and
state Public Health response teams responded
to 15 suspicious substance calls that required
interagency analysis and response.
n State and local Public Health teams responded
to a Department of Defense environmental de-
tector alarm for tularemia.
n Local, regional, state and federal teams re-
sponded to a threatening passenger on an in-
coming flight. The passenger was threatening
the other passengers with a substance he iden-
tified as smallpox.
n State Public Health investigated potential toxic-
ity from a dietary supplement with high levels
of selenium in a multi-state incident.
n Local, regional and state Public Health has in-
vestigated at least four large multi-state food
borne illness outbreaks.
n Local and state Public Health teams provided
critical expertise on re-entry of a community
after evacuation for a chemical plant fire (2007).
n Responded to statewide emergencies includ-
ing Drought 2007, and the Pocosin Lakes
Wildfire 2008.
– Provided by Steve Cline
Better Safe than Absolute Certainty: The
New Jersey Public Health Response to
Terrorism
By Dr. George DiFerdinando, Jr., M.D., M.P.H., FACP, Director, New Jersey Center for Public Health Preparedness
at UMDNJ-SPH Co-PI, New York-New Jersey Preparedness and Emergency Response Learning Center Adjunct
Professor of Epidemiology, UMDNJ-SPH
On September 11, 2001, almost 700 New Jerseyeans lost their lives in theWorld Trade Center. Yet, as New Jersey is often seen as a crossroads be-
tween New York and Philadelphia, many do not recognize the huge impact 9/11,
and the subsequent Anthrax letters, had on our state and how involved NJ’s public
health personnel were in the response.
I had been named acting commissioner of the
NJ Department of Health and Senior Services
(NJDHSS) less than a month before the attacks.
We held our first staff meeting the morning of
the 9/11 attacks. While the attacks were on New
York soil, the interdependence between NYC
and NJ made it clear that our response would
need to be as supportive to the region-wide pub-
lic health needs as possible.
On 9/11 itself, we spent most of our time at-
tempting to gain situational awareness of  any in-
jured survivors, and to mobilize health resources
— vaccinations, blood products, and burn unit
beds — that might be needed. With the Depart-
ment of Human Services in the lead, NJ  imme-
diately set up a support area at Liberty State Park,
which is little over a mile from Ground Zero,
across the Hudson River. This location was cho-
sen based on the presumption that there would
be many injured people and we’d need a triage
area to take care of those injured before trans-
port. We needed contingencies if hospitals be-
came overwhelmed and thousands of people
needed blood, wound treatment, or even tetanus
shots. Sadly, all these needs became moot as it be-
came clear that the nature of the disaster had led
to many deaths, but few others severely injured. 
The Liberty State Park site, not needed for the
injured, was rapidly ‘repurposed’ as a support
site for the social and immediate psychological
needs of survivors and family members of those
who had died. Less dramatically, and yet just as
supportive, was the development of a ‘paper-
work’ support network, to process documents
for survivors and families of the dead in a situa-
tion where documentation of death was missing.
On the day of 9/11, and in the weeks that fol-
lowed, the simple public health functions — reg-
istrations, surveillance, documentation —
assumed new importance for the public, and re-
quired many hours of ‘routine’ but critical work. 
The transition between this supportive role, dur-
ing 9/11, and a leadership role during the Octo-
ber anthrax exposures, was oddly imperceptible.
As one of our public health reactions to 9/11 was
the set up and maintenance of  phone banks for
citizens to call in with any types of questions, a di-
rect connection between NJDHSS and NJ public
health staff and the public was almost constant.
Still, as call volume tapered off near the end of
September, we decided to decrease those as-
signed to the phone banks. 
At that same time, the first Florida anthrax case
was found, and we, of course, were placed on
alert, but at a distance.  Even when we received
notification from the NYC Department of
Health that cases were appearing in media out-
lets in Manhattan, the threat in NJ seemed re-
mote. Still, as many New Jerseyeans worked at
the media centers in NYC — such as the famed
30 Rockefeller Plaza Building — we reactivated
the phone center, anticipating calls from citizens
regarding their risk. On Saturday, October 13,
we reopened the phone bank. 
On that same day, my team participated in a con-
ference call with all the health officers in the
United States. At the end of the call, it was men-
tioned that the anthrax likely was delivered by
mail and probably came from somewhere in New
Jersey. Then the call ended. My team looked at
each other, perplexed at the casual way the origin
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of the letters was handled, almost as an after-
thought. Although the first (at that time only)
known batch of letters were apparently processed
in NJ, a few miles from our office, we were assured
that ‘mere’ processing was not a public health
concern. Basically, the consensus interpretation
of the available data at the time was that, if a letter
is sealed and it goes through postal processing, it
was not a threat until formally opened.
Stunningly, while we were being reassured on
that call, data was coming though our phone
bank that would shortly forever overturn that
consensus. Two perceptive local NJ physicians,
having read new reports of the NYC cases, and
the NJ postal center origin, called our phone
banks to report unusual, persistent skin illnesses
in two postal workers from that center. The
physicians calling were ‘sure’ these cases were
most likely to be a spider bite, but they wanted to
be safe rather than sorry. Similarly, the highly
competent but still junior staff who took the
calls was almost apologetic in passing the reports
on, but wanted to make sure all information was
available to the Department’s leadership. 
I immediately informed the Federal Bureau of In-
vestigation (FBI) and began the process of obtain-
ing permission to test the samples the private
physicians had. As I did this, the FBI seized the sam-
ples and sent them to Atlanta for anthrax testing. 
The following Monday, just two days later, there
were confirmed anthrax letters in Washington,
D.C. We were still waiting on our samples to be
processed, however we knew that they came
from the Hamilton postal facility. By Wednesday,
when one of the two NJ suspect cases was con-
firmed as a case of cutaneous anthrax, the FBI
shut the processing center down to do a thor-
ough but rapid crime scene investigation.  After
a few hours of processing evidence, the FBI let
us know that the building was ours. 
We met with the post office staff well into that
evening and eventually I decided that, since the
building was closed and occupationally related
anthrax had already occurred there, I couldn’t
deem the building safe unless I was offered some
rapid testing method to show it ‘clean.’ I was as-
sured that this could happen within 72 hours; my
response was, then we’ll reopen in 72 hours.
It turned out it was over three years before that
building was deemed safe to reopen. 
After another worker developed cutaneous an-
thrax that following Friday, we began operating
on the premise that any worker at that site was
potentially exposed, and we decided to imme-
diately propose post exposure antibiotic pro-
phylaxis. Unfortunately, the Centers for Disease
Control and Prevention (CDC) didn’t agree that
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the cases here demonstrated exposure at a dis-
tance, and did not support our decision to treat,
and discouraged my request for materials from
the Strategic National Stockpile. I still regret not
pushing my Governor to demand SNS deploy-
ment anyway, as a way to force CDC’s hand. 
Without CDC support, NJDHSS scrambled to
find Cipro and a place to deliver the medication.
At that time NJ didn’t have an Emergency
Health Powers Act, so there wasn’t a specific law
that gave the public health commissioner direc-
tion or powers to organize such a mobilization
of private resources on short notice. Today, a NJ
Health Commissioner, with gubernatorial sup-
port, could do things like work directly with
pharmacies and pharmaceutical distributors to
get the necessary antibiotics, and with local fa-
cilities like hospitals to immediately use their fa-
cilities to dispense medicine. 
While our unilateral decision to keep the facility
closed and to treat early led to much debate in
our state press, it clearly prevented further ex-
posure in a grossly contaminated building.  It
also probably saved exposed workers from de-
veloping disease — if not from dying of anthrax.
And, even while this debate raged around, the
NJ public health and health care community
worked to ‘make it happen’, collecting Cipro,
setting up treatment clinics, doing thousands of
‘white powder’ laboratory tests, and continuing
to man the phones. 
We made the particularly fortunate decision to
inform the postal service and unions of the in-
formation at exactly the same time each day.
This gave all interested parties time to hear new
information, to vent about the stress and uncer-
tainty in private, and then to present the public
a consistent story. There were no arguments in
the media — at least between the postal works,
management, and public health — and this sol-
idarity undoubtedly led to NJ workers showing
the best adherence to their treatment compared
to other, more contentious sites. Miraculously —
or perhaps due to early preventive treatment
and diligent diagnosis in the community, NJ had
no fatalities due to anthrax. We had a lot of cases
and a lot of people exposed, but we did early
preventive therapy and had health care workers
on the front lines who bought into our response. 
Basically, by applying general public health prin-
ciples, making sure communication systems
were set up, listening to what the public and
providers were telling us, working closely with
the workers involved and reacting quickly to get
samples tested, our response saved lives. 
It has been 10 years since September 11, 2001
and the anthrax attacks, yet the lessons for public
health from the series of months will not go away.
To me, the biggest change the public health
world has seen over the last decade has been our
incorporation into the law and public safety com-
munity. Surveillance, preparedness, prevention
and population based thinking come to play re-
peatedly during both the planning and response
phases of most of our emergency responses.
However, I’d have to be willfully blind not to see
that there are fewer people in public health de-
partments in NJ now than there were in 9/11.
Today, we might respond with a better trained
and equipped workforce, but there would be
many fewer at the front lines. To me, the most
tired and dangerous cliché is ‘doing more with
less.’ Any individual public health worker will al-
most certainly do more individually then he or
she might have during those months in the fall of
2001, but, as a group, we’re at clear risk of ‘doing
less with less’. Which action of that fall would be
shortchanged today due to lack of staff — one
less worker on a phone line to take a report, one
less physician to consider making that call? What
impact would that have on the outcome?  At the
time, if we had a second postal site that had been
grossly contaminated we would have been over-
whelmed. We simply didn’t have the ability to
fully respond across multiple locations. Now,
would we be able to handle even one?
Given the times we live in, I’m sure we’ll find out
just what we can accomplish with our current re-
sources. 
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The Model State Public Health Act (MSPHA) was created to bolster the legal framework for public
health professionals in a time of crisis, such as the 2001 anthrax tragedies. 
Funded by the Robert Wood Johnson Foundation, MSPHA was released on September 16, 2003 after
three years of development and a national commentary period. The act, which focuses on the organi-
zation and provision of essential public health services and functions, is a resource for government of-
ficials when amending health statutes and regulations.
According to the law, state and local public health agencies are authorized to provide or implement
essential public health services and functions, such as:
n Utilizing a broad range of flexible powers to protect and promote the public’s health, including
compulsory or mandatory powers as defined in the Act;
n Providing public health information programs or messages to the public that promote healthy be-
haviors or lifestyles, or educate individuals about health issues;
n Promoting efforts among public and private sector partners to develop and fund programs or initia-
tives that identify and ameliorate health problems;
n Conducting, funding, providing or endorsing performance management standards for the public
health system; 
n Developing and providing certification, credentialing or effective training for members of the public
health workforce; 
n Developing, adopting and implementing public health plans through administrative regulations, for-
mal policies or collaborative recommendations that guide or support individual and community
public health efforts;
n Establishing formal or informal relationships with public or private sector partners within the public
health system;
n Enforcing existing laws and administrative regulations (including emergency regulations), and pro-
pose new laws, amendments to existing laws or administrative regulations that may serve as tools
to protect the public’s health;
n Identifying, assessing, preventing and ameliorating conditions of public health importance through
surveillance; epidemiological tracking, program evaluation and monitoring; testing and screening
programs; treatment; abatement of public health nuisances; administrative inspections or other
techniques;
n Promoting the availability and accessibility of quality health care services through health care facili-
ties or providers; 
n Promoting availability of and access to preventive and primary health care when not otherwise
available through the private sector, including acute and episodic care, prenatal and postpartum
care, child health, family planning, school health, chronic disease prevention, child and adult immu-
nization, testing and screening services, dental health, nutrition and health education and promo-
tion services; and
n Systematically and regularly reviewing the public health system to recommend modifications in its
structure or other features to improve public health outcomes.
From January 1, 2003  —  August 15, 2007, the act was featured in 133 bills or resolutions in 33 states.
Sources: The Centers for Law and the Public’s Health (http://www.publichealthlaw.net/ModelLaws/ MSPHA.php)
& from the Law itself (http://www.hss.state.ak.us/dph/improving/turningpoint/PDFs/ MSPHAweb.pdf)
THE MODEL STATE PUBLIC HEALTH ACT (MSPHA)
The Public Health Response to 9/11 and
Anthrax: A Great Example of American
Spirit, Talent and Teamwork
By James Blumenstock, Chief Program Officer, Public Health Practice, Association of State and Territorial Health
Officials and former Deputy Commissioner of Health, New Jersey
As I look back on the public health response to the 9/11 and anthrax tragedies, my perception hasn’t changed. If anything, I am even more impressed with
how the public health community, many different jurisdictions and the nation as a
whole dealt with two historic acts of terrorism.
At the time, I was the senior as-
sistant commissioner of health
for New Jersey and the health
department’s weapons of mass
destruction coordinator. Ulti-
mately, I became the incident
commander for both terrorist
events.  It was absolutely amaz-
ing, but not really surprising,
how the jurisdictions (Wash-
ington, D.C., Florida, Maryland, Virginia, etc.),
against all odds, effectively responded to meet the
immediate and long term needs of the public. I saw
people do things for the public’s good and push
themselves beyond the limits of what they ever
thought they could. They never took a break, never
buckled and never faltered. 
When the towers went down, people evacuated into
New Jersey, and those who had minor injuries were
coming to our hospitals. In addition, many New Jer-
seyans worked in New York City. The response and
recovery was a huge activity; we sent a lot of our
urban search and rescue and ground and air med-
ical transports to the scene and nearby mustering
points. We also used some of the properties across
the river in New Jersey as staging areas for equip-
ment and recovery planning, including Liberty
State Park.  As it continued over time, a large por-
tion of our response shifted to mental health coun-
seling and grief support. Many people who lost their
lives were residents of the great Garden State. 
When anthrax was confirmed, the public health
community had just spent four weeks managing
the daunting response to the 9/11 attacks. Many
states were still running significant response/re-
covery activities. Then, someone in Florida con-
tracted anthrax, yet you find out that ground zero
for that attack was actually in New Jersey. All of a
sudden, you are dealing with a crime scene and
law enforcement investigation across several ju-
risdictions.  There was potentially a fatal biologi-
cal agent being distributed by a terrorist using the
postal system that could do harm to innocent
people all across the country. You had public fear
on an unprecedented scale, all the while health
agencies were dealing with a biological agent they
weren’t accustomed to — sure some dealt with
naturally occurring anthrax and had trained for
such an event, but this was the first “real deal.”
Then the lab samples start flooding in and they
need to be tested in labs that were not originally
designed and built for this kind of event.
Prior to the 2001 anthrax attack, New Jersey did
about 10-15 specimen tests a year, principally for
Federal Bureau of Investigation (FBI) powder in-
vestigations. In the fall of 2001 alone, our public
health lab tested over 3,000 specimens. The de-
mand for surge capacity was huge because we had
samples coming in from local post offices and FBI
as part of the investigation and other “white pow-
der” scares. We also knew we would get positives,
so we had people under incredible stress testing
specimens they knew to be hot. Yet, all 3,000 were
done and there was not one incident of cross con-
tamination at our laboratory nor did any worker
get infected. This is just one of a hundred stories
that can be shared that show the true grit of the
public health workforce. When you get down to
it, they were working in outdated labs that didn’t
have the state of the art containment features that
we have today. They maximized the use of what
they had, innovated when necessary, and relied
on their formal training to get the job done as
safely, effectively and reliably as possible.
This was a great example of American spirit,
pride in public service, talent and teamwork. 
As I see it, there are three milestones when it
comes to public health and emergency pre-
paredness and response:
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n 1999: The country began to invest in public
health preparedness, giving many states a cou-
ple of years to start developing capacity to han-
dle those types of events.   There is no doubt in
my mind that this foundational work made all
the difference in the world in better prepar-
ing us for the events that were soon to follow!
n 2001: Every aspect of the country’s public
health system felt the impact of 9/11 and an-
thrax and learned what it took to respond to a
massive terrorism and bioterrorism emergency.
n The decade since: Through the passage of key
federal laws and establishment of critical fed-
eral cooperative agreement programs with
the states, there has been exponential growth
in the capacity and capability of local, county,
state, territorial and national public health
professionals to be more at the ready to re-
spond to and recover from all hazards and
threats, not just acts of terrorism. 
As a result of the attacks, the public health, law
enforcement and full family of emergency serv-
ices communities were thrust together. It was a
clear turning point, sending the signal that we
were all in this together and that incredibly dif-
ferent sectors had to work together. Over the last
10 years there has been success after success that
shows this. When you look at other events the
emergency/disaster/terrorism community has
responded to — such as the H1N1 Pandemic
and many natural disasters such as hurricanes
and other flooding events — clearly public
health, law enforcement and emergency man-
agement are much more in step and familiar
with each other’s disciplines and specializations. 
It truly is impressive how far we have come in the
past 10 years.  When I think back to the fall of 2001,
the biggest limiting factor was human resources. As
an example, there really weren’t protocols fully de-
veloped and implemented at that time for having
workers cross-trained as a means to provide suffi-
cient surge capacity. Most of the work that was
being done fell to primary responders (planning,
hazmat, and bio hazardous lab folks) because there
wasn’t yet a mature means to stand up a robust in-
cident command system, which would have created
tiers of state workers and possibly even use private
sector assets and volunteers able to stand in and
take shifts across disciplines. 
So, we had to overwork the folks responding to
9/11 and anthrax because we couldn’t cross-train
others in time. Today, we know you have to build
depth on the bench to enable a public health sys-
tem to have the capacity to scale up as necessary to
deal with long-term and multiple events at the
same time. No question about it, we pulled it off
but it also was a huge wake up call for America that
we cannot expect to fully protect the public “next
time” without a better developed, trained and
equipped public health system. Ten years later, we
are much smarter and better prepared as far as hav-
ing a competent, resilient and flexible workforce. 
Following the 2001 tragedies, Congress and Pres-
ident Bush authorized a significant increase in
funding for public health systems to build up ca-
pacity, capabilities, tools and knowledge. This was
a huge turning point. Preparedness is a process,
not an endpoint. The main take-away from 2001:
the United States responded well, not only to the
specific attacks, but recognizing it as a reality
check that we needed a better and more resilient
public health system and that decades of neglect
should be reversed. To our credit, our public
health system has been improved dramatically
over the last decade. State of the art biosafety lab-
oratories and Emergency Operations Centers
have been built and equipped, real time infor-
mation collection and sharing systems are in
place, plans and procedures have been refined,
stockpiles of lifesaving medical countermeasures
have been purchased and strategically stored, and
many drills and exercises have taken place to pre-
pare for real world events. There is no doubt that
we would be able to handle a response better and
for a longer period of time in 2011. 
We need to keep our eyes and minds open to
any and all threats — an all-hazards approach —
because anything is possible in this world. We
also must overcome complacency. The longer
we go without an incident, the public and poli-
cymakers think that it’s something that we don’t
have to continue to worry about. That’s flawed
thinking and the public/policymakers must view
and treat this as a matter of national priority.
To that end, even during times of economic dif-
ficulty, we must continue to invest in public
health as a prevention strategy and maintain
what we have built and continue to identify and
fill remaining gaps.  To be truly prepared, every
aspect of the public health system must be de-
veloped and refined, we can’t let the system that
we built crumble or fall apart from a lack of con-
tinued investment. Public health emergency
preparedness is a matter of national security.
I dedicate my reflection of the events of Sep-
tember 2001 to the many men and women of
the New Jersey State Department of Health and
Senior Services who gave everything they had to
help protect the health of the public whom they
proudly and tirelessly serve. 
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Public Health Plays Prominent Role in
Homeland Security 
By Mary C. Selecky, Secretary of Health, Washington State Department of Health
In public health, we once devoted the great majority of our disaster preparednessand response efforts to naturally occurring events — floods, fires, earthquakes
and the like, especially in Washington state.
On February 28, 2001 when the Nisqually earth-
quake hit, my agency got a firsthand look at being
on both ends of that response. The epicenter was
11 miles northeast of our office location at the time
in downtown Olympia. Our buildings were dam-
aged. We had to look out for our own, along with
other people around the state. It was a long time
before I even had a chance to go home and change
clothes. Naturally, we responded as a public health
agency. We knew the basics to make sure residents
were safe, yet it was clear we had a lot to learn.
Less than seven months later, on September 11,
the landscape of public health changed com-
pletely. Before that time, the only thing public
health and Homeland Security had in common
were being part of government. When emergency
management plans were drawn up to respond to a
biological event, public health was largely left out.
Soon after September 11, however, a series of
anthrax attacks began around the country. Gary
Locke, our governor at the time, asked me to ex-
plain what was happening — what anthrax was
and what the ramifications could be.
I took an epidemiologist, an environmental
health specialist, and a member of my commu-
nication team to the meeting. Governor Locke
was surprised I had that many people involved.
But it quickly became clear we needed diverse
skills and talents to fully grasp what was hap-
pening, what the biological agent was, and how
this might affect people in Washington.
We hadn’t prepared for anything quite like this, so
there were no specific emergency plans to coordi-
nate between public health and law enforcement.
We knew, though, that we didn’t have the re-
sources at our lab to test every white powder sam-
ple that someone brought in. With help from the
Washington State Patrol and the Federal Bureau
of Investigation we built a package screening pro-
tocol on the spot. Unlike other labs, we decided
law enforcement would determine whether there
was a credible threat. I know a lot of my colleagues
were inundated and overrun with samples.
Our “white powder protocol” is still in place today.
It may be the first example of ongoing collabora-
tion between law enforcement and public health.
Before I was secretary of health, I ran a local
health department for 20 years. I know people
will first turn to their local health department be-
fore looking to the state and national levels. In
Washington, we have something known as “meet
me calls”  —  regular conference calls with local
health agencies to share and gather information
and to answer questions during disasters. We’re
fortunate this existed before the attacks; these
calls were vital to sharing information and to
help prevent public panic.
With the protocols we established, and with the
constant flow of information through the “meet
me calls,” we ended up testing only a few more
than 100 samples. Still, because of how the at-
tacks developed, public health wound up with a
permanent seat at the Homeland Security table
—  and with a prominent role. In short, it
changed the landscape of national defense.
We’ve come a long way in the decade since an-
thrax and September 11. On that day, I had to
go to a local hospital in Olympia just to watch a
Centers for Disease Control and Prevention
presentation because it was the only place with
the technology to do it. Now we have video links
with many local health agencies and tribal
health centers.
In addition to technological advances, we’ve
seen big changes in the creation of comprehen-
sive emergency management plans. We now
have warning systems throughout the state, and
turnkey operations that allow us to anticipate
what the public will demand in crises. In the
events that followed 2001, we’ve learned to plan,
and to make our plans work, instead of waiting
to react. The work is far from done, yet Wash-
ington state and our national public health sys-
tem has taken a big step forward we can all be
proud of.  The people of our nation are safer
and healthier because of it. 
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By Georges C. Benjamin, M.D., FACP, FACEP (E), FNAPA, Hon FRSPH, Executive Director, American Public
Health Association
On September 11, 2001, our country’s notion of national defense foreverchanged. With the subsequent anthrax attacks, it became apparent that public
health is just as important to protecting our citizens as any missile defense shield. 
In 2001, I was secretary of the Maryland De-
partment of Health and Mental Hygiene and
also serving as president of the Association of
State and Territorial Health Officials (ASTHO),
so I had my fingers on the pulse of many public
health programs and priorities around the coun-
try.  I always knew we protected people and im-
proved their health, but we had never before
seen ourselves as an integral part of the home-
land security infrastructure.
We were fortunate in Maryland. A few years be-
fore the attacks, my state had begun to build a
bioterrorism plan. While serving on the Institute
of Medicine’s Bioterrorism and Chemical Pre-
paredness Committee, my eyes opened to the po-
tential threats out there. I worked to ensure that
Maryland was one of the early grantees of the
Centers for Disease Control and Prevention
(CDC) Bioterrorism grants. By mid-2001, we had
already made substantial investments in time,
training, plans, and creating relationships with
law enforcement. We had included the Federal
Bureau of Investigation (FBI) and other law en-
forcement agencies in our plan, mostly, to forge
relationships that would be needed if an attack
took place. I didn’t want us first exchanging busi-
ness cards in the middle of a disaster. We also
identified a “go-to place” for an alternative com-
mand center should we not be able to use our
building. This is where we convened on 9/11 be-
cause no one knew if there were other planes and
there were rumors that any additional planes
might be targeting Baltimore and Annapolis.
After 9/11, we knew we had to be prepared for
another attack. In October, I learned through
the beltway rumor mill about a confirmed case of
anthrax in Washington, D.C. So, I picked up the
phone and called District of Columbia health of-
ficer, Dr. Ivan Walks, and offered our help. I per-
ceived it was his problem, but quickly learned
otherwise. The victim was a Maryland resident
who was hospitalized in Virginia who worked in
Washington, D.C. Clearly this case eclipsed bor-
ders and the entire metropolitan area needed a
coordinated, consistent and coherent response. 
The victim was Thomas L. Morris Jr., a postal
worker whose job was to carry mail from the Brent-
wood facility in Washington, D.C. to Baltimore
Washington International Airport (BWI). At the
time, Brentwood hadn’t been clearly established
as the site where he was exposed — which we refer
to as the powder drop — so we had to quickly de-
termine where he got infected. If he was exposed
at the airport, people all over the country and pos-
sibly the world could have been exposed. 
Working through the night, we began piecing it
together. We determined that the victim primarily
carried mail to an air cargo facility on the outskirts
of BWI and consequently could not have con-
tracted anthrax in the airport. This was a great re-
lief, but it also raised other concerns. If
Brentwood was the most likely place of exposure,
that would mean not only were other workers and
residents at significant risk, but so were other
members of the Washington metropolitan region. 
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In addition, many of Baltimore city’s (and other
Maryland counties) mail came directly (one
“mail stop” away) from the D.C. Brentwood Fa-
cility. Several banks and other businesses were
impacted by this, some having mail rooms with
high speed sorting machines similar to those
used in the Brentwood postal facility. We re-
ceived calls from bankers and others whose em-
ployee’s wouldn’t go near the mail even to
process checks. They needed to know if the mail
was safe. Unfortunately, we didn’t have a good
answer for them, so we ended up conducting a
state wide testing program for business mail
rooms to define our risks and reassure the pub-
lic. Like other public health agencies we tested
all kinds of things, from personal mailboxes to
powders that turned out to be from donuts. 
It was incredibly difficult to allay public fears be-
cause there were few reliable rapid tests for an-
thrax in the environment. In some cases we were
inventing new testing methods based on the best
science we had. We simply didn’t have a lot of
experience with environmental testing under
these conditions and no experience with mass
exposure to anthrax. We got through it, but with
a lot of ingenuity and teamwork. 
Ten years ago, public health workers answered
our nation’s call to action.  Before that, pre-
paredness had not always been considered cen-
tral to our jobs.  Some feel that the added
responsibilities undermine our other important
work.  But in the 21st century, it’s clear that pre-
paredness is an integral and important part of
public health.  It is not an either or thing.  At
the end of the day, preparing for any threat
makes us better prepared for all threats, whether
it’s bioterrorism or a flu pandemic.  
We learned a lot from these attacks. There is no
question that the old Boy Scout motto “be pre-
pared” is still very relevant today, and we are
much better prepared for bioterrorism, pan-
demics and basically any public health emer-
gency. However, I do worry that our short-sighted
zeal for financial solvency is putting our health
preparedness and safety at risk. Simply trading
our long-term health future for short-term fiscal
stability isn’t a reasonable trade off. 
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SUMMARY:  A Decade of Public 
Health Preparedness
Ten years ago, the September 11th and anthrax tragedies clearly demon-strated that the public health system was not prepared for the range of mod-
ern health threats we face.  Since then, significant investments have resulted in the
country being much better prepared to respond to public health emergencies rang-
ing from threats of bioterrorism to major infectious disease outbreaks like a pan-
demic flu or natural disasters like hurricanes, tornadoes, and floods.
For the past eight years, in the annual Ready
or Not? Protecting the Public’s Health from
Diseases, Disasters, and Bioterrorism, TFAH
has documented progress and ongoing vul-
nerabilities in the nation’s ability to respond
to health crises.  The following provides an
overview of key areas of progress, gaps, and
recommendations for America’s public health
preparedness.
Progress In Preparedness Since 2001
Since 2001, major investments in improving pre-
paredness have led to significant improvements in
preparedness planning and coordination; public
health laboratories; vaccine manufacturing; the
Strategic National Stockpile; pharmaceutical and
medical equipment distribution; surveillance;
communications; legal and liability protections; in-
creasing and upgrading staff; and surge capacity.
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Planning and Coordination n In June 2002, Congress passed the Public Health Security and Bioterrorism Response Act 
of 2002, which included cooperative agreement funding support for states around the
country.  In 2006, Congress reauthorized the legislation as the Pandemic and All-Hazards
Preparedness Act (PAHPA) of 2006.
n Homeland Security Presidential Directive (HSPD) 21 was issued in 2007 setting a National
Strategy for Public Health and Medical Preparedness.
n All 50 states and Washington, D.C. completed initial bioterrorism response plans by 
September 2003.
n The federal government created a comprehensive National Strategy for Pandemic 
Influenza, involving all federal agencies and partners within state and local governments,
businesses, and communities around the country — and more than $7 billion was provided
to improve pandemic preparedness in the United States.
n All 50 states and Washington, D.C. developed pandemic flu plans that were reviewed by
HHS before the 2009 outbreak of H1N1.  In 2003, only 13 states had pandemic flu plans.
n 44 states and Washington, D.C. activated their Emergency Operations Center (EOC) a
minimum of two times in a year.***
n 44 states and Washington, D.C. reported that pre-identified staff were able to 
acknowledge notification of emergency exercises or incidents within a target time of 60
minutes at least twice.***
n 48 states and Washington, D.C. developed at least two After-Action Reports/Improvement
Plans within 60 days of an exercise or actual incident.***
n In 2007, all 50 states and Washington, D.C. reported conducting an emergency preparedness
drill or exercise that included both the health department and the National Guard.
MAJOR AREAS OF IMPROVEMENTS
Source:  TFAH’s Ready or Not reports, data from 2003-2010.  **  Source: ASTHO Profile Survey, data from 2010.
*** Source: CDC’s Strengthening the Nation’s Emergency Response State by State Report, data from 2007-08.
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Public Health Laboratories n 47 states report having enough staffing capacity to work five, 12-hour days for six to eight
weeks in response to an infectious disease outbreak, such as novel influenza A H1N1.
n 49 states and Washington, D.C. increased or maintained their Laboratory Response
Network for Chemical Threats (LRN-C) chemical capacity from August 10, 2009 to 
August 9, 2010.  In 2005, only 10 state public health labs had adequate chemical terrorism
response capabilities.
n By 2007, 44 states and Washington, D.C. reported sufficient bio-testing capabilities, an
increase from six in 2003.
n In 2007, only one state and Washington, D.C. reported their labs did not have the capability
to provide 24/7 coverage to analyze samples.
n By 2006, 47 states reported having sufficient numbers of trained scientists to test for 
possible anthrax and plague, an increase from 10 in 2004.
Vaccine Manufacturing n Congress appropriated billions of dollars through Project BioShield and the Biomedical
Advanced Research and Development Authority (BARDA) to invest in vaccine research and
development, but there are still limited financial and business incentives for companies to
pursue research and development.
n BARDA awarded a contract to develop the first cell-based flu vaccine, expected in 2014.
Strategic National n The SNS maintains a variety of critical pharmaceuticals and medical supplies including 
Stockpile (SNS) antibiotics, chemical nerve agent antidotes, antiviral drugs, pain management drugs, 
vaccines for a number of agents, and radiological countermeasures.  The SNS is positioned 
in undisclosed locations throughout the United States and is configured to provide flexible
response strategies.
n In advance of the H1N1 outbreak, the SNS contained pandemic flu countermeasures,
including 50 million antiviral treatment courses, 105.8 million N95 respirator masks, and 
51.7 million surgical masks. 
Pharmaceutical and n All 50 states and Washington, D.C. have adequate plans to receive and distribute supplies 
Medical Equipment from the SNS based on a CDC evaluation of planning and management.  In 2003, only two 
Distribution states had adequate plans according to CDC.
n 47 states and Washington, D.C. increased vaccination rates for seniors against the seasonal
flu from 2008 to 2009.  In 2006, only 38 states increased rates from the year before.
Surveillance n 44 states and Washington, D.C. reported using a disease surveillance system that is compatible
with CDC’s National Electronic Disease Surveillance System (NEDSS), as of 2009.  In 2004, 
only 18 states had disease surveillance systems that were NEDSS-compliant.
n 43 states and Washington, D.C. can send and/or receive electronic health information with
health care providers.**
n 40 states and Washington, D.C. have an electronic surveillance system that can report and
exchange information.**
n 29 states were able to rapidly identify disease-causing E.coli O157:H7 and submit the lab
results in 90 percent of cases within four days.***
n CDC, in partnership with state and local health agencies, was able to provide real-time
summarized daily data for flu surveillance ahead of the second wave of the H1N1 flu outbreak.
MAJOR AREAS OF IMPROVEMENTS
Source:  TFAH’s Ready or Not reports, data from 2003-2010.  **  Source: ASTHO Profile Survey, data from 2010.
*** Source: CDC’s Strengthening the Nation’s Emergency Response State by State Report, data from 2007-08.
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Communications and n 25 states and Washington, D.C. mandate all licensed child care facilities to have 
Community Resiliency a multi-hazard written evacuation and relocation plan.  
n The Pandemic and All-Hazards Preparedness Act and Homeland Security Presidential
Directive-21 make community resiliency a top priority of preparedness.
n The Long-Term Disaster Recovery Group, composed of the Secretaries and Administrators
of more than 20 federal departments, agencies, and offices, was created in 2009 to
strengthen disaster recovery and help communities recover more quickly and effectively
after emergencies.  
Legal and Liability n Every state had adequate statutory authority to implement a quarantine in response 
Protections to a hypothetical bioterrorism attack as of 2005.
n In 2009, at least 33 states have liability protection for entities or organizations that provide
volunteer assistance during emergencies.
Increasing and Upgrading n All 50 states and Washington, D.C. met three key criteria for the Medical Reserve Corps 
Staff and Volunteer Health (MRC) (having a coordinator, a majority of units in the state meeting incident management 
Responders guidelines, and the majority of units are part of a registry), which is a national network of
community-based groups which engage volunteers to strengthen public health emergency
response and community resilience.  In 2007, 13 states did not meet a minimum threshold
for MRC volunteers for every 100,000 citizens.  In 2008, 16 states did not have MRC
coordinators.
Surge Capacity n In 2002, the National Bioterrorism Hospital Preparedness Program  —  renamed the
Hospital Preparedness Program in 2006  —  was created and has provided around $400
million annually to support hospital preparedness and surge capacity development.  
n In 2009, the Institute of Medicine published Guidance for Establishing Crisis Standards of
Care for Use in Disaster Situations: A Letter Report, which included a five-step process for
emergency planners to follow when developing crisis standards of care.
n An online system for tracking the availability of hospital beds (HAvBED) started in wide 
use in 2009, helping health care systems and regions care for a surge of patients in the 
event of a mass casualty incident. 
MAJOR AREAS OF IMPROVEMENTS
Source:  TFAH’s Ready or Not reports, data from 2003-2010.  **  Source: ASTHO Profile Survey, data from 2010.
*** Source: CDC’s Strengthening the Nation’s Emergency Response State by State Report, data from 2007-08.
The United States often takes a band-aid ap-
proach to public health preparedness.  As new
emergencies and concerns emerge and atten-
tion shifts, it often means resources are diverted
from one pressing priority to another, leaving
other ongoing areas unaddressed.
After September 11th and the anthrax attacks,
the federal government made an unprece-
dented investment to quickly shore up areas of
preparedness, which have led to major im-
provements  —   however, it was not at a suffi-
cient level to backfill long-standing gaps in
infrastructure or update technologies to meet
state-of-the-art standards.
Currently, there is an additional new threat to
preparedness  —  the current economic climate
and budget cuts at the federal, state, and local
level mean that the progress made over the past
decade could be lost.  
Until public health emergency preparedness re-
ceives sufficient and sustained funding, Ameri-
cans will continue to be needlessly at risk for a
range of public health threats.
ONGOING GAPS IN PREPAREDNESS
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A Funding Gap Historically, funding for emergencies is often substandard until there is an actual emergency,
and then there is a call for emergency supplemental support.  This dynamic means the country
is often unprepared to immediately respond during crises.  The current economic difficulties
have meant major cuts in federal, state, and local support for public health and preparedness,
leaving Americans unnecessarily more vulnerable during emergencies.
n State cuts:  33 states cut funding for public health from fiscal year (FY) 2008-2009 to 
2009-2010, 18 of these states cut funding for a second year in a row.  According to the
Center on Budget and Policy Priorities (CBPP), states have experienced overall budgetary
shortfalls of $425 billion since FY 2009.2
n Local cuts:  As of December 2010, approximately 29,000 jobs have been cut from local
public health departments since January 2009 — totaling 19 percent of the local public 
health workforce.3
n Federal cuts:  Since FY 2005, federal support for public health preparedness has also been
cut by 37 percent.4
A Workforce Gap There is already a major shortage of trained public health workers and funded positions.  There are
not enough workers, particularly experts, to effectively respond during public health emergencies.
The United States has 50,000 fewer public health workers than it did 20 years ago, and one-third of
public health workers will be eligible to retire within five years.5,6 As baby boomers begin to 
retire, there is not a new generation of workers being trained to fill the void.  Also, under current
policies and in some cases, public health workers in one area are not allowed to be shifted to help in
other areas, even during emergencies.  The recent budget cuts are intensifying the problem, with a
reduction of 15 percent of the local public health workforce in the past two years, and, at the same
time, health departments around the country are experiencing furloughs or shortened work weeks.  
A Surge Capacity Gap In the event of a major disease outbreak or attack, the health care system is stretched beyond
normal capabilities.  Surge capacity, the ability of the medical system to care for a massive influx of
patients, remains one of the most serious challenges for emergency preparedness.  A large-scale
disaster also requires having enough equipment and appropriate space to treat patients.  There 
are numerous ongoing surge capacity issues around response in primary care settings beyond just
hospitals including crisis of care standards, alternative care sites, coordinating volunteers to help
and providing them with adequate liability protection, and regional coordination.
A Surveillance Gap The United States still lacks an integrated, national approach to biosurveillance — which would
dramatically improve response capabilities ranging from a bioterrorism attack to catastrophic
disasters to contamination of the food supply.  There is not a standardized system using up-to-
date technology, like systems major retail chains use to track inventory and customer patterns.
Currently, there is major variation in how quickly states collect and report data, which 
hampers bioterrorism and disease outbreak identification and control efforts.  
A Gap in Community The ability to work with communities around ways to cope and recover from a disaster or public 
Resiliency Support health emergency is another major challenge for preparedness.  It is particularly difficult to address
the needs of at-risk, special needs, and vulnerable populations, such as children, the elderly, people
with underlying health conditions, and lower-income communities.  The existing gaps in day-to-day
public health departments make it challenging to build and maintain the relationships needed to
identify and work with vulnerable Americans who need the most help during emergencies.
Gaps in Vaccine and The research and development of medical countermeasures — including diagnostics, antiviral 
Pharmaceutical Research, medications, and vaccines — is outdated in the United States, in large part because it is not a 
Development, and particularly profitable venture for pharmaceutical investors.  Project BioShield and the BARDA 
Manufacturing were developed to help spur innovation and investment in medical countermeasures, but, so
far, the result of new, effective products has been limited and we have not created new
platforms for multi-use product development and manufacturing.  The investments made in
vaccine research and development did help lead to the production of a vaccine for the H1N1
flu strain in record time, but manufacturers were only able to produce limited quantities 
by the beginning of the flu season because of limited capacity and reliance on an old and
outdated egg-based production strategy.
MAJOR ONGOING GAPS
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The Goals of 24/7 Public Health Emergency Response Include:
n Rapid detection of and response to emergency disease threats, including those caused by
bioterrorism.
n Intensive investigative capabilities to quickly diagnose an infectious disease outbreak or to identify
the biological or chemical agent used in an attack.
n Surge capacity for mass events, including adequate facilities, equipment, supplies, and trained
health professionals.
nMass containment strategies, including pharmaceuticals needed for antibiotic or antidote
administration and isolation and quarantining when necessary.
n Streamlined and effective communication channels so health workers can swiftly and accurately
communicate with each other, other front line workers, and the public about 1) the nature of an
emergency or attack, 2) the risk of exposure and how to seek treatment when needed, and 3) any
actions they or their families should take to protect themselves.
n Communications must also be able to reach and take into consideration at-risk populations.
n Streamlined and effective evacuation of at-risk populations with special medical needs.
n An informed and involved public that can provide material and moral support to professional
responders, and can render aid when necessary to friends, family, neighbors, and associates.
What it will take to achieve basic levels of preparedness:
n Leadership, planning, and coordination: An established chain-of-command and well defined
roles and responsibilities for seamless operation across different medical and logistical functions and
among federal, state, and local authorities during crisis situations, including police, public safety
officials, and other first responders.
nWell-funded core public health infrastructure:  Basic public health systems and equipment,
including laboratory testing and communications, that keep pace with advances in science and
technology.  
n An expert and fully-staffed workforce: Highly trained and adequate numbers of public health
professionals, including epidemiologists, lab scientists, public health nurses and doctors, and other
experts, in addition to back-up workers for surge capacity needs.
nModernized technology: State-of-the-art laboratory equipment, information collection, and
health tracking systems.
n Rapid development and ability to manufacture vaccines and medications:  A streamlined,
safe, effective system to ensure rapid research and production of medical countermeasures to
protect people for emerging threats.
n Pre-planned, safety-first rapid emergency response capabilities and precautions: Tested
plans and safety precautions to mitigate potential harm to communities, public health professionals,
and first responders.
n Immediate, streamlined communications capabilities: Coordinated, integrated
communications among all parts of the public health system, all frontline responders, and with the
public. Must include back-up systems in the event of power loss or overloaded wireless channels.
WHAT DOES PREPAREDNESS LOOK LIKE?
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The U.S. public health system is responsible for protecting the American people from a range of
potential health threats. 
EXAMPLES OF MAJOR EMERGENCY PUBLIC HEALTH THREATS
Agroterrorism: The “…deliberate introduction of an animal or plant disease with the goal of
generating fear, causing economic losses, and/or undermining stability.”7 Agroterrorism can be
considered a subcategory of “bioterrorism” and foodborne diseases.
Bioterrorism: The intentional or deliberate use of germs, biotoxins, or other biological agents that
cause disease or death in people, animals, or plants. Examples include anthrax, smallpox, botulism,
Salmonella, and E. coli.
Blast Injuries:  Explosions, whether deliberate or accidental, can cause multi-system, life threatening
injuries among individuals and within crowds.  In addition, blunt and penetrating injuries to multiple
organ systems are likely when an explosion occurs and unique injuries to the lungs and central
nervous system occur during explosions.
Chemical terrorism: The deliberate use of chemical agents, such as poisonous gases, arsenic, or
pesticides that have toxic effects on people, animals, or plants in order to cause illness or death.
Examples include ricin, sarin, and mustard gas. 
Chemical incidents and accidents: The non-deliberate exposure of humans to harmful chemical
agents, with similar outcomes to chemical terrorism.
Food-borne diseases:  Food-borne illness is caused by harmful bacteria, viruses, parasites or
chemicals that are found in food and beverages and enter the body through the gastrointestinal tract.
The Centers for Disease Control and Prevention (CDC) estimates there are approximately 76 million
pathogen-induced cases of food-borne diseases each year in the United States, causing approximately
325,000 hospitalizations and 5,000 deaths.  Examples include botulism, Salmonella, E.coli 0157:H7,
shigella, and norovirus.
Natural disasters: Harm can be inflicted during and after natural disasters, which can lead to
contaminated water, shortages of food and water, loss of shelter, and the disruption of regular health
care. Examples include hurricanes, earthquakes, tornados, mudslides, fires, and tsunamis.
Pandemic flu: A novel, potentially lethal strain of the influenza against which humans have no natural
immunity. The H1N1 flu was the first pandemic flu of the 21st century.  Historically, pandemic flu
occurs two to three times every hundred years or so.  In the 20th century the world experienced the
1918, 1957/58, and 1968 pandemic flu, although the severity of the disease varied greatly among them.
Radiological threats: Intentional or accidental exposure to radiological material. For example, a
terrorist attack could involve the scattering of radioactive materials through the use of explosives
(“dirty bomb”), the destruction of a nuclear facility, the introduction of radioactive material into a
food or water supply, or the explosion of a nuclear device near a population center.
Vector-borne diseases: Diseases spread by vectors, such as insects. Examples include Rocky
Mountain spotted fever and malaria.  
Water-borne diseases: Diseases spread by contaminated drinking water or recreational water, such as
typhoid fever and cholera.  According to CDC, more than 1,000 persons become ill from contaminated
drinking water and more than 2,500 persons become ill from recreational water disease outbreaks
annually in the United States.8
Zoonotic/Animal-borne diseases: Animal diseases that can spread to humans and, in some cases,
become contagious from human to human. Examples include Avian flu, West Nile virus, and SARS.  In
2000, the World Health Organization (WHO) identified more than 200 diseases occurring in humans
that were known to be transmitted through animals.9 Experts believe that the increased emergence
of zoonotic diseases worldwide can be attributed to population displacement, urbanization and
crowding, deforestation, and globalization of the food supply. 
ALL-HAZARDS APPROACH TO EMERGENCY PUBLIC HEALTH THREATS
ENDNOTES
1 Mitroff, Ian. Crisis Leadership: Planning for the Unthink-
able. Wiley, 2003.
2 McNichol E., et al.  States Continue to Feel Recession’s Im-
pact.  Washington, D.C.: Center on Budget and Policy
Priorities,  October 2010.  http://www.cbpp.org/
files/9-8-08sfp.pdf (accessed November 15, 2010). 
3 National Association of County & City Health Offi-
cials. Local Health Department Job Losses and Program
Cuts: Findings from January 2011 Survey and 2010 Na-
tional Profile Study. Washington, D.C.: National Associ-
ation of County & City Health Officials, June 2011.
http://www.naccho.org/topics/infrastructure/lhd-
budget/loader.cfm?csModule=security/getfile&PageI
D=197485  (accessed June 22, 2011).
4 Adjusting for inflation.
5 Association of the Schools of Public Health.  Con-
fronting the Public Health Workforce Crisis: ASPH State-
ment on the Public Health Workforce.  Washington, D.C.:
Association of Schools of Public Health, 2008. 
6  Association of State and Territorial Health Officers.
2007 State Public Health Workforce Survey Results. Ar-
lington, VA:  Association of State and Territorial
Health Officers, 2007.  
7 Monke J. Agroterrorism: Threats and Preparedness. Wash-
ington, D.C.: Congressional Research Service, 2004.
8 Blackburn BG, et al. “Surveillance for Waterborne
Disease Outbreaks Associated with Drinking Water
—  United States, 2001-2002.” Morbidity and Mortality
Weekly 53, (SS08), 23-45, October 22, 2004.
9 Ellis K. “One Health Initiative Will Unite Veterinary,
Human Medicine: Experts Urge Collaboration Be-
tween Veterinarians, Physicians in Wake Of Emerging
Zoonotic Diseases, Potential Epidemics.” Infectious
Disease News. February 2008. http://www.infectious-
diseasenews.com/200802/veterinary.asp (accessed
July 15, 2008).
89
1730 M Street, NW, Suite 900
Washington, DC  20036
(t) 202-223-9870
(f) 202-223-9871
